Yaya tsawon lokacin da waɗannan alamun suka kasance?
Kuma musamman ma a cikin mutanen da suka kai shekarunka, duk wani ciwon kirji da ya faru ya kamata a bi da shi a wannan hanyar.
Da kuma zazzaɓin da yake a cikinsa.
Kuma a gwada yawan ƙwayar cholesterol da jini da ke jikinka
Kuma kana da zazzabi a yanzu?
Kuma yanzu, kuna jin wannan ciwon a kirjinku?
Ƙari ga haka, shin kuna da matsalar numfashi?
Za ka iya gaya mini wasu alamun da ke nuna cewa kana da ciwon?
Kuma yawan zafin jikinka
Ina da ciwon tari.
Ina da ɗan sanyi da kuma tari.
Kuma ina da ciwon kirji mai tsanani a kirji a yau.
Kuma wannan ne lokacin da ya dace da zazzabin hay
Kuma yana da zafi a kirji.
Kuma ina tsammanin ina da ɗan zazzabi.
Kuma ina so ku nuna mana inda ciwon ya ke a kirjinku.
Kuma sunã da wata azãba mai tsanani.
da kuma tarihin ciwon sukari da kake da shi
Kuma ina so in gaya muku cewa abin da nake ji kamar an nausa mini kirji ne.
Kuma ina son in gaya muku cewa mutane suna yawan zagina
Kuma kuna jin ciwon kirji a cikin kirjinku.
Kuma kun ce yana da matsin lamba a cikin kirjinku.
Kowa a cikin iyalin yana da ciwon zuciya, ciwon zuciya, bugun zuciya, yawan hawan jini, hawan jini
Shin akwai wasu alamun da ke tattare da ciwon tsoka?
Shin akwai wasu da ke da ciwon nan a cikin gidanku da suke da irin wannan ciwon?
Shin kana da wata alama?
Shin numfashinka yana da ƙarfi?
Shin har yanzu kuna jin zafi a cikin kirji?
Domin lokacin mura ne.
Amma kuma, kada mu ware ciwon kirji daga zuciya.
Amma, wata matsala da ta fi muhimmanci yanzu ita ce ciwon kirji.
Amma ina da matsalar numfashi.
Amma na san cewa mutane da yawa suna raina ni
Amma muna bukatar mu ɗauki dukan ciwon da ke damun mu da muhimmanci.
Amma kana da numfashin da ya dace a yanzu?
Wannan ciwon kirji ya sa na manta da kome.
Shin yana jin kamar wani yana matse kirjinka?
Shin har yanzu kuna jin numfashin ku?
Shin suna da irin wannan rashin lafiya?
Kuna da wata cuta mai ciwo kamar hawan jini ko wani abu makamancin haka?
Kuna da wasu cututtuka na kullum kamar su ciwon sukari?
Kuna da matsalar numfashi da ciwon kirji?
Shin kana da cutar hawan jini?
Shin kana da wasu matsaloli na numfashi da ke tattare da wannan?
Ka san abin da alamun cutarsa suke?
Shin kuna ganin hoton?
Ka sha ruwa mai yawa a yau.
Amma, ina yin gwajin ciwon sukari.
Ko da yake alamun cutarsa kamar nawa ne.
Yaya zafin jikinka yake?
Yaya karfin jininka yake?
Idan zafin jikinka yana da tsanani sosai
Idan zafin jikinka ya kai ɗigo ɗari biyu ko fiye da haka
Idan ka ga cewa wata alama ko matsala tana bukatar kulawa sosai
Na yi zazzabi a jiya.
Na yi zazzaɓi kaɗan.
Na yi zafin jiki a jiya.
Ina da ciwo mai tsanani a kirji a nan.
Ina da ɗan wahalar numfashi.
Zan aika muku da hoton.
Ina jin ɗan ciwo a kirji yau
Ina da ɗan ciwon kai da zazzaɓi a yau.
Ina ganin dai cutar ne.
Ina ganin kamar dai wannan ne kawai.
Kamar wani mutum mai nauyi a kan kirjinka?
Ya fara da ciwon kai da zazzabi.
Yana sa ni jin zafi a tsakiyar kirji na.
Yana kama da ciwon kirji.
Yana cikin ƙirjina.
Yana tsakiyar kirji na.
Yana tsakiyar kirjin.
Ina jin zafi a kirji.
Ina jin tsananin damuwa game da wannan ciwon a kirji.
Ina so ku yi mini bayani dalla - dalla game da wannan ciwon kirji.
kamar su hauhawar jini ko ciwon sukari
Kamar a tsakiyar kirji.
Yanzu, don zafin zafin za ku iya shan wani takkipirina
Yanzu Maryamu, tun yaushe ne kake da wannan alamun?
Yanzu kun ce kuna jin ciwon kirji.
Wani lokaci ina jin wani ciwo a kirji.
To, shin akwai wata alama da ke nuna cewa ba ka jin zafi?
Ko kuma kana jin kamar wani yana zaune a ƙirjinka?
Ya yi kama da zazzabi da kuma tari da ciwon kai da kuma tsoka.
A tsakiyar ƙirjina
Ka nuna mini hoton da ke nuna inda kake jin zafi
Tun da yake kana da zazzabi
To, kuna tsammanin wasu daga cikin waɗannan alamun na iya zama da alaƙa da yin ciki?
Don haka yaranku suna nuna wasu alamun?
Ka gaya mini game da ciwon da ke cikin kirjinka
Zafin jiki yana ƙaruwa da dare
Ina da zazzabi da nake da shi a kwana biyu da suka wuce
Zafin ya fara tashi a daren jiya.
Ni ne Dr. Porter a cikin dakin gwaje-gwaje na asibitin gaggawa.
Za ku iya gaya mani game da ciwon da ke cikin kirjinku?
Ina jin ciwo a kirji a gaba na.
Ina da ciwo mai tsanani a cikin kirji na.
A lokacin da nake jin ciwon kirji a kirji
Wace irin ciwo ce a kirjinka?
Yaushe ne ciwon kirjin ya fara?
A ina ne ƙwanƙanin zuciyarka yake?
A ina kuke jin wannan ciwon a kirji?
Za ka ji wani abu a ƙirjinka.
Ina so in gaya muku cewa ina da ciwon sukari.
Ka ce kana da ciwon kirji.
Babban hauhawar cutar cutar Coronavirus (COVID-19) a cikin Tarayyar Turai / Yankin Tattalin Arzikin Turai da Burtaniya, daga 1 ga Janairu zuwa 15 ga Maris, 2020
Yawan adadin masu kamuwa da cutar coronavirus (COVID-19) ya nuna irin wannan yanayin a cikin kasashen EU/EEA da kuma United Kingdom wanda ya tabbatar da cewa annobar COVID-19 tana tashi cikin sauri a duk ƙasashe, yayin da take da matakai daban-daban dangane da ƙasa.
Dangane da gogewa daga Italiya, ya kamata ƙasashe, asibitoci da rukunin kulawa mai tsanani su haɓaka shirye-shiryen su don saurin karuwar marasa lafiya na COVID-19 waɗanda za su buƙaci kulawar lafiya, musamman kulawa mai tsanani.
A ranar 31 ga Disamba, 2019, an ba da rahoton rukunin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka da ba a sani ba a Wuhan, lardin Hubei, China.
A ranar 9 ga watan Janairun 2020 ne Cibiyar Kula da Cututtuka ta China ta sanar da cewa cutar ta Coronavirus, wadda yanzu ake kira da cutar ta SARS-CoV-2 ta zama mai haddasa cutar.
Tun daga wannan lokacin, cutar da SARS-CoV-2 ke haifarwa an sake masa suna Coronavirus Disease (COVID-19).
Shaidar da ke akwai a yau ita ce, kashi 80% na mutanen da ke da COVID-19 suna da cutar mai laushi, wato cututtukan numfashi tare da ko ba tare da cutar nimoniya ba kuma yawancin waɗannan suna warkewa.
A cikin kashi 14 cikin dari na shari'o'in, COVID-19 ya zama mafi munin cuta wanda ke buƙatar asibiti yayin da sauran kashi 6 cikin ɗari na shari'o'in suna da mummunan cuta wanda ke buƙatar kulawa mai tsanani.
Halin mutuwar da aka yi wa marasa lafiya da aka kwantar da su a asibiti sakamakon COVID-19 ya kai kusan kashi 4 cikin ɗari.
A cikin wannan binciken, mun bincika yanayin yanayin cutar COVID-19 a kowace ƙasa a cikin EU / EEA da United Kingdom (UK) kuma mun kwatanta shi da lardin Hubei, China.
Mun kuma kwatanta adadin COVID-19 na yanzu a cikin ƙasashen EU/EEA da UK da Italiya a lokacin 31 ga Janairu-15 ga Maris, 2020.
COVID-19 a cikin ƙasashen EU/EEA da UK
Bayan China, COVID-19 ya ci gaba da samun ci gaba ta hanyar yanayin ƙasa kuma a halin yanzu, cutar ta COVID-19 ta kasance mafi girma a duniya.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
An ba da rahoton farkon shari'o'in COVID-19 na Turai da aka tabbatar da farko bisa ga ma'anar shari'ar WHO a cikin fitowar 5 ga Maris, 2020 na Eurosurveillance, Spiteri et al.
A cikin EU/EEA, Faransa ta ba da rahoton farkon kamuwa da cutar guda uku da aka tabbatar a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China a ranar 24 ga Janairu, 2020.
Har zuwa ranar 15 ga Maris, 2020, an sami masu cutar COVID-19 a cikin ƙasashe 30 na EU/EEA da United Kingdom (UK), tare da 39,768 da mutuwar 1,771 da aka ruwaito tsakanin 31 ga Disamba, 2019 da wannan ranar, tare da 17,750 da mutuwar 1,441 daga Italiya kawai.
Samun adadin adadin COVID-19 da kuma adadin adadin cutar
A cikin Cibiyar Kula da Cututtuka ta Turai (ECDC), ana sabunta adadin COVID-19 da aka ruwaito daga kowace ƙasa a duniya daga tushe na hukuma kamar ma'aikatun kiwon lafiya na ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki da WHO a kowace rana a 8:00 na safe.
An yi amfani da wannan bayanan don tantance yanayin COVID-19 a cikin EU / EEA da UK da kuma kwatanta shi da Italiya.
A matsayin wakili na yaduwar COVID-19 na aiki, mun lissafa taƙaitaccen adadin adadin COVID-19 na kwanaki 14 a cikin kowane EU/EEA da UK a cikin yanayin yanayin COVID-19 na yau da kullun a cikin Janairu 1 - Maris 15, 2020.
Mun kuma nuna adadin adadin wadanda aka samu a kowace kasa da karfe 8:00 na safiyar 15 ga watan Maris 2020 idan aka kwatanta da Italiya a cikin lokacin 31 ga Janairu - 15 ga Maris 2020.
Yanayin COVID-19 a cikin ƙasashen EU / EEA da UK
Yanayin gajerun kwanaki 14 na karuwar yaduwar cutar COVID-19 a cikin ƙasashen EU/EEA da UK gabaɗaya ya bi lardin Hubei (China) (Fig. 1).
A cikin EU/EEA da kuma UK baki ɗaya, jimillar annobar COVID-19 ta fara ƙaruwa a ranar 21 ga Fabrairu, kuma ta yi saurin ƙaruwa a ranar 28 ga Fabrairu, 2020 (Karin bayani).
Wannan ya kasance ne saboda karuwar yawan karuwar da aka samu a Italiya, amma duk sauran ƙasashen EU/EEA da UK sun ga irin wannan karuwar a cikin tarin cutar COVID-19 (Matakan kari).
Hoto na 2 ya nuna jimillar adadin masu kamuwa da COVID-19 a cikin EU/EEA da UK idan aka kwatanta da Italiya a cikin lokacin 31 ga Janairu - 15 ga Maris 2020.
Wannan ya nuna musamman cewa a ranar 15 ga Maris da karfe 8:00 na safe, sauran ƙasashe 15 na EU/EEA da UK sun riga sun ba da rahoton jimillar adadin masu cutar kwatankwacin na Italiya makonni 3 da suka gabata ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin rahoton COVID-19 yana ƙaruwa cikin sauri a cikin EU/EEA da UK.
Abubuwan da aka lura a cikin tarin tarin COVID-19 ya nuna cewa cutar tana ƙaruwa da sauri a cikin dukkan ƙasashe.
Wannan ya faru ne duk da cewa kasashe suna cikin matakai daban-daban, bambance-bambance a cikin martani na lafiyar jama'a na ƙasa da ƙila ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyar ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyar ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyar ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddunƙun ƙayyar ƙididdiga.
A farkon Maris 2020, likitoci a yankunan da cutar ta shafa a Italiya sun ba da rahoton cewa kashi 10% na marasa lafiya na COVID-19 suna buƙatar kulawa mai tsanani kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da rukunin kulawa mai tsanani a waɗannan yankuna sun riga sun kai iyakar ƙarfin su.
A halin yanzu ana samun bayanai ne kawai a matakin EU/EEA na asibiti da/ko kuma shiga cikin ICU na COVID-19 da suka kai kashi 6% da 1% na masu cutar (ba a nuna adadi ba).
Koyaya, yakamata a tattara su a cikin tsari mai ɗorewa don haɓaka ƙididdigar sa ido na yanzu wanda ke mai da hankali kan adadin shari'o'in da aka ruwaito da yawan mutuwar.
Binciken da aka yi a shekara ta 2010-11 ya nuna cewa akwai bambanci mai yawa a cikin gadaje na kulawa mai tsanani da gadaje na kulawa a Turai daga gadaje 29.2 a Jamus zuwa 4.2 a Portugal a kowace yawan jama'a 100,000.
Wannan yana nufin cewa ƙasashe na iya samun ƙarin ko ƙarancin albarkatu fiye da na Italiya (12.5 na kula da kulawa mai tsanani da gadaje na kulawa na matsakaici a kowace yawan jama'a 100,000 a cikin 2010 - 11).
Samun damar COVID-19 na asibiti da ke da alaƙa da 90% na haɗarin ƙarfin gado na ICU an samar da shi a cikin sabuntawa na shida na ECDC na ƙididdigar haɗarin haɗarin haɗari akan COVID-19 tare da ƙididdigar ƙarfin ƙarfin kiwon lafiya na kowace EU/EEA da UK.
Tun da yake har yanzu ana samun tarin cututtuka a cikin ƙasashen EU/EEA da kuma wasu yankuna na UK, kuma asibitoci da kuma rukunin kula da masu tsananin rauni suna ba da sabis ga jama'a na yanki da aka ƙayyade, ya kamata a samar da bayanai game da cututtuka da gadaje a matakin Nomenclature of Territorial Units for Statistics 2 (NUTS-2).
Kwarewar da aka samu daga Italiya da kuma yanayin da ake ciki a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ƙara yin tsanani a cikin EU/EEA da UK.
Kasashe, asibitoci da kuma cibiyoyin kulawa mai zurfi dole ne su shirya kansu don ci gaba da yaduwar SARS-CoV-2 a cikin al'umma da kuma karuwar yawan masu fama da COVID-19 da ke buƙatar kulawa ta kiwon lafiya, musamman a yankunan da ke fama da cutar kamar Italiya.
Kamar yadda aka nuna a cikin sabon binciken ECDC na saurin haɗarin haɗari, tare da sauya ra'ayi daga iyakancewa zuwa ragewa, ana buƙatar saurin, mai saurin aiki da kuma daidaitawa don rage saurin yaduwar SARS-CoV-2, saboda idan ba a aiwatar da shi a kan lokaci ba, ƙaruwar saurin da ake tsammani a cikin lamuran lamuran na iya ba da isasshen lokacin da masu yanke shawara da asibitoci za su fahimta, yarda da daidaita martani daidai.
Binciken haɗarin gaggawa ya kuma lissafa matakan kiwon lafiyar jama'a don magance tasirin cutar.
Kasashe suna da 'yan damar da za su iya kara inganta kokarin da suke yi na dakile yaduwar SARS-CoV-2 da kuma rage matsin lamba kan kula da lafiya.
Idan hakan ya gaza, akwai yiwuwar tsarin kiwon lafiya na sauran EU/EEA zai fuskanci karuwar masu bukatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar cutar Coronavirus 2019 (COVID-19) da ke haifar da cutar sankarar huhu mai tsanani (SARS) Coronavirus 2 (SARS-CoV-2) ya yi sanadiyyar mutuwar mutane sama da 3,000 zuwa yanzu kuma sama da 80,000 sun kamu a China da sauran wurare a duniya, sakamakon hakan ya haifar da bala'i ga mutane.
Kamar dai kwayar cutar SARS-CoV, wadda ta haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 na iya zama mai yaduwa daga bats kuma yana haifar da irin wannan alamun ta hanyar aiki iri ɗaya.
Ko da yake, COVID-19 yana da ƙananan ƙwarewa da mutuwa fiye da SARS, amma yana da saurin yaduwa kuma yana shafar tsofaffi fiye da matasa da maza fiye da mata.
Dangane da yawan adadin wallafe - wallafe kan cututtukan da ke fitowa, wannan labarin yana ƙoƙari ya ba da cikakken bayani game da batun bincike mai saurin ci gaba.
Za mu haɗa da abubuwan da suka shafi ilimin cututtuka, ilimin cututtuka, ilimin ƙwayoyin cuta, bincike, magani, tsinkaya da kuma rigakafin cutar.
Ko da yake akwai tambayoyi da yawa da za a amsa, muna fatan wannan bita zai taimaka wajen fahimtar cutar da kuma kawar da ita.
Sanadiyar barkewar cutar kwayar cutar, bikin bazara a ranar 25 ga Janairu, 2020 ya zama abin mamaki da ba za a iya mantawa da shi ba ga duk Sinawa da aka nemi su zauna a gida a duk lokacin hutun da kuma makonni da yawa bayan haka.
Kwayar cutar ta yi kama da kwayar cutar coronavirus (CoV) wacce ta haifar da barkewar cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka (SARS) a cikin 2003; Saboda haka, a ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya (WHO) ta ba shi suna SARS-CoV-2 kuma ta ba da sunan cutar da ke da alaƙa da CoV Disease-19 (COVID-19).
Cutar ta fara ne a Wuhan, China kuma ta yadu cikin sauri a duk faɗin ƙasar da kuma kusan ƙasashe 50 na duniya.
Ya zuwa 2 ga Maris 2020, an sami fiye da 80,000 da aka tabbatar da cutar COVID-19 tare da fiye da 40,000 marasa lafiya da aka sallama daga asibiti saboda cutar da kuma fiye da 3,000 marasa lafiya da suka mutu.
WHO ta yi gargadin cewa COVID-19 na iya zama babban abokin gaba na 1, kuma mai yiwuwa ya fi ƙarfin ta'addanci.
A cikin ƙasa da watanni biyu bayan rahoton farko a ranar 7 ga Janairu, 2020, an buga sama da labarai 200 kan COVID-19, gami da virology, epidemiology, epidemiology, causology, diagnostics, da treatments, don ware marasa lafiya da yawa da kuma tsara jerin ƙwayoyin cuta, in ji PubMed (https://www.ncbi.nlm.nih.gov/pubmed/).
Wannan bita yana ƙoƙarin taƙaita ci gaban bincike a kan sabon da kuma saurin ci gaban fannin.
A duk lokacin da zai yiwu, za mu yi kokarin gwada COVID-19 da SARS da CoV da kuma cututtukan da ke haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka na MERS (MERS, 2012).
Za mu tattauna abin da muka koya a yanzu game da rigakafi da kuma tsinkaya da kuma wasu tambayoyi da suka rage, amma kuma masu muhimmanci.
CoVs an saba da su a matsayin marasa cutarwa ga mutane, tare da haifar da kusan 15% na sanyi na yau da kullun 4.
Koyaya, a cikin wannan ƙarni mun fuskanci mutum CoVs masu saurin kamuwa da cuta sau biyu, wato, SARS-CoV da MERS-CoV, waɗanda suka fara bulla a China a 2003 da Saudi Arabia a 2012 kuma suka bazu cikin wasu ƙasashe da yawa cikin sauri tare da mummunan rashin lafiya da mutuwa.
Don haka, COVID-19 na yanzu shine barkewar cutar ta uku a cikin tarihin ɗan adam.
Kamar yadda aka nuna a Hoto na 1.1, an fara samun tarin cutar nimoniya, wanda ba a san asalinsa ba, daga Wuhan zuwa Hukumar Lafiya ta Kasa ta China a ranar 31 ga Disamba, 2019.
An saki jerin CoVs bayan kwana bakwai.
An ba da rahoton shari'ar farko daga Wuhan a ranar 15 ga Janairu, 2020.
A wannan lokacin, cutar ta yadu cikin sauri zuwa birane, larduna da ƙasashe masu kusa.
A ranar 20 ga Janairu, masu kula da lafiya sun ba da rahoton kamuwa da cutar, wanda ya nuna cewa yiwuwar watsawar mutum zuwa mutum yana yiwuwa.
A ranar 23 ga watan Janairu, an rufe garin Wuhan tare da rufe dukkan zirga-zirgar jama'a.
A ranar 24 ga Janairu, an ba da rahoton binciken farko na asibiti kan cutar cewa daga cikin mutane 41 da aka tabbatar da cutar, 21 ne kawai ke da alaƙa kai tsaye da kasuwar abincin teku a Wuhan, wanda ake tsammanin shine asalin kamuwa da cutar daga wani tushen kwayar halitta da ba a sani ba.
A ranar 30 ga Janairu, WHO ta ayyana barkewar cutar a matsayin bala'in lafiyar duniya.
A lokacin wannan rahoto, cutar ta riga ta yadu a duk faɗin China da kuma kusan wasu ƙasashe 50 na duniya (Hotuna (Hotuna 2). 2).
Tun da yanayin yana kara tsanantawa, ba a tantance ainihin girman da kuma tsananin cutar ba.
A cikin binciken da aka yi na cibiyoyin cibiyoyin da aka yi na marasa lafiya 8,866, ciki har da 4,021 da aka tabbatar da COVID-19 a ranar 11 ga Fabrairu, 2020 an sami ƙarin hoto na yau da kullun game da cutar ta hanyar (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane na kowane zamani, amma galibi masu shekaru 30-65.
Kusan rabin (47.7%) na mutanen da suka kamu da cutar sun kasance sama da shekaru 50, kaɗan suna ƙasa da shekaru 20, kuma 14 ne kawai ke ƙasa da shekaru 10.
Maza sun kamu da SARS-CoV-2 fiye da mata (0.27/100,000) fiye da maza (0.31/100,000).
COVID-19 ya bazu ne a cikin garken dabbobi da kewayen Hubei.
COVID-19 ya ɗauki matsakaicin kwanaki 5 (2-9) daga farawa zuwa ganewar asali.
Matsakaicin lokacin shiryawa ya kasance 4. 8 (3. 0 - 7. 2) days.
Matsakaicin lokacin daga farawa zuwa mutuwa ya kai kwanaki 9. 5 (4. 8 - 13).
Ƙididdigar asali (R0) ita ce 3. 77 (95% CI: 3. 51 - 4. 05) kuma an daidaita R0 zuwa 2. 23 - 4. 82.
Yawan mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, wanda ya yi daidai da yawan zirga-zirgar ababen hawa kafin bikin bazara a China.
Yawan mutuwar marasa lafiya da aka tabbatar da cutar ya kai kashi 1.44% (95% CI: 1.10-1.86%) da kuma yawan mutuwar marasa lafiya da aka tabbatar da cutar ya kai kashi 3.06% (95% CI: 2.02-4.59%).
Babban haɗarin COVID-19 guda uku sune jinsi (maza), shekaru (≥60), da kuma cutar nimoniya mai tsanani.
CoVs wani iyali ne na manyan ƙwayoyin cuta da ke da RNA guda ɗaya.
Za a iya rarraba su zuwa rukuni huɗu, wato, alpha, beta, gamma da delta daga waɗanda aka san cewa alpha da beta-CoVs suna iya cutar mutane.
Glycoprotein na murfin (S) yana haɗuwa da mai karɓar angiotensin-converting enzyme 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) a cikin SARS-CoV da MERS-CoV bi da bi sannan kuma yana haɗuwa da membrane.
Kwayar RNA genome an kwance shi a cikin kwayar halitta; bayan kwayar kwayar kwayar kwayar kwayar kwayar cuta ta ninka, ta yi kwayar RNA mai dauke da kwayar kwayar cuta tare da glycoproteins da nucleocapsid proteins, wanda daga baya ya haɗu a cikin membrane na plasma don kwance kwayar cutar.
An ba da rahoton farkon jerin kwayoyin halittar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV tare da fiye da 99.98% na kwayoyin halitta a cikin samfuran 10 da aka tsara waɗanda aka tattara daga kasuwar abincin teku ta Huanan a Wuhan, asalin barkewar.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV ta hanyar kwayar halitta.
An gano SARS-CoV-2 a cikin sassan da ba su da isasshen iskar gas na jikin mutum ta hanyar daukar kwayar cutar ta hanyar daukar kwayar lantarki.
An gano mai karɓar mai karɓa don SARS-CoV tare da ACE2 ɗan adam, SARS-CoV-2.
Koyaya, furotin S na SARS-CoV-2 yana haɗuwa da ACE2 na ɗan adam tare da mafi ƙarancin ƙarfi fiye da SARS-CoV wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da ƙananan cututtukan cututtuka a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya yin sabon kwayar halitta mai suna orf3b da kuma kwayar halitta mai suna orf8.
orf3b na SARS-CoV-2 na iya taka rawa a cikin cututtukan ƙwayoyin cuta kuma yana hana bayyanar IFNβ; kodayake orf8 ba shi da wani sanannen yanki ko sifa.
A ranar 18 ga Fabrairu, 2020, Zhou, et al. sun ba da rahoton tsarin cryo-EM na cikakken tsayin mutum ACE2 a cikin cakuda tare da amino acid mai ɗaukar B0AT1 a ƙuduri na 2.9 Å.
Sun gano cewa cakuda, wanda ke dauke da bude da kuma rufe, an hada shi a matsayin dimer kuma cakuda ACE2-B0AT1 na iya hada sunadarin S guda biyu wanda ke ba da shaida ga ganewar CoV da kamuwa da cutar.
B0AT1 na iya zama wata manufa ta magani don gwajin magani don hana kamuwa da SARS-CoV-2.
Na farko da kuma na tsakiya
An san cewa SARS-CoV da MERS-CoV duka sun samo asali ne daga barbashi kuma an watsa su cikin mutane ta hanyar kuli da raƙumi bi da bi.
Ta hanyar kwatanta SARS-CoV-2 da sauran CoVs, an gano cewa bat shine asalin kwayar cutar SARS-CoV-2 saboda sabon kwayar cutar yana da kwatankwacin 96% na CoVs biyu masu kama da SARS-like da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, ba a san ko wane matsakaiciyar abinci ya taimaka wa kwayar cutar ta ƙetare shingen jinsin ta kamu da mutum ba kuma har yanzu ana nan ana binciken hanyar watsawa.
Ji, et al., sun ba da shawarar cewa maciji zai iya ɗauke da kwayar cutar daga barasar zuwa mutum, wanda ya haɗa da irin wannan recombination tare da furotin S.
A wani binciken, masu bincike a Guangzhou, China sun nuna cewa pangolins - dabbobi masu dogon hanci, masu cin tururuwa da ake yawan amfani da su a maganin gargajiya na kasar Sin - sune masu yiwuwar shiga tsakanin SARS-CoV-2 bisa ga kamannin kwayoyin 99% da aka samu a cikin SARS-CoV-2 da CoV da aka samu a cikin pangolin.
Duk da haka, yaduwar bambancin 1% a cikin dukkanin kwayoyin halittar biyu har yanzu babban bambanci ne; sabili da haka, sakamakon sakamako yana jiran tabbataccen shaida (Fig. (Fig. 33)).
Abubuwan da ke cikin SARS-CoV-2 ba a san su ba tukuna.
SARS-CoV da MERS-CoV na iya rayuwa har zuwa kwanaki 5 a cikin yanayin bushewar kewaye na 48 a ƙarƙashin 20 °C da zafi 40% - 50%.
SARS-CoV-2 na iya samun irin wannan halayen.
An ba da rahoton cewa SARS-CoV-2, yana da ƙarfin jiki na 56 °C na minti 30 kuma yana da saukin kamuwa da hasken ultraviolet; ether, 75% ethanol, maganin kashe kwayoyin cuta mai dauke da chlorine, paracic acid, chloroform da sauran masu narkar da kitse na iya kashe kwayar cutar, amma ba chlorhexidine ba.
Gabaɗaya, yawan mutanen da ke da cikakkiyar rigakafi ga SARS-CoV-2 kuma saboda haka suna iya kamuwa da cutar.
A halin yanzu, babu wani cikakken bincike da aka bayar game da amsar rigakafi ga SARS-CoV-2.
Saboda haka, za mu iya kawai yin la'akari da nazarin da aka yi a baya na sauran CoVs, musamman SARS-CoV da MERS-CoV (Fig. 4).
A yadda aka saba, bayan kwayar cutar ta shiga cikin mai karɓar, ana fara gane ta ta hanyar tsarin rigakafin ƙwayar cuta na mai karɓar, wanda ya haɗa da masu karɓar ƙwayar cuta na C - irin, masu karɓar ƙwayar cuta na Toll (TLR), NOD-like receptor (NLR), da masu karɓar ƙwayar cuta na RIG-I-like (RLR).
Ta hanyoyi daban -daban, kwayar cutar tana haifar da bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan, balaga na ƙwayoyin dendritic da kuma samar da nau'in I na interferon (IFNs) wanda ke iyakance yaduwar kwayar cutar da kuma hanzarta fasogogin macrosophagic na ƙwayoyin cuta na kwayar cuta.
Koyaya, furotin N na SARS-CoV na iya taimakawa kwayar cutar don guje wa amsawar rigakafi.
Ba da daɗewa ba, an daidaita tsarin garkuwar jiki don yaƙi da ƙwayoyin cuta.
Kwayoyin T lymphocyte, ciki har da CD4 + da CD8 + T cells, suna da muhimmiyar rawa wajen karewa.
Kwayoyin CD4+ T suna motsa B-cells don samar da ƙwayoyin cuta na musamman na ƙwayoyin cuta kuma CD8+ T suna kashe ƙwayoyin cuta na ƙwayoyin cuta kai tsaye.
T-helper cells suna samar da cytokines masu taimakawa don taimakawa sel masu kare.
Koyaya, CoVs na iya hana ayyukan T ta hanyar kashe kwayoyin T.
Har ila yau, rigakafin triad, tare da kari da rigakafi kamar C3a da C5a, suna da mahimmanci don yaƙi da kamuwa da cutar ƙwayoyin cuta.
Misali, rigakafin da aka ware daga mai cutar da aka warke ya kashe MERS-CoV.
A wani ɓangaren kuma, yawan amsawar da tsarin garkuwar jiki yake yi yana haifar da yawan adadin ƙwayoyin cuta da ke fitowa a cikin jiki wanda zai iya haifar da mummunar illa ga huhu da sauran gabobin jiki, kuma a mafi munin yanayi, rashin iya aiki da yawa da mutuwa.
Cutar SARS-CoV-2 da ke nuna farawar garken, na iya shafar tsofaffi da mata masu juna biyu.
A yau da kullum, mutanen da suka kamu da ƙwayoyin cuta da yawa ko kuma waɗanda ke da haɗin kai na rigakafi sun fi kamuwa da cutar.
Dangane da nazarin shari'o'i 425 na farko a Wuhan, an kiyasta matsakaicin lokacin shiryawa na SARS-CoV-2 ya kasance kwanaki 1-14, mafi yawa kwanaki 3-7.
Koyaya, nazarin shari'o'in 1,099 ya nuna cewa lokacin shiryawa ya kasance kwanaki 3 a matsakaici kuma ya kasance tsakanin kwanaki 0 zuwa 24.
Kamar yadda aka ambata a sama, binciken da aka yi kwanan nan bisa ga yanayin yanayin 8,866 ya nuna cewa lokacin ƙwanƙwasawa ya kasance kwanaki 4.8 (3.0-7.2).
Daidaita lokacin keɓewa mai tasiri dangane da lokacin da ya fi dacewa da ke cikin jiki kuma don haka hana masu cutar amma marasa cutar watsa kwayar cutar ga wasu mutane yana da mahimmanci ga hukumomin kiwon lafiya.
A matsayinka na al'ada, mutanen da suka kamu da cutar ko suka kamu da ita suna bukatar su kasance a killace na tsawon kwanaki 14.
Shin ya kamata a tsawaita lokacin killacewa zuwa kwanaki 24?
Zazzabi shine mafi yawan alamun farko na COVID-19 wanda ba zai iya haɗuwa da alamun bayyanar cututtuka ba ko kuma ya haɗa da wasu alamun kamar tari mai bushewa, rashin numfashi, ciwon tsoka, dizziness, ciwon kai, ciwon makogwaro, hanci, ciwon kirji, zawo, tashin zuciya, da amai.
Wasu marasa lafiya sun sami matsalar numfashi da / ko hypoxemia a cikin mako guda bayan fara cutar.
A cikin mawuyacin hali, marasa lafiya sun sami saurin haɓaka ci gaban cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka, cututtukan cututtukan cututtukan cututtuka, cututtukan cututtukan cututtukan cututtukan cututtuka, cututtukan cututtuka, cututtuka na cututtuka, cututtuka na cututtuka, cututtuka na cututtuka, cututtuka na cututtuka na cututtuka, cututtuka na cututtuka na cututtuka.
Dole ne a gwada masu cutar don gano cutar a cikin lokaci, musamman ma marasa lafiya da zazzabi mai tsanani da kuma alamun cututtukan numfashi, ba tare da alamun cutar numfashi ba.
A ƙarshen Disambar 2019, nazarin yanayin al'umma ya nuna cewa yawan alamun cutar ya kai kashi 98 cikin ɗari na zazzabi, kashi 76 cikin ɗari na tari mai bushe, kashi 55 cikin ɗari na rashin numfashi da kashi 3 cikin ɗari na zawo; 8% na marasa lafiya sun buƙaci taimakon iska.
Binciken kwanan nan guda biyu na garken garken da ke haifar da cutar ta hanyar watsawa daga garken iyali da kuma marasa lafiya sun ba da rahoton irin wannan binciken.
Idan aka kwatanta, binciken alƙaluma na 2012 ya nuna cewa zazzabi (98%), tari mai laushi (47%) da kuma rashin numfashi (55%) sune manyan alamomin cutar a cikin marasa lafiyar MERS-CoV.
Koyaya, fiye da COVID-19, 80% na marasa lafiya sun buƙaci taimakon iska kuma wannan ya yi daidai da yawan mutuwar MERS fiye da COVID-19.
An kuma lura da zawo (26%) da kuma ciwon makogwaro (21%) a cikin marasa lafiyar MERS.
A cikin masu cutar SARS, an lura da zazzabi (99-100%), tari mai bushe (29%-75%), wahalar numfashi (40%-42%), zawo (20-25%) da kuma ciwon makogwaro (13-25%) sune manyan alamun bayyanar kuma kusan 14% -20% na marasa lafiya suna buƙatar taimakon iska.
Yawan mutuwar COVID-19 ya kai kashi 2 cikin dari har zuwa ranar 14 ga Fabrairu, lokacin da aka tabbatar da adadin masu kamuwa da cutar a duniya ya kai 66,576.
Don kwatantawa, mutuwar SARS har zuwa Nuwamba 2002 ya kai kashi 10% na 8,096 da aka tabbatar.
Ga MERS, yawan mutuwar ya kai kashi 37 cikin dari na mutane 2,494 da aka tabbatar da cutar, bisa ga binciken da aka yi a watan Yuni na 2012.
Nazarin farko ya ba da rahoton cewa R0 na SARS-CoV-2 ya kasance 6.47 tare da tazarar amincewa kashi 95% (CI) na 5.71-7.23 yayin da R0 na SARS-CoV ya kasance tsakanin 2 da 4 kawai.
An kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da alamomi, mutuwa da R0 a cikin Table 1.1.
Bayanan da ke sama sun nuna cewa SARS-CoV-2 ya fi MERS-CoV da SARS-CoV yaduwa, amma ba shi da haɗari kamar na biyun.
Saboda haka, sarrafa annobar SARS-CoV-2 ya fi ƙalubale fiye da MERS-CoV da SARS-CoV.
A cikin garke, sukan fara ne da iyali ɗaya ko kuma jama'a ɗaya ko kuma da jirgin ruwa kamar jirgin ruwa.
Yawancin lokaci, masu cutar suna da tarihin tafiya ko zama a Wuhan ko wasu yankuna da abin ya shafa, ko kuma sun yi hulɗa da mutanen da suka kamu da cutar ko kuma masu cutar, a cikin makonni biyu da suka gabata.
Koyaya, an ba da rahoton cewa mutane na iya ɗaukar kwayar cutar ba tare da bayyanar cututtuka ba fiye da makonni biyu kuma marasa lafiya da aka sallama daga asibiti na iya ɗaukar kwayar cutar, wanda ke ba da shawarar tsawaita lokacin keɓewa.
A cikin marasa lafiya na farko, adadin ƙwayoyin farin jini na waje (musamman lymphocytes) na iya zama na al'ada ko kuma ƙarancin.
Misali, an sami lymphopenia tare da ƙididdigar ƙwayoyin lymphocyte 1 × 109 / L da ƙididdigar ƙwayoyin farin jini 4 × 109 / L tare da ƙara matakan aminotransferase na aspartate da toxicosis a cikin marasa lafiya 1,099 na COVID-19.
Wasu marasa lafiya sun sami hawan jini na enzymes na hanta da tsoka da myoglobin kuma yawancin marasa lafiya sun sami hawan jini na furotin C-reactive da kuma ragewa na erythrocyte.
A cikin marasa lafiya masu tsananin ciwo, matakan D - dimer, wani abu da ke tattare da lalacewar fibrin a cikin jini, ya ƙaru kuma adadin ƙwayoyin lymphatic ya ragu.
Yawancin marasa lafiya na COVID-19 suna da alamun rashin daidaituwa a cikin radiography na kirji kuma an nuna su ta hanyar hotuna masu ɗumbin ido ko kuma ƙarancin gilashin ƙasa a cikin huhu.
Marasa lafiya sukan kamu da cutar huhu, cutar huhu mai tsanani, da kuma cutar numfashi mai tsanani (ARDS).
Lokacin da ARDS ta faru, gas ta yi musayar da ta yi musayar da ta yi daidai da rashin tsari, tarin jini da kuma ci gaba da fibrosis.
Rashin aiki na nau 'in I da II na pneumocytes yana rage matakin aiki na surface da kuma ƙara matsin lamba, don haka rage ƙarfin huhu da kuma ƙara haɗarin ƙuntataccen aiki na huhu.
Saboda haka, mafi munin sakamakon binciken radiyo na kirji sau da yawa yakan yi daidai da mafi munin yanayin cutar.
A cikin bincike na farko na bincike kan COVID-19 a ranar 18 ga Fabrairu, 2020 an ga raguwar ƙwayoyin cuta a cikin huhu na mai cutar da ya mutu, samuwar membrane na Halin da leakage na lymphatic, da kuma ƙwayoyin polynuclear polynuclear waɗanda suka dace da ilimin kwayar cutar kwayar cutar da ARDS kuma sun yi kama da na SARS da MERS.
An yi amfani da binciken SARS-CoV-2 RNA ta hanyar maganin rikodin-transcriptase polymerase chain reaction (RT-PCR) a matsayin babban ma'auni don tantance COVID-19.
Koyaya, saboda babban mummunan mummunan sakamako, wanda zai iya haifar da cutar, an fara amfani da shi a cikin China don gano bayyanar cututtukan asibiti (wanda ba ya dogara da RT-PCR kawai) a ranar 13 ga Fabrairu 2020.
Haka kuma ya faru da cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, binciken dakin gwaje - gwaje da binciken rediyo yana da mahimmanci kuma ya zama dole don yin ingantaccen bincike.
A ranar 14 ga Fabrairu, 2020, Feng Zheng Group ya ba da rahoton wata yarjejeniya ta amfani da fasahar CRISPR-based SHERLOCK don gano SARS-CoV-2, wanda ke gano sassan SARS-CoV-2 RNA na wucin gadi a 20 × 10-18 mol/L (kwayoyi 10-100 a kowace microliter na shigarwa) zuwa 200 × 10-18 mol/L (kwafin 10-18 mol/L na shigarwa) ta amfani da dipsticks, ba tare da buƙatar kayan aiki mai yawa ba.
Idan an tabbatar da shi a cikin gwajin asibiti, ana fatan cewa sabuwar fasahar za ta iya haɓaka ƙwarewa da sauƙin amfani.
Saboda rashin ƙwarewa tare da sabon CoV, likitoci na iya ba da kulawa mai taimako ga marasa lafiya na COVID-19 tare da gwada magunguna daban-daban da aka yi amfani da su a baya ko aka ba da shawarar don magance wasu CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta (Table (Table 2).2).
Wadannan jiyya sun hada da magungunan da ake yi da kuma wadanda ake iya yi da maganin rigakafi, maganin rigakafi, magungunan steroid, plasma daga marasa lafiya da suka warke, maganin magungunan Sinadarin, da kuma taimakon masu halin kirki.
An kuma ba da shawarar amfani da plasma daga marasa lafiya da suka warke.
Kamfanonin harhada magunguna suna ta fafatawa don samar da rigakafi da allurar rigakafi ga cutar.
SARS-CoV-2 da farko yana mamaye huhu ne kuma mai yiwuwa a ƙaramin iyaka zuwa wasu gabobin da ke bayyana ACE2 kamar su tsarin gastrointestinal da na koda.
Duk da haka, rashin numfashi da rashin nasara na ci gaba da zama babban haɗari ga marasa lafiya kuma babban dalilin mutuwa ne.
Saboda haka, taimakon numfashi yana da mahimmanci don kawar da alamun cutar da ceton rai kuma ya haɗa da maganin oxygen na yau da kullun, oxygen mai gudana mai yawa, ba da iska mai shiga ciki da kuma iska mai shiga ciki, dangane da tsananin cutar.
Marasa lafiya da ke da alamun cututtukan numfashi masu tsanani ana iya taimaka musu ta hanyar amfani da ECMO, ingantaccen hanyar da ake amfani da ita wajen magance cututtukan zuciya da ke da haɗari ko kuma rashin numfashi.
Hakanan, kula da daidaiton electrolyte, hanawa da kuma kula da cututtukan cututtukan biyu da raunin da ke tattare da cutar ta septic, da kuma kare ayyukan gabobin jiki masu mahimmanci suna da mahimmanci ga marasa lafiya na SARS-CoV-2.
An san cewa guguwar cytokine tana haifar da matsanancin martani na tsarin rigakafi a cikin marasa lafiya na SARS da MERS.
Cytocin Storm wani nau 'in martani ne na tsarin kumburi wanda ke nuna sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, and MCP-1.
Waɗannan suna motsa ƙwayoyin rigakafi don sakin adadi mai yawa na ƙwayoyin cytocin da ke cikin ƙwayoyin cuta waɗanda ke da alhakin ARDS da kuma haifar da rashin ƙarfi na gabobin jiki da yawa.
Yin rigakafin rigakafin yana da mahimmanci a cikin maganin guguwar cytokine, musamman a cikin marasa lafiya masu tsanani.
Corticosteroids da tosilisumab, IL6- hanawa monoclonal immunosuppressants, an yi amfani da su don magance cytocin guguwa.
Sauran hanyoyin magance rigakafin cutar cytokine sun haɗa da sauyawar T-cell da ke jagorantar amsawar rigakafi; hana IFN-γ, IL-1, da TNF; hana JAK; blinatumob; hana siginar cytokine 4; da masu hana HDAC.
An yi amfani da steroid a matsayin mai hana garkuwar jiki, a maganin SARS don rage tsananin lalacewar ƙwayar cuta.
Koyaya, yawan maganin steroid bai taimaka ba a cikin mummunan lalacewar huhu a cikin marasa lafiyar SARS da COVID-19.
Maimakon haka, suna iya shafan ganewar asali, suna iya haifar da mummunan sakamako masu illa, musamman ma rashin jijiyoyin jini.
Duk da haka, ana ba da shawarar yin amfani da gajeren gajere na corticosteroids a ƙananan zuwa matsakaici a hankali a cikin marasa lafiya marasa lafiya COVID-19.
A lokacin da ake rubutu, babu wani maganin da aka tabbatar yana da inganci.
Koyaya, an gano Remdesivir, analog na nucleotide, wanda aka ba da shi cikin jijiya, yana da tasiri a cikin wani mai haƙuri na Amurka da ke da COVID-19.
Remdesivir wani sabon maganin ne da kamfanin Gilead ya samar don magance cututtukan da ake samu daga cutar Ebola da kuma Malburg.
Daga baya, an kuma nuna yiwuwar hana sauran kwayoyin RNA masu kama da juna, ciki har da MERS da SARS.
Dangane da wannan, Gilead ya samar da sinadarin ga China don gudanar da gwaje-gwaje biyu akan mutanen da ke da cutar SARS-CoV-2 kuma ana tsammanin sakamakon.
Bugu da ƙari, an ba da shawarar baricitinib, interferon-α, iodopinavir / ritonavir, da ribavirin a matsayin yiwuwar magani ga marasa lafiya da ke fama da cututtukan cututtukan numfashi.
Diarrhoea, maƙarƙashiya, tashin zuciya, lalacewar hanta da sauran halayen rashin kyau na iya faruwa bayan an haɗa iopainavir/ ritonavir.
Dole ne a lura da hulɗar da magungunan da aka yi amfani da su a cikin marasa lafiya.
Plasma da kuma samar da antibodies daga warke marasa lafiya.
Akwai dogon tarihi na tattara jini daga marasa lafiya da suka warke daga wata cuta don a iya magance wasu marasa lafiya da ke da cutar ko kuma a hana lafiyayyun mutane kamuwa da cutar.
A gaskiya, jinin da aka warkar yana da matakan rigakafi masu yawa ga cutar.
Immunoglobulin (Ig) shine kwayar cutar da kwayar B lymphocytes ke samarwa don yaƙi kwayar cuta da sauran abubuwan da ke waje kuma suna gano kwayoyin da ke cikin kwayar cuta kuma suna kashe su kai tsaye.
Dangane da wannan, an tattara plasma daga jinin ƙungiyar marasa lafiya waɗanda suka warke daga COVID-19 kuma an ba da su ga marasa lafiya 10 masu rauni.
Alamominsa sun inganta cikin sa'o'i 24 tare da rage kumburi da nauyin ƙwayoyin cuta da ingantaccen oxygen saturation a cikin jini.
Duk da haka, ana bukatar a tabbatar da kuma bayyana hanyoyin don a yi amfani da su a kan babban taro, har sai an samu maganin da aka ƙayyade.
Bugu da ƙari, duk da tasirin magani, wasu lahani da ke tattare da plasma ya kamata a yi la'akari da su a hankali.
Alal misali, kwayoyin za su iya sa rigakafin jiki ya yi aiki sosai kuma ya sa mutum ya kamu da cuta mai suna cytokine release syndrome, wadda za ta iya sa mutum ya mutu.
Yawan kwayar cutar ta immunoglobulin a cikin jini yana da ƙananan, kuma ana buƙatar plasma don kula da marasa lafiya masu tsanani.
Yana da wuya a samar da takamaiman maganin da sauri don yaƙi da annobar duniya.
Saboda haka, yana da mahimmanci da amfani a ware ƙwayoyin B daga marasa lafiya da suka warke kuma a gano lambar kwayar halitta da ke ƙunshe da ƙwayoyin cuta masu tasiri ko kuma a bincika ƙwayoyin cuta masu tasiri ga sunadarai masu mahimmanci na kwayar cutar.
Ta haka ne, za mu iya ƙara yawan allurar rigakafin da sauri.
An yi amfani da TCM don magance cututtuka da yawa a cikin China na dubban shekaru.
Koyaya, tasirinsa ya dogara ne akan haɗuwa da abubuwa daban -daban a cikin tsari daban -daban dangane da ganewar cutar dangane da ƙa'idodin TCM.
Yawancin abubuwan da ke da tasiri har yanzu ba a san su ba ko kuma ba su da amfani saboda yana da wuya a gano da kuma tabbatar da irin waɗannan abubuwan ko kuma mafi kyawun haɗuwa.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, TCM ya zama ɗayan manyan hanyoyin magani na madadin ga marasa lafiya waɗanda ke da alamu masu laushi ko waɗanda suka warke daga mawuyacin yanayi.
Misali, Shu Feng Ji Du Capsules da Lian Hua Qing Wen Capsules an gano su masu tasiri don magance COVID-19.
Yawancin lardunan China da ke amfani da TCM sun ga mafi yawan dawowar farfadowa daga COVID-19 a cikin marasa lafiya 87% da suka yi amfani da TCM, gami da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei inda kawai kusan 30% na COVID-19 marasa lafiya suka yi amfani da TCM, suna da ƙarancin dawowar farfadowa (13%).
Koyaya, wannan kwatanci ne mai yawa saboda dole ne a haɗa wasu abubuwan tasiri, kamar yawan marasa lafiya da tsananin cutar, a cikin kimantawa.
A ranar 18 ga Fabrairu 2020, Bole Zheng da abokan aikinsa sun wallafa wani bincike da ya kwatanta maganin maganin yammacin duniya (WM) da kuma maganin da aka hada da WM da TCM.
Sun gano cewa lokacin da za a iya samun zafin jiki na al'ada, bayyanar cututtuka da kuma buƙatar asibiti a cikin rukunin WM + TCM ya kasance ƙasa da ƙasa da na ƙungiyar WM kawai.
Mafi mahimmanci, yawan cutarwa na cutarwa (mai saurin zuwa mai tsanani) ya kasance mafi ƙanƙanta a cikin rukunin WM + TCM fiye da rukunin WM kawai (7.4% vs 46.2%) da kuma mutuwar ya kasance mafi ƙanƙanta a cikin rukunin WM + TCM fiye da rukunin WM kawai (8.8% vs 39%).
Duk da haka, ana jiran ƙarin gwaji da aka sarrafa a manyan wurare da kuma a cikin cibiyoyi da yawa don tabbatar da inganci da amincin TCM.
Zai zama mai ban sha'awa don gano tsarin aiki da kuma bayyana ingantattun abubuwan haɗin TCM ko haɗuwa da su idan zai yiwu.
Masu cutar da ake zargi ko aka tabbatar sun kamu da COVID-19 suna fuskantar babban fargaba daga cutar mai saurin yaduwa da kuma kisa, kuma mutanen da aka killace suna fuskantar rashin kwanciyar hankali, kadaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzaɓi, rashin isasshen ruwa da tari, da kuma mummunan tasirin magani kamar rashin bacci da corticosteroids ke haifarwa, na iya haifar da rashin barci, tashin hankali da kuma ciwon hankali.
A farkon barkewar cutar SARS, an samu rahotannin cututtukan halayyar mutum da dama, da suka hada da ci gaba da damuwa, rashin kwanciyar hankali, tashin hankali, tashin hankali, alamun hauka, hallucinations, har da kashe kansa.
Binciken tuntuɓar da ake buƙata da keɓewa a matsayin wani ɓangare na martani na lafiyar jama'a na COVID-19 na iya sa mutane su zama masu damuwa da damuwa game da tasirin cutar, keɓewa da kuma tasirin abin kunya ga danginsu da abokansu.
Don haka, ya kamata a ba da kulawar lafiyar kwakwalwa ga marasa lafiya na COVID-19, waɗanda ake zargi da cutar, da kuma waɗanda suka zo wajan su, da kuma ga jama'a.
Tallafin kwakwalwa ya kamata ya haɗa da kafa ƙungiyoyin kiwon lafiya na kwakwalwa da yawa, sadarwa a bayyane tare da sabuntawa na yau da kullun da kuma daidai game da barkewar cutar ta SARS-CoV-2 da shirye-shiryen magani da amfani da na'urorin lantarki na ƙwararru da aikace-aikace don kauce wa kusanci da juna.
Ana buƙatar allurar rigakafi mai tasiri don hana yaduwar ƙwayoyin cuta daga ƙwayoyin dabbobi da mutane masu ƙwayoyin cuta masu saurin kamuwa da cuta kuma sau da yawa suna taimakawa maganin rigakafin cutar a cikin yaɗuwar ƙwayoyin cuta.
An yi ƙoƙari don haɓaka alluran rigakafin S-protein don samar da rigakafi na dindindin da mai ƙarfi da kuma / ko kariya ga SARS-CoV.
An yi nazarin alluran rigakafin da aka haifa a cikin kwayar SARS.
Koyaya, tasirin waɗannan alluran rigakafin masu zuwa a cikin tsofaffi da kuma ƙwayoyin cuta masu haɗari da kariya daga kamuwa da cutar kwayar cutar zoonotic har yanzu za a iya tantance su kafin fara kowane binciken asibiti.
Wannan na iya kasancewa saboda SARS ya ƙare a hankali shekaru 17 da suka gabata kuma ba a sami sabon labarin ba tun daga lokacin.
Akasin haka, a wurare da yawa, bazuwar MERS da garkunan da ke faruwa a yankin Gabas ta Tsakiya suna ci gaba da tasowa kuma suna yaduwa zuwa wasu yankuna saboda kasancewar tushen zoonotic a yankunan da ke fama da cutar.
An haɓaka dabarun rigakafin MERS ta amfani da ƙwayoyin cuta masu aiki, DNA plasmids, masu ɗaukar hoto na kwayar cuta, nanoparticles, ƙwayoyin cuta masu kama da ƙwayoyin cuta da kuma subunits na sunadarai masu haɗuwa kuma an kimanta wasu a cikin ƙwayoyin cuta.
Haɓaka ingantaccen allurar rigakafi mai aminci da inganci ga SARS-CoV-2 ga mutanen da ba su da rigakafi, yana da mahimmanci kuma babban aiki ne don magance cutar.
Koyaya, ƙalubalen da ake fuskanta saboda tsayi da ake buƙata (a matsakaita watanni 18) a cikin haɓaka allurar rigakafi da kuma bambancin canjin yanayin CoVs suna da ƙalubale.
A matsayin sabon cuta, COVID-19 kwanan nan ya fara bayyana cikakkiyar tsarin bincikensa a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya suna samun sauƙi ba tare da alamun wasu cututtuka ba.
Koyaya, kamar SARS da MERS, COVID-19 yana da alaƙa da cutar mai saurin kamuwa da cutar da yawan mace - macen marasa lafiya.
Saboda haka, ya zama wajibi ga hukumomin kiwon lafiya su kirkiri tsarin bincike domin saita fifiko ga ayyukan su, musamman a yankunan da ke da karancin albarkatu.
Dangane da nazarin asibiti da aka kawo yanzu, abubuwan da ke ƙasa na iya shafar ko alaƙa da cutar COVID-19 (Table (Table 33)):
Shekaru: Shekaru shine mafi mahimmancin mahimmanci don ganewar SARS, wanda yake daidai da COVID-19.
A cikin nazarin shari'o'i 8,866, COVID-19 ya faru ne da farko a cikin shekaru 30-65, daga cikinsu 47.7% na marasa lafiya sun kasance sama da shekaru 50, kamar yadda aka bayyana a sama.
Marasa lafiyar da ke buƙatar kulawa mai ƙarfi sun fi fuskantar cututtuka da rikitarwa kuma sun tsufa sosai fiye da waɗanda ba sa buƙatar haka (a kan matsakaicin shekaru 51 da 66), wanda ke nuna cewa shekaru ya zama babban abin da ke haifar da sakamakon marasa lafiyar COVID-19.
JIND: Maza sun fi kamuwa da SARS-CoV-2 fiye da mata (0.31 / 100,000 vs 0.27 / 100,000), kamar yadda aka nuna a sama.
Abubuwa da matsaloli: Marasa lafiyar COVID-19 da ke buƙatar kulawa mai tsanani suna da haɗarin kamuwa da mummunan rauni na zuciya da kuma rashin lafiya.
Hatsarin zuciya shi ne ya fi kashe mutanen da suka kamu da cutar SARS.
An bayar da rahoton cewa SARS-CoV-2 na iya haɗuwa da collagenosytes masu inganci na ACE2 wanda zai iya haifar da cutar hanta a cikin marasa lafiya na COVID-19.
Yana da kyau a lura cewa shekaru da kuma rashin lafiya suna da alaƙa mai zurfi kuma suna iya tsoma baki da juna.
Abun da ba a saba gani ba: Matakin C-Reactive Protein (CRP) a cikin jini yana nuna tsananin kumburin ko lalacewar nama kuma an ba da shawarar a matsayin mai yiwuwa mai faɗi na cutar, amsawa ga magani da kuma warkewa na ƙarshe.
An kuma ba da shawarar alaƙar CRP da ƙimar COVID-19 da kuma yanayin cutar.
Hakanan, ƙaruwa a cikin lactate hydrogenesis (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT) da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Ana bayyana waɗannan enzymes a cikin gabobin jiki da yawa, musamman a cikin zuciya da hanta, kuma ana sakin su yayin lalacewar kyallen takarda.
Saboda haka, alamun na nuna cututtukan zuciya ne ko na hanta.
Babban alamun asibiti: Radiography na kirji tare da sauran matsalolin da ci gaban alamun asibiti dole ne a yi la'akari da su don hasashen sakamakon COVID-19 da rikitarwa.
Yin amfani da magungunan steroid: Kamar yadda aka ambata a baya, magungunan steroid sune magungunan rigakafin da ake amfani da su a matsayin maganin rigakafi a cututtukan cututtuka, don rage munin cutar da ta haifar.
Tun da aka yi amfani da allurai masu yawa na corticosteroids a cikin marasa lafiya masu tsanani na SARS, yawancin waɗanda suka tsira sun kamu da cutar ta non-vascular osteoporosis tare da nakasa rayuwa da ƙarancin ingancin rayuwa.
Saboda haka, ya kamata a yi amfani da steroid a marasa lafiya da ke da COVID-19 a ƙananan allurai da kuma gajere, idan ya zama dole.
Tashin hankali: Kamar yadda aka ambata a sama, marasa lafiya da yawa sun sha wahala daga matsanancin damuwa yayin barkewar COVID-19, saboda sun sha jimre wa tsawan lokacin keɓewa da matsanancin rashin tabbas da kuma shaidar mutuwar dangi da abokan asibiti.
Ba da shawara na tunani da kuma tallafi na dogon lokaci yana da muhimmanci don taimakawa waɗannan mutane su fita daga damuwa kuma su koma rayuwa ta al'ada.
Dangane da nazarin yanayin jama'a da aka gudanar, COVID-19 yana nuna halaye na cututtukan cututtukan cuta daban da na SARS.
Tare da yin kwafi a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 na iya yin kwafi a cikin hanyoyin numfashi na sama kuma yana haifar da alamu masu sauƙi ko babu alamun cutar a farkon kamuwa da cuta kamar sauran CoVs masu saurin sanyi.
Saboda haka, marasa lafiya da suka kamu da cutar na iya haifar da babban adadin kwayar cutar yayin ayyukan yau da kullun a farkon matakan ko lokacin ɓoyewa, yana haifar da babban wahala a cikin kula da cutar.
Koyaya, an yi imanin cewa SARS-CoV ya yadu lokacin da marasa lafiya ke da rashin lafiya, yayin da yawancin cututtuka ba su faru ba a farkon farkon.
Saboda haka, cutar COVID-19 da ke faruwa a yanzu ta fi na SARS tsanani da kuma wahalar sarrafawa.
A halin yanzu, manyan ayyuka suna gudana a cikin China, gami da kulle-kulle a Wuhan da biranen da ke kewaye da kuma ci gaba da keɓe kusan dukkanin jama'a, tare da fatan hana yaduwar SARS-CoV-2.
Duk da cewa waɗannan matakan suna lalata tattalin arziki da sauran sassan ƙasar, yawan sabbin marasa lafiya yana raguwa, yana nuna alamun annobar ta ragu.
Hasashen da ya fi dacewa shi ne cewa barkewar cutar za ta ƙare a ƙarshen Maris kuma za ta ci gaba da kasancewa cikin watanni 3-4.
Amma, wasu masana ba su da wannan ra'ayin.
Paul Hunter, et al., sun yi hasashen cewa COVID-19, wanda ya bayyana da cutar fiye da SARS, ba zai ƙare a 2020 ba.
Ira Longini, et al., sun kafa samfurin don yin hasashen sakamakon annobar kuma sun nuna cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Kungiyar Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin mid-turbinet da kuma makogwaron makogwaron marasa lafiya da aka warke kuma aka sallama su a asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zama mai maimaitawa kamar cutar mura.
Koyaya, akwai alamun da ke nuna alamar daga China dangane da raguwar sabbin lamura, wanda ke nuna cewa dabarun na yanzu na iya aiki.
Da farko an yi hasashen cewa akwai mutane miliyan daya da suka kamu da cutar Ebola da kuma mutuwar mutane rabin miliyan.
Duk da haka, ta hanyar tsananin keɓewa da keɓewa, cutar ta ƙarshe ta sami iko.
Yana yiwuwa cewa kamar SARS-CoV, SARS-CoV-2 zai iya zama mai rauni a cikin kwayar cutar kuma a ƙarshe ya mutu ko kuma ya zama ɗan kwayar cutar cuta mai ƙarancin cuta wanda ke rayuwa tare da mutane.
An kwatanta COVID-19 da SARS da MERS kamar yadda aka nuna a ƙasa (Hotuna (Hoto na 55)).
SARS-CoV-2 kuma yana iya yaduwa ta hanyar yin tari ko hancin kai da kuma hulɗa kai tsaye da abubuwan da ke dauke da kwayar cutar.
An kuma gano kwayar cutar a cikin fitsari, wanda hakan ya haifar da sabon damar watsawa ta baki ta hanyar fitsari.
Wani binciken da aka yi kwanan nan na mutane 138 ya ba da rahoton cewa kashi 41 cikin 100 na wadanda suka kamu da cutar, ciki har da marasa lafiya 17 da ke da wasu cututtuka, da kuma masu ba da lafiya 40, wataƙila sun kamu da cutar a asibiti.
Saboda haka, dole ne a yi taka tsantsan wajen kare mutane, musamman ma masu ba da kiwon lafiya, ma'aikatan zamantakewa, 'yan uwa, abokan aiki da marasa lafiya, da kuma mutanen da ke tsaye kusa da su ko kuma waɗanda ke da cutar.
Layin farko na kariya wanda za'a iya amfani dashi don rage haɗarin kamuwa da cuta shine sanya abin rufe fuska; amfani da abin rufe fuska na tiyata da abin rufe numfashi na N95 (series # 1860s) na taimakawa wajen sarrafa yaduwar kwayar cutar.
Abin da ake kira masks na fuska yana hana ruwa daga saukowa daga mutum mai cutar zuwa cikin iska ko kuma a kan abubuwa, inda za su iya zuwa wasu.
Koyaya, tare da kawai 5% na virion da za a iya wucewa gaba ɗaya, kawai N95 (jerin # 1860s) masks na iya hana virion ƙanana kamar 10 zuwa 80 nm daga shiga cikin numfashi; SARS-CoV-2 yayi kama da SARS-CoV a cikin girma kuma duka suna kusan 85 nm.
Tun da yake ƙwayoyin za su iya wucewa har zuwa masks guda biyar da aka ɗora a kan juna, masu ba da kula da lafiya waɗanda ke da alaƙa kai tsaye da marasa lafiya dole ne su sa N95 (jerin # 1860s) masks, amma ba masks na tiyata ba.
Tare da abin rufe fuska, masu ba da kiwon lafiya ya kamata su sa rigunan keɓewa don ƙara rage hulɗa da ƙwayoyin cuta.
Ƙwayoyin cuta suna iya cutar da mutum ta idanu.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2, duk da cewa yana sanye da abin rufe fuska na N95; ƙila kwayar cutar ta shiga cikin jiki ta idanunsa masu ƙonewa.
Saboda haka, masu ba da kiwon lafiya ya kamata su sa abin rufe fuska ko tabarau masu haske sa'ad da suke aiki da marasa lafiya.
A cikin yankunan da abin ya shafa ko kuma zai iya shafawa, ana ba da shawara ga jama'a da su wanke hannayensu da sabulu mai kashe ƙwayoyin cuta sau da yawa fiye da yadda ya kamata, da kuma ƙoƙarin zama a cikin gida don keɓe kai da kuma iyakance hulɗa da mutanen da za su iya kamuwa da cutar.
An dauki nisan kafa uku ne a matsayin mafi kyau don mutane su nisanci mai cutar.
Waɗannan ayyukan suna da tasiri wajen rage haɗarin kamuwa da cuta da kuma hana yaduwar kwayar cutar.
Ko da yake SARS-CoV-2 ya zo duniya a matsayin sabon kwayar cuta ga 'yan Adam, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, ya kamata ya yi gargadin kasar Sin bisa la'akari da irin yadda ya yi kama da SARS-CoV, bisa la'akari da zurfin ƙwaƙwalwar cutar SARS a 2003.
Sai dai a ranar 19 ga watan Janairun 2020 darekta na cibiyar dakile cututtuka a Wuhan ya yi wa jama'a ta'aziyya da cewa cutar ta Novel tana da karancin yaduwar cutar daga mutum zuwa mutum da iyakantaccen iya haifuwa, kuma babu wata matsala a hana ko rage yaduwar cutar.
Wannan sakon ya kwantar da hankulan jama'a, musamman a lokacin da kasar ke shirin bikin bazara, kuma lokaci ya yi da za a rage yaduwar cutar a Wuhan.
Hukumomin kula da cututtuka a China za su iya koya daga wannan kuma su yi gyara a nan gaba.
Misali, wadannan hukumomin ya kamata (1) su yi taka tsantsan wajen yin sanarwar jama'a saboda kowane kalma yana da mahimmanci ga 'yan ƙasa kuma yana iya canza ra'ayinsu da yanke shawara; (2) ya kamata su zama masu saukin kai da kuma amsawa ga bayanai masu ban mamaki daga dakunan shan magani maimakon jiran sanarwar da aka bayar daga likitoci ko hukumomi; (3) ya kamata a yi ƙarin takunkumi don iyakance yiwuwar barkewar cutar a farkon matakin maimakon ƙoƙarin ta'azantar da jama'a; kuma (4) ci gaba da yin amfani da takamaiman da ingantaccen aiki don haɓaka wayar da kan jama'a game da cutar, kuma a kai a kai bincika da inganta tsarin mayar da martani na jama'a.
Cutar COVID-19 da sabon kwayar cutar SARS-CoV-2 ya haifar ta ɓarke a ƙarshen Disamba 2019.
A kasa da watanni biyu, ya yadu a China da kuma kusan kasashe 50 a duniya a lokacin da ake wannan rubutu.
Tun da yake kwayar cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da COVID-19 da SARS, barkewar COVID-19 ta haifar da maimaita SARS.
Koyaya, akwai wasu bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS, waɗanda suke da mahimmanci don iyakance cutar da kuma kula da marasa lafiya.
COVID-19 ya fi shafar tsofaffi da maza fiye da matasa, da kuma mata fiye da mata, kuma tsufa da mutuwa sun fi ƙarancin shekaru.
Halin SARS ya fi COVID-19 (10.91% da 1.44%) yawan mace-mace.
Masu COVID-19 suna yada kwayar cutar yayin da ba su da alamun cutar, yayin da masu SARS galibi suna yin hakan lokacin da suka kamu da rashin lafiya, wanda ke haifar da ƙalubale wajen iyakance yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana a wani ɓangare dalilin da ya sa SARS-CoV-2 ke yaduwa da sauri da kuma yaduwa fiye da SARS-CoV.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau a cikin wasu marasa lafiyar COVID-19.
A wani bangaren kuma, marasa lafiya da suka warke daga cutar na iya sake samun cutar.
Wadannan binciken suna kara hadarin yaduwar cutar.
Duk da irin wannan saurin ci gaba a cikin bincike kan COVID-19, akwai wasu batutuwa masu mahimmanci da ba a warware su ba, kamar haka:
Daga ina ne SARS-CoV-2 ya fito?
Duk da cewa an gano 96% na kamanceceniyar kwayoyin halitta tsakanin SARS-CoV-2 da CoVs masu kama da SARS-bats, har yanzu ba za mu iya yanke hukuncin cewa SARS-CoV-2 ya fito ne daga bats ba.
A matsayin mai ciyarwa na asali, wane nau'in dabba ne ya kasance tsaka - tsakin watsa kwayar cutar daga bat zuwa ga mutum?
Ba tare da mun gano amsar #1 da 2 ba, ba za mu iya hana yaduwar cutar ba kuma za mu iya sake samun barkewar cutar.
Kodayake an gano SARS-CoV-2 yana haɗuwa da ACE2 a cikin samfurin kwayoyin halitta da gwaje-gwajen biochemical, ta yaya kwayar cutar ke shiga cikin ƙwayoyin iska kuma ta haifar da canje-canje na cututtukan cuta?
Shin kwayar cutar tana ɗaure ga ƙwayoyin cuta na ACE2 a wasu gabobin?
Ba tare da amsoshi masu kyau ga waɗannan tambayoyin ba, ba za mu iya samun saurin ganewar asali da kuma magani mai inganci ba.
Har yaushe ne cutar za ta ci gaba?
Ta yaya kwayar cutar ke bunkasa yayin yaduwa a cikin mutane?
Shin zai zama annoba ta duniya, ya mutu a hankali kamar SARS ko kuma ya sake dawowa lokaci-lokaci kamar mura?
Wannan yana da muhimmanci, amma zai ɗauki lokaci kafin a sami amsoshin tambayoyin da aka ambata a sama da kuma wasu.
Duk da haka, ko da menene farashin, ba mu da wani zaɓi sai dai mu kawo ƙarshen annobar da wuri-wuri kuma mu dawo da rayuwarmu yadda take.
Asalin kwayar halittar mutum
Sabili da canji da kuma dacewa, kwayar cutar Corona (CoVs) da masu ɗaukar nauyinta (ciki har da mutane) sun samo asali tare a cikin dubban shekaru.
Kafin 2003, an san CoVs na mutum guda biyu (HCoVs) da ke haifar da cutar sanyi mai laushi.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka (SARS) da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka (MERS) sun nuna yanayin hallaka da kuma cutar HCoV.
Bayyanar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake dawo da CoVs zuwa haske kuma ya ba mu mamaki tare da ƙarin ƙarfin kamuwa da cuta fiye da ɗan'uwanta SARS-CoV amma rage cutarwa.
HCoVs cuta ne mai zoonotic cuta da kuma fahimtar zoonotic asalin HCoVs zai zama da amfani a gare mu.
Yawancin HCoVs sun samo asali ne daga kwari, waɗanda ba su da cutarwa.
Akwai kuma bayanai game da masu ɗaukar kwayar cutar na tsakiya na wasu HCoVs.
Gano abubuwan da ke gina dabbobi yana da tasiri kai tsaye a cikin rigakafin cututtukan mutane.
Binciken hulɗar CoV-mai gina jiki a cikin dabbobi na iya ba da mahimmin haske game da cutar ta CoV a cikin mutane.
A cikin wannan bita, mun gabatar da bayyani na bayanan yanzu game da HCoVs bakwai, tare da mai da hankali kan tarihin ganowa da kuma asalin asalin da kuma watsawa tsakanin jinsuna.
Abu mai mahimmanci, muna kwatanta da kuma bambanta HCoVs daban-daban ta hanyar juyin halitta da kuma sake fasalin kwayar halittar ƙwayoyin cuta.
Ana tattauna cutar COVID-19 ta yanzu a cikin wannan mahallin.
Hakanan, an nuna mahimmancin maye gurbin abubuwan gina jiki cikin nasara da kuma tasirin ci gaba da kwayar cutar akan tsananin cutar.
Kwayar cutar Corona (CoVs) na cikin dangin coronaviridae wanda ya kunshi gungun kwayar cuta masu dauke da kwayar cuta guda daya mai dauke da kwayar RNA.
Wadannan ƙwayoyin cuta waɗanda ke da mafi girman kwayoyin halittar 26 zuwa 32 kilobases a cikin ƙwayoyin RNA, an sanya su CoVs  saboda kambi-samar da siffa a ƙarƙashin microscope na lantarki.
A tsarin tsari, CoVs suna da kwayoyin halittar da ba su da tsari wanda suke da tsari iri ɗaya.
Kusan kashi biyu bisa uku na kwayoyin halittun suna da manyan bangarori biyu masu karantawa (ORF1a da ORF1b), waɗanda aka canza zuwa pp1a da pp1ab replicase polyproteins.
Ana sarrafa polyprotein ɗin don samar da sunadarai 16 marasa tsari da ake kira nsp1 ~ 16.
Sauran ɓangaren kwayoyin halittar suna da ORFs don sunadarai masu tsari, ciki har da spike (S), envelope (E), membrane (M) da nucleoprotein (N).
Hakanan akwai furotin masu taimakawa na musamman na asali waɗanda ke yin lamba ta hanyar jinsi daban-daban na CoVs.
Dangane da bambancin jerin sunayen sunadarai, CoVs an rarraba su zuwa tsararraki huɗu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), daga cikinsu, beta-CoVs sune mafi yawan HCoVs kuma an rarraba su zuwa jerin sunayen (A, B, C da D).
Shaidar genealogical ta nuna cewa bat da mussel sune mafi yawan al'adun Alpha-CoVs da Beta-CoVs, yayin da tsuntsaye sune mafi yawan al'adun gamma-CoVs da Delta-CoVs.
A cikin shekaru dubbai, CoVs sun ci gaba da ƙetare shingen jinsin kuma sun fito a matsayin wasu mahimman ƙwayoyin cuta na ɗan adam.
Zuwa yau, an san CoVs na mutum bakwai (HCoVs).
HCoV-229E da HCoV-NL63 alpha-CoVs suna cikin su.
Sauran beta-CoV guda biyar sun haɗa da HCoV-OC43, HCoV-HKU1, Cutar cututtukan cututtukan cututtukan cututtuka na cututtuka na cututtuka (SARS-CoV), Cutar cututtukan cututtuka na Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 galibi suna haifar da alamomi masu laushi kamar sanyi da/ko zawo.
Akasin haka, SARS-CoV, MERS-CoV da sabuwar da aka gano SARS-CoV-2, suna da cutarwa sosai, suna haifar da cututtukan ƙananan hanyoyin numfashi masu tsanani a cikin marasa lafiya da yawa tare da yiwuwar bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka (ARDS) da kuma bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka.
An ware HCoV-229E na farko, B814 daga hancin marasa lafiya da suka kamu da mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin bayani ta hanyar nazarin HCoV-229E da HCoV-OC43, duka biyun suna haifar da alamun ƙuntatawa.
A zahiri, har zuwa barkewar SARS, an yarda da ra'ayi cewa kamuwa da HCoVs yawanci ba shi da lahani.
Cutar SARS a 2003 ta kasance daya daga cikin mafi yawan barkewar cutar a tarihin yanzu, inda ta kamu da mutane sama da 8,000 tare da yawan mutuwar marasa lafiya da kusan 10%.
Shekaru goma bayan haka, cutar MERS ta haifar da annobar da ta ci gaba da addabar yankin Larabawa, tare da yaduwa a wasu sassan duniya.
2019 Novel HCoV (2019-nCoV), wanda daga baya aka sake masa suna SARS-CoV-2, shine mai haifar da cutar ta cutar Coronavirus Disease 2019 (COVID-19) wanda ya yi sanadin mutuwar mutane 3,120 da kamuwa da cutar fiye da 91,000 har zuwa 3 ga Maris, 2020.
Kararrawa tana tashi kuma duniya na bukatar a shirya don barkewar cutar SARS-CoV-2.
Dukkanin HCoVs bakwai suna da asali daga ƙwayoyin cuta daga bat, bera ko dabba.
Yawancin shaidu suna tallafawa ci gaban da aka samu daga duka HCoVs daga bats, tare da ƙwayoyin cuta waɗanda suka dace da kyau kuma ba su da cutar, amma suna nuna bambancin halittar jini mai yawa.
Cutar COVID-19 ta haifar da ƙalubalen kiwon lafiya, kimiyya, zamantakewa da ɗabi'a ga China da duniya baki ɗaya.
Gano asalin jinsin HCoVs yana ba da tsarin don fahimtar tarihin halitta, motsawa da abubuwan haɗin kai na nau'in kwari.
Wannan na iya jagorantar ko sauƙaƙa gano ƙwayoyin cuta, tsaka-tsakin, da kuma haɓaka SARS-CoV-2 tare da tasiri mai mahimmanci akan hana yaduwar ci gaba.
A cikin wannan bita, mun gabatar da wani bayyani game da asalin kwayoyin halittar, yaduwar kwayoyin halitta da kuma ilimin ilimin HCoVs.
Musamman, muna haskakawa da tattauna batun gama gari cewa ƙwayoyin cuta na kakannin HCoVs ba su da cutarwa a cikin ƙwayoyin halittun su na asali, amma sun zama masu cutarwa bayan an watsa su cikin sabon mai ɗaukar hoto.
Za mu kuma duba yanayin ci gaban HCoVs wanda yawan kamuwa da cuta ke faruwa tare da raguwar cutar.
Hakanan ana tattauna sakamakon barkewar cutar SARS-CoV-2 a cikin wannan mahallin.
An gano CoVs na dabbobi tun daga ƙarshen 1930s.
Kafin nau'in HCoV-229E da aka fara warewa daga hancin hanci na marasa lafiya da suka kamu da cutar sanyi, an ware CoVs daban -daban daga dabbobi masu yawa da suka kamu da cutar, ciki har da turkey, rat, shanu, alade, kuli da kare.
An gano HCoVs bakwai a cikin shekarun da suka gabata.
Takaitaccen taƙaitaccen tarihin tarihin gano HCoV (Table 1) zai zama mai ba da bayani da ilimantarwa.
An ware nau'in farko na HCoV-229E a cikin 1966 daga hanyoyin numfashi na marasa lafiya da ke fama da kamuwa da cutar ta sama, wanda daga baya ya dace da ci gaba a cikin layukan WI-38 na huhu.
Alamun cututtukan sanyi, ciki har da ciwon kai, saurin zufa, rashin jin daɗi, da kuma ciwon makogwaro, tare da zazzabi da tari, an lura a tsakanin 10 zuwa 20% na marasa lafiya da suka kamu da HCoV-229E.
Daga baya a 1967, an ware HCoV-OC43 daga hanyar da aka bi ta cikin kwakwalwar beraye da kuma daga ci gaban gabobin jiki.
HCoV-OC43 yana da alamun cututtukan da ke kama da na HCoV-229E wanda ke da alamun da ba a iya ganowa ba tare da sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka.
HCoV-229E da HCoV-OC43 duka suna da yaduwa a duniya kuma ana iya samun saurin watsawa yayin hunturu tare da yanayin sanyi.
Yawanci, tsawon lokacin ci gaban waɗannan ƙwayoyin cuta ba ya wuce mako guda, wanda ke biyo bayan kusan makonni biyu na rashin lafiya.
Wani bincike da aka yi a kan masu sa kai a asibiti ya nuna cewa, mutane masu lafiya da suka kamu da HCoV-229E sun kamu da cutar sanyi mai laushi.
Wasu marasa lafiya da ba su da rigakafi suna da mummunar cuta ta ƙananan hanyoyin numfashi.
SARS, wanda aka fi sani da A.Typical Pneumonia, shine farkon cutar da aka rubuta sosai a tarihin ɗan adam wanda ya haifar da HCoV kuma dalilin da ya sa, na uku HCoV da aka gano, shine SARS-CoV.
An gano farkon cutar SARS a lardin Guangdong na kasar Sin a karshen shekarar 2002.
An samu 8,096 da suka kamu da cutar SARS tare da mutuwar 774 yayin da cutar ta bazu zuwa kasashe da nahiyoyi da dama.
Baya ga mafi yawan masu yaduwa, an yi hasashen cewa kusan shari'o'i biyu na iya tashi saboda kowace shari'ar da ke da tsawon lokaci na ci gaba na kwanaki 4 zuwa 7 da kuma mafi girman tasirin cutar a ranar 10 ga cutar.
Marasa lafiya da SARS-CoV ya kama sun fara nuna alamun ciwon tsoka, ciwon kai, zazzabi, rashin lafiya da kuma sanyi, tare da wahalar numfashi, tari da rashin numfashi.
Lymphopenia, rashin aikin hanta da kuma ƙaruwar ƙwayoyin creatine kinase sune abubuwan da suka saba faruwa a asibitin SARS.
An kuma lura da lalacewar airway, yaduwar kwayar epithelial da kuma karuwar macrophages a cikin marasa lafiyar SARS.
Kimanin kashi 20-30 cikin ɗari na marasa lafiya suna buƙatar kulawa mai zurfi da kuma iska mai iska.
Baya ga ƙananan hanyoyin numfashi, yawanci tare da cytocin guguwa, gabobin ciki da hanta da ƙwayoyin cuta da yawa, ciki har da hanta da ƙwayoyin cuta, suma suna iya kamuwa da waɗannan cututtukan masu tsanani, wanda zai iya zama mai haɗari ga marasa lafiya marasa ƙarfi.
An fara ware kwayar cutar ne daga wani mutum da ke dauke da cutar a cikin wani mutum da ya yi tafiya daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin, an yi ƙoƙari sosai a binciken HCoVs.
An ware HCoV-NL63 daga wani jariri ɗan wata 7 a Netherlands a ƙarshen shekara ta 2004.
An fara samun karuwarsa ne a cikin yara ƙanana, tsofaffi da kuma marasa lafiya da ke fama da cututtukan numfashi.
Cutar da ta haifar da HCoV-NL63 na da alaƙa da cutar sanyi, kamuwa da cuta, zazzabi, da kuma cutar bronchiolitis.
Wani bincike kuma na daban ya gano wannan kwayar cutar a cikin samfurin hanci na wani yaro dan wata takwas da ke fama da cutar nimoniya a Netherlands.
Ko da yake an gano shi a cikin Netherlands, a gaskiya ya yaɗu a dukan duniya.
An kiyasta cewa HCoV-NL63 yana haifar da kusan 4.7% na cututtukan numfashi na yau da kullun kuma mafi girman abin da ya faru shine a farkon lokacin rani, bazara, da kuma lokacin sanyi.
HCoV - NL63 yana da alaƙa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka.
A cikin wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 da aka kwantar da shi a asibiti a Hong Kong da ciwon huhu da kuma cutar kutse.
Baya ga cutar huhu da cutar bronchiolitis da aka samu a cikin al'umma, an kuma bayar da rahoton cewa HCoV-HKU1 na da alaƙa da cutar asma mai tsanani.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an gano HCoV-HKU1 a duk faɗin duniya yana haifar da ƙananan cututtukan numfashi.
Duk waɗannan HCoVs huɗu da aka samo daga al'umma sun daidaita sosai a cikin mutane kuma ba su da yuwuwar canzawa don haifar da cututtukan cututtuka, kodayake akwai haɗari da ba a sani ba kamar yadda ya faru a cikin wani yanayi mai ban mamaki na wani nau'in HCoV-NL63 mai ƙarancin guba, wanda kwanan nan aka ba da rahoton ya haifar da cutar ta ƙananan hanyoyin numfashi a China.
A yadda aka saba, idan HCoVs suka sami ikon watsawa da kuma ci gaba da kaiwa ga mutane, su ma ba su da guba ko kuma cutar.
An fara ware MERS-CoV ne a Saudi Arabia a 2012 daga huhu na wani mai shekaru 60 da ya kamu da cutar huhu mai tsanani da kuma ciwon koda.
Duk da yake yawancin lokuta da aka tabbatar da su daga dakin gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an ba da rahoton shigo da cutar zuwa ƙasashen Turai da yawa da Tunisia, tare da bazuwar yaduwar cutar a cikin dangi.
Wani fashewa na biyu ya faru ne a Koriya ta Kudu a shekarar 2015 tare da mutane 186 da suka kamu da cutar.
Bayyanarwar asibiti na MERS, wanda ke nuna ci gaban cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka, sun yi daidai da SARS.
Ba kamar SARS ba, mutane da yawa da ke da MERS suna ci gaba da rashin saurin koda, wanda har yanzu ba a gani ba a cikin MERS kawai a cikin cututtukan da HCoV ke haifarwa.
Fiye da 30% na marasa lafiya suna nuna alamun gastrointestinal kamar zawo da amai.
Ya zuwa ranar 14 ga Fabrairu, 2020, an ba da rahoton fiye da 2500 da aka tabbatar da lab tare da babban mutuƙar da aka yi na 34.4%, wanda ya sa MERS-CoV ta zama ɗaya daga cikin cututtukan da suka fi cutar da mutane.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano tarin cututtukan huhu na SARS-CoV-2 da ke da alaƙa da cutar a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana barkewar cutar cututtukan ƙananan hanyoyin numfashi wanda ya haifar da SARS-CoV-2 a matsayin matsalar lafiyar jama'a ta kasa da kasa kuma ta ba da sunan cutar COVID-19.
Ya zuwa 3 ga Maris, 2020, an tabbatar da mutane 90,053 a duniya tare da mace-mace na marasa lafiya da kashi 3.4%.
Abin lura, yawan mutuwar masu cutar a Hubei China ya kai kashi 4.2% yayin da yake waje da shi da kashi 1.2%.
SARS-CoV-2 yana haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka kamar SARS-CoV da MERS-CoV, wanda ya bayyana a cikin zazzabi, tari, da kuma rashin numfashi.
An kuma ga wasu marasa lafiya suna da zawo.
Ciwon huhu yana daya daga cikin mafi munin alamun kuma zai iya saurin zama ciwon huhu mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda babban kamannin tsari na nucleotide na 82%, sun faɗi a cikin rassa daban-daban na zuriya.
SARS-CoV-2 a bayyane yake ba shi da cutarwa kamar SARS-CoV da MERS-CoV, amma ya fi saurin yaduwa.
An ba da rahoton marasa lafiya marasa lafiya da ke dauke da SARS-CoV-2 kuma suna iya ba da gudummawa ga saurin yaduwar cutar a duniya.
Yin kwatankwacin SARS-CoV-2 da sauran HCoVs guda shida da kuma duba bambancin da aka gano sun nuna kamanceceniya da bambance-bambance masu ban sha'awa.
Na farko, lokacin da HCoV ke ci gaba da kamuwa da cutar da kuma lokacin da cutar ke ci gaba da kamuwa da ita sun yi kama sosai.
A wannan batun, SARS-CoV-2 ya bi al'ada na sauran HCoVs guda shida.
Na biyu, tsananin bayyanar cututtuka na COVID-19 ya yi kama da na SARS-CoV da HCoVs guda huɗu da aka samo daga al'umma (wato HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna alamomin da aka saba gani yayin kamuwa da HCoVs da aka samo daga al'umma, gami da rashin ƙayyadaddun, mara nauyi ko rashin bayyanar cututtuka.
A gefe guda, ana iya ganin ƙaramin ƙaramin ƙaramin lamuran COVID-19, kamar yadda ake gani game da kamuwa da SARS-CoV, kodayake adadin ya ɗan yi ƙasa.
Na uku, ana samun nau'ikan HCoVs da SARS-CoV da aka samo daga al'umma a cikin yaduwar SARS-CoV-2.
A gefe guda, yaduwar SARS-CoV-2 ta kai aƙalla yaduwar HCoVs da aka samo daga cikin al'umma.
A gefe guda, har yanzu ba a tabbatar ko cutar ta SARS-CoV-2 ta ragu ba bayan ta ci gaba a cikin mutane kamar yadda SARS-CoV da MERS-CoV suka yi.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfuran faeces.
Ko watsawar SARS-CoV-2 daga farji zuwa baki yana taka muhimmiyar rawa aƙalla a wasu yanayi kamar SARS-CoV, har yanzu ana shirin bayyana shi ta hanyar karatun gaba.
Hakanan yana da matukar sha'awa don ganin ko SARS-CoV-2 na iya yin halayen yanayi kamar na HCoVs da aka samu daga al'umma.
Duk da haka, halayen SARS-CoV-2 da suka haɗa da kamuwa da cuta, cututtuka da kuma ci gaba da yaduwa bayan ya shiga cikin mutane zai yi tasiri a kan ƙarshen barkewar cutar COVID-19.
HCoVs da aka samo daga dukkanin al'ummomi huɗu, waɗanda ke haifar da alamu masu laushi, sun dace sosai a cikin mutane.
A wata ma'ana kuma, yana iya zama cewa mutane sun saba da waɗannan HCoVs guda huɗu.
A wasu kalmomi, duka HCoVs na iya zama waɗanda suka tsira daga annoba na dā.
An kawar da HCoVs da ke haifar da cututtuka masu tsanani a cikin mutane da kuma HCoVs da ke haifar da cututtuka masu tsanani a cikin mutane.
Don haka ya faru, tarin canjin da aka daidaita wanda ke hana abubuwan ƙuntataccen abinci mai gina jiki dole ne ya haifar da HCoVs a cikin mutane a cikin isasshen iyaka.
A wannan ma'anar, tsawon lokacin da SARS-CoV-2 ke ci gaba da yaduwa kuma yawancin mutanen da ya kamu da su, da alama zai iya zama cikakke ga mutane.
Idan ya yi daidai, zai yi wuya a hana yaduwarsa ga mutane ta hanyar keɓewa ko kuma sauran matakan da za a yi don hana yaduwar cutar.
Shekaru da yawa, CoVs huɗu da aka samo daga al'umma suna yaduwa cikin yawan mutane, suna haifar da sanyi a cikin marasa lafiya marasa lafiya.
Wadannan ƙwayoyin cuta ba sa bukatar dabbobi.
A akasin wannan, SARS-CoV da MERS-CoV masu cutarwa ba su dace da mutane ba kuma ba za a iya kula da yaduwar su ba.
Suna buƙatar zama da yaduwa a cikin kwayar halittar su kuma wataƙila su sami damar watsawa ta hanyar ɗaya ko fiye da matsakaici da masu haɓaka masu haɓaka zuwa maƙasudin ɗan adam mai karɓar.
Abubuwan da ke tattare da SARS-CoV-2 sun yi kama da na SARS-CoV/MERS-CoV da HCoVs da aka samu daga al'umma guda huɗu.
Aƙalla a yanzu, yana da saurin kamuwa da cuta kamar HCoVs da aka samo daga al'umma.
Koyaya, yana da cutarwa fiye da HCoVs da aka samu daga al'umma kuma ba shi da cutarwa kamar SARS-CoV ko MERS-CoV.
Har yanzu za a ga ko za a iya daidaita shi sosai a cikin mutane kuma a iya watsa shi ba tare da wani kwayar halitta ko kuma wani mai ba da abinci ba.
Kafin mu tattauna asalin dabbobi na HCoVs, zai yi kyau mu tattauna ma'anar da halayen kwayoyin halittar HCoVs, da na halitta, da na asali, da na tsakiya, da na haɓaka.
Dabbobi ne masu ci gaba da ci gaba na HCoV idan sun kasance suna da kusanci da kakanninmu tare da babban daidaituwa a matakin kwayar halittar nucleotide.
Kwayar cutar mahaifa yawanci tana da kyau a cikin wannan abincin kuma ba ta da cutar.
Hakazalika, masu shayarwa suna ba HCoVs mafaka na dindindin da na dogon lokaci.
A cikin duka waɗannan yanayi, kwayoyin halitta suna kamuwa da cutar ta hanyar halitta kuma suna zama kwayoyin halitta na HCoV ko kuma ƙwayoyin halittarsu.
Akasin haka, idan HCoV ya shiga wani sabon matsakaici mai cin abinci kafin ko kuma kusa da shigarsa cikin mutane, ba zai iya daidaitawa da kyau ba kuma yakan zama mai cutarwa.
Wannan matsakaici na iya zama tushen kwayar halittar cututtukan ɗan adam kuma ya zama mai haɓaka ta hanyar barin kwayar cutar ta ɗan lokaci don yin kwafi sannan kuma ta watsa shi ga ɗan adam don haɓaka matakin kamuwa da cutar.
HCoV na iya shiga cikin wani nau'in kamuwa da cuta idan ba zai iya ci gaba da watsawa a cikin matsakaiciyar mai cin abinci ba.
A gefe guda, HCoVs kuma suna iya daidaitawa zuwa ga matsakaiciyar mai ɗaukar hoto kuma suna iya riƙe da mazauni na dogon lokaci.
A wannan yanayin, mai gina jiki na tsakiya ya zama mai gina jiki na halitta.
Bayanai na rigakafin cutar sun nuna cewa SARS na da tarihin hulda da dabbobi masu wasa.
Binciken da aka yi na saurin saurin cutar ya nuna cewa IgG na SARS-CoV-anti ya fi yawa a cikin dillalan dabbobi fiye da jama'a.
A kasuwannin dabbobi masu rai, an gano masked palm civet (Paguama larvata) da raccoon dog a matsayin masu ɗaukar kwayar cutar SARS-CoV-kamar ƙwayoyin cuta waɗanda suka yi kama da SARS-CoV.
Wannan ya sami goyon baya ta hanyar cewa ba a sake samun rahoton SARS ba bayan an kashe dukkan masu sayar da kayayyaki.
Koyaya, an bayar da rahoton cewa mafi yawan masked dabbar dabbar dabbar da ba ta da alaƙa da kasuwannin dabbobi masu rai, ko dai daji ko gonaki, sun kasance marasa inganci ga SARS-CoV, wanda ke nuna cewa masked dabbar dabbar dabbar masara za ta iya zama mai tsanani a matsayin mai haɓaka abinci mai gina jiki kawai a cikin teku kuma ba a matsayin mai ɗaukar SARS-CoV ba.
Abin sha'awa, tunda 80% na nau'ikan dabbobi a cikin kasuwannin Guangzhou suna da rigakafin SARS-CoV, ba za a iya musanta yiwuwar cewa yawancin ƙananan dabbobi masu shayarwa na iya zama matsakaici na haɓaka SARS-CoV ba.
Duk waɗannan suna da alama su ne masu ba da abinci na ƙarshe na SARS - CoV.
Binciken da aka yi na masu shayarwa na SARS-CoV ya gano wani CoV mai suna Rhinolephus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke da nasaba da SARS, wanda aka samo a cikin kwari na Horseshoe na kasar Sin.
Waɗannan ƙwayoyin sun sami maganin rigakafin SARS-CoV da kuma tsarin kwayoyin halittar SARSr-Rh-BatCoV HKU3.
Waɗannan da sauran CoVs na bat suna da kamanceceniya da SARS-CoV da kashi 88-92% na jerin nucleotide.
Waɗannan nazarin sun ba da tushe ga sabon ra'ayi cewa kwari suna da amfani ga ƙwayoyin cuta na ɗan adam da ke fitowa.
An kuma gano SARS da yawa kamar CoVs (SL-CoVs) a cikin beyar amma ba a ware wani daga cikin su ba a matsayin kwayar cutar da ke raye banda WIV1.
An san enzyme mai canza angiotensin 2 na mutum (ACE2) a matsayin mai karɓar SARS-CoV.
WIV1 da aka cire daga samfuran fitsari na bat an nuna shi don amfani da bat, sevet, da kuma ACE2 na ɗan adam a matsayin mai karɓar shiga cikin kwayar halitta.
Abin sha'awa, ƙwayar ƙwayar cuta ta marasa lafiya na SARS da suka warke sun sami damar kashe WIV1.
Ya zuwa yanzu, WIV1 shine mafi kusantar magajin SARS-CoV a cikin zuma, tare da raba daidaiton jerin nucleotide 95%.
Duk da irin kamanceceniya da ke tsakanin waɗannan ƙwayoyin cuta biyu, an yarda da cewa WIV1 ba shine kwayar halittar SARS-CoV da kuma baƙon baƙon ba shine mafi kusa da SARS-CoV.
Nazarin ƙwayoyin cuta ya haɗa MERS-CoV a cikin rukuni ɗaya kamar Bat CoV-HKU4 da Bat CoV-HKU5.
Kwayar cutar CoV-HKU4 da MERS-CoV suna amfani da mai karɓar mai karɓar mai karɓa, dipeptidyl peptidase 4 (DPP4) don shigar da ƙwayoyin cuta.
Jerin RNA-tushen RNA polymerase na MERS-CoV yana da kusanci da tsarin halittar bat beta-CoV da aka gano a Turai da Afirka.
Ya zuwa yanzu, ba a gano MERS-CoV mai rai a cikin barkonon daji ba.
MERS-CoV da CoV-HKU25 wanda yake shi ne mafi kusa da shi yana da daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun.
Saboda haka, ba za a iya cewa baragu su ne masu kula da ƙwayoyin cuta na MERS-CoV ba.
A gefe guda, a cikin Gabas ta Tsakiya, bincike ya nuna cewa kamar raƙuman raƙuman raƙuman da ke Gabas ta Tsakiya, a cikin ƙasashe da yawa na Afirka, raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman ra ra raƙuman raƙuman ra raƙuman rauman ra ra rauman rauman ra ra ra rauman ra ra ra ra ra rauman rauman rauman ra ra ra ra ra rauman ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra
An gano MERS-CoV mai kama da kwayar cutar da aka gano a cikin mutane daga hanci na raƙumi mai ƙyamar ƙyamar raƙumi, wanda ke nuna cewa raƙumi shine ainihin kwayar MERS-CoV.
Hakanan yana da mahimmanci cewa raƙuman da aka kamu da su da MERS-CoV sun kasance suna da laushi amma suna da yawa.
Abin lura, raƙuman da suka kamu da cutar ba sa fitar da ƙwayoyin cuta ta hanyar numfashi kawai, amma kuma ta hanyar da ke cikin bakin, wanda kuma shi ne babban hanyar fitar da ƙwayoyin cuta daga dabbobi.
Koyaya, tambayoyi har yanzu suna wanzuwa tunda babu tarihin hulɗa da raƙuma kafin bayyanar cututtukan da aka tabbatar da lamuran MERS, mai yiwuwa saboda watsawar mutum-zuwa-mutum ko kuma hanyoyin watsawa da ba a san su ba wanda ya haɗa da nau'in dabbobi da ke ba da MERS-CoV.
CoV RaTG13 da aka ware daga ƙudaje masu alaƙa da jinsin Rhynolophus, SARS-CoV-2 ya yi daidai da 96.2% na kwayar nucleotide tare da ƙudaje.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RaTG13 ya isa ya tabbatar da alaƙar kakanni.
Wato, ƙwari ba za su iya zama mafi kusa ga SARS-CoV-2 ba har sai an gano CoVs na bat kusan iri ɗaya a nan gaba.
Wataƙila, matsakaiciyar halittar SARS-CoV-2 ya kasance daga cikin nau'in namun daji da aka sayar da su kuma aka kashe a kasuwar sayar da kayan kifin Huanan wanda ke da alaƙa da wasu lokuta na farko na COVID-19 da ke nuna yiwuwar kamuwa da cutar daga dabbobi zuwa mutum.
Yawancin karatun kwanan nan, dangane da jerin matashin halitta, sun ba da shawarar cewa ƙungiyar ƙananan ƙananan dabbobi masu haɗari da aka sani da Pangolin (Manus javanica) na iya ba da mafaka ga magabata na SARS-CoV-2 mai suna Beta-CoVs.
Waɗannan sabbin ƙwayoyin CoV na pangolin suna da daidaiton tsari na nucleotide 85-92% tare da SARS-CoV-2.
Koyaya, suna da alaƙa da RaTG13 da kusan kusan 90% na kama da juna a matakin jerin nucleotide.
SARS-CoV-2 iri ɗaya ne da ƙwayoyin cuta a cikin jinsin jinsi a cikin ƙananan rukuni biyu na ƙwayoyin cuta guda ɗaya wanda ke da alaƙa da yankin ɗaure mai haɗuwa (RBD) tare da SARS-CoV-2 tare da 97.4% amino acid jerin daidaito.
Akasin haka, RBD na SARS -CoV-2 da RaTG13 sun bambanta sosai duk da cewa sun yi kama da juna a cikin kwayoyin halitta.
Binciken da aka yi a baya na ƙwayoyin pangolin da ke da cutar ya kuma ba da rahoton gano wani nau'in DNA na kwayar cutar daga samfuran huhu, wanda ya yi kama da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyi daban-daban na hadewa da kuma maganin hannu don samar da jerin kwayoyin halittar kashi 86.3 cikin dari na tsawon kwayar cutar.
Ba za mu iya yin watsi da yiwuwar cewa pangolin yana ɗaya daga cikin abubuwan da ke tattare da SARS-CoV-2 ba.
Koyaya, a halin yanzu babu wata shaida da ke goyan bayan asalin pangolin kai tsaye na SARS-CoV-2 saboda bambancin tsari tsakanin beta-CoVs na SARS-CoV-2 da pangolin SARS-CoV-2.
Hakanan, tazara tsakanin SARS-CoV-2 da RaTG13 ya fi ta SARS-CoV-2 da kuma beta-CoVs masu alaƙa da pangolin SARS-CoV-2.
Har yanzu ba a tabbatar da hanyar da SARS-CoV-2 ya bi ba a cikin berayen da ke da kwanyar, da kuma sauran dabbobi masu shayarwa.
An sami daidaito mafi yawa tsakanin SARS-CoV-2 da pangolin a cikin RBDs, beta-CoVs na SARS-CoV-2 da RaTG13 suna da daidaito mafi yawa a cikin kwayoyin halitta.
Wannan ra'ayi ne mai ban mamaki cewa babban kamance tsakanin beta-CoVs masu alaƙa da pangolin SARS-CoV-2 da RBDs na SARS-CoV-2 ya samo asali ne daga zaɓin haɓakar haɗuwa ta tsaka-tsaki.
Wani zaɓi na daban yana goyon bayan sake haɗuwa tsakanin SARS-CoV-2 da ke da alaƙa da beta-CoV da RaTG13 a cikin nau'in halittar dabbobi na uku.
A matsayin mai motsa juyin halitta, recombination yana nan a cikin beta-CoVs.
Har yanzu ba a san asalin zoogenetic mafi kusa na SARS-CoV-2 ba.
Bugu da ƙari, HCoVs masu saurin kamuwa da cuta, an kuma yi nazarin asalin halittar HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar jinsi ta nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali ne daga CoVs na bat, yayin da aka gano kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin al'amuran al'ada.
An bayar da rahoton cewa an ga wani CoV na bat mai suna ARCoV.2 (Applachen Ridge CoV) a cikin ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararru.
A gefe guda kuma, HCoV-229E yana da nasaba da kwayar halittar wata kwayar cutar batir da ake kira Hipposideros/GhanaKwam/19/2008, wadda aka gano a Ghana, duk da cewa kwayar kamel tana da alaƙa da ita.
Don ƙarin haske, an taƙaita bayanan yanzu game da asalin dabbobi na HCoVs da aka sani a Figure 1 da Table 2.
Nazarin halittu ya ba da shaidar abubuwan da suka faru na watsawa tsakanin HCoVs a tarihi.
Lokacin da HCoV-OC43 ya ƙetare jinsin don ya kamu da mutane daga dabbobi a kusa da 1890, an lura da annobar kamuwa da cututtukan numfashi.
Tarihin watsawa tsakanin jinsin HCoV-229E bai bayyana ba.
An gano bat-alpha-CoVs masu kusa da HCoV-229E.
Daga cikin su akwai Alpaca Alpha-CoV.
Akwai shaidu da yawa da ke goyan bayan watsa kwayar cutar daga bats kai tsaye zuwa ga mutane.
Na farko, mutane ne, ba alpacas ba, waɗanda suka yi hulɗa da bats a cikin mahalli ɗaya.
Maimakon haka, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, HCoV-229E-associated bat alpha-CoVs suna da bambanci kuma ba su da cutarwa a cikin bats, yayin da Alpaca alpha-CoVs ya haifar da barkewar cutar numfashi a cikin dabbobin da suka kamu.
A ƙarshe, ba a gano alpaca alpha-CoV a cikin dabbobin daji ba.
Saboda haka, ba za a iya musanta yiwuwar cewa alpaca ta sami HCoV-229E-related alpha-CoV daga mutane ba.
A gaskiya, ƙwayoyin cuta na rabies na dabbar, ƙwayoyin cuta na Ebola, ƙwayoyin cuta na Nipah, da ƙwayoyin cuta na Hendra sune tushen ainihin ƙwayoyin cuta na mutum.
Saboda haka, ba abin mamaki ba ne cewa kuliyoyi na iya watsa HCoV-229E kai tsaye zuwa ga mutane.
A madadin haka, inda bat-alpha-CoVs ke da kwayar halittar HCoV-229E, alpaca da raƙuman raƙumi na iya zama matsakaitan matsakaici waɗanda ke watsa ƙwayoyin cuta ga mutane, kamar yadda lamarin yake a MERS-CoV.
MERS-CoV misali ne mai kyau na watsawa tsakanin jinsin mutum zuwa bat, raƙumi mai ƙwanƙwasa, da raƙumi mai ƙwanƙwasa.
Abubuwan da aka sani game da haɓakar MERS-CoV daga barkonan kwari an san shi a farkon ganowa kuma an ƙara ƙarfafa shi ta hanyar binciken da aka yi.
A bayyane yake cewa bat yana ba da wadataccen tarin nau'in ƙwayoyin cuta don musayar ƙwayoyin cuta da kuma watsawa tsakanin ƙwayoyin cuta.
Tsawon rayuwa, wurin zama mai yawa, hulɗar zamantakewa da kuma iyawar tashi sama, duk suna da yanayi mai kyau don kasancewa masu yada kwayar cutar.
A gefe guda, MERS-CoV ya shiga cikin raƙuman raƙumi shekaru da yawa.
Ya dace sosai da raƙuman da suka canja daga matsakaiciyar abinci zuwa abinci mai gina jiki da ke cikin ƙwayoyin halitta.
MERS-CoV yana haifar da cutar mai laushi kuma yana riƙe da ƙananan ƙananan canjin canji a cikin waɗannan nau'ikan.
Rashin isar da shi cikin mutane ya faru ne a bazata kuma mutane ne suka zama masu daukar nauyin MERS-CoV na ƙarshe saboda ba za a iya ci gaba da yaduwar cutar ba.
Ba kamar raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman ra raƙuman raƙuman raƙuman raƙuman raƙuman ra raƙuman raƙuman raƙuman ra raƙuman ra raƙuman ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra
Musamman, beta-CoVs na pangolin suna da ƙwayoyin cuta sosai a cikin pangolin.
Suna iya zama masu ciyar da ƙarshen SARS-CoV-2-da ke da alaƙa da beta-CoVs kamar su ciyawa a cikin yanayin SARS-CoV.
Akwai yiwuwar yiwuwar watsa SARS - CoV-2 daga dabbobi zuwa ga mutane a cikin jinsuna da yawa da za a yarda da su ko kuma a musanta su a cikin karatun gaba.
Na farko, bats na iya zama masu ɗaukar kwayar kwayar cutar SARS-CoV-2 mai alaƙa da SARS-CoV-2, kusan iri ɗaya da SARS-CoV-2.
Mutane suna iya raba wurin zama da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararru.
Na biyu, pangolins na iya zama ɗaya daga cikin abubuwan haɓaka na matsakaici wanda sabon kwayar cutar SARS-CoV-2 mai alaƙa ta shiga.
Mutane suna kamuwa da cutar ta hanyar kashewa da cin naman da aka kama.
Yana yiwuwa cewa dabbobi masu shayarwa da yawa, ciki har da dabbobin gida, na iya zama masu saurin kamuwa da SARS-CoV-2.
Ana buƙatar binciken rigakafi a cikin dabbobin gida da na daji.
Na uku, kamar yadda aka ambata a sama, SARS-CoV-2 na iya sake haɗuwa da kuma daidaitawa a cikin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'i nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'i nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'i nau'in nau'in nau'i nau'in nau'in nau'in nau'i nau'i nau'in nau'in nau'in nau'i nau nau'in nau'in nau'i nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau.
Har yanzu ana binciken asalin kwayar halittar SARS-CoV-2.
Bayan nau'ikan kwayoyin halitta, manyan abubuwa guda uku dangane da kwayar cutar suna da mahimmanci wajen shawo kan shingen jinsin CoV.
Na farko, yawan maye gurbin da suke yi a cikin kwayar halittar RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ana iya ɗaukar ƙididdigar canjin CoV a matsayin matsakaici zuwa babba tare da matsakaicin canjin canjin canji na ~10-4 a kowace shekara ta 2 a kowace shekara, dangane da matakin daidaitawa na CoV a cikin sabon mai ɗaukar hoto.
CoVs suna da hujja-karanta exoribonuclease, wanda ɓacewar sa na iya haifar da babban canji da kuma raguwa ko kuma rage rayuwa.
Abin sha'awa, ana tsammanin cewa Remdesivir, analog na nucleotide, yana hana CoV yin kwafi ta isobrinobuclease da RNA-based RNA polymerase.
Remdesivir yana ɗaya daga cikin mafi kyawun wakilan anti-SARS-CoV-2 da ake bincika a cikin gwajin asibiti.
Duk da haka, ƙwayoyin juyin halittar CoVs sun fi sau miliyan ɗaya masu karɓa.
Hakanan, yawan canjin hali yakan zama mafi girma lokacin da CoVs ba su dace da abinci mai gina jiki ba.
Idan aka kwatanta da SARS-CoV tare da babban canjin canji, SARS-CoV-2 yana da ƙananan canjin canji, wanda ke nuna babban matakin daidaitawa a cikin mutane.
Wataƙila ya riga ya saba da wani mai cin abinci kusa da mutane.
Tare da SARS-CoV-2, wannan ya shafi MERS-CoV wanda ya daidaita sosai a cikin raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman ra ra raƙuman ra ra ra rauman ra ra ra ra rawan ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra
A ka'ida, ba zai yiwu ba cewa gudanawar kwayar halitta za ta sa alluran rigakafi da maganin rigakafi su yi aiki da sauri a kan SARS-CoV-2.
Na biyu, babban RNA a cikin CoV yana ba da ƙarin filastik akan canjin kwayar halitta don maye gurbi da sake haɗuwa, yana ƙara yiwuwar haɓakar co-in-genome, wanda ke da fa'ida ga fitowar sabon CoVs idan yanayin ya dace.
Wannan yana da goyon baya ta hanyar wani tsari na musamman na buɗewa da kuma ayyukan furotin da aka rubuta a ƙarshen 3rd na genome.
Na uku, CoVs suna canzawa da maimaitawa a cikin kwafin RNA ta hanyar tsarin "kwafin-zaɓi" na musamman.
A cikin abubuwan gina jiki waɗanda suke aiki a matsayin cakuda, sauyawar zaren galibi yakan faru ne yayin fassarar RNA na CoV.
Mafi yawan cikakkun - tsawon da kuma subgenomic RNAs, za su iya sake haɗuwa don samar da sabon CoVs.
An gano shaidar jinsi na sake haɗuwa ta halitta a cikin duka HCoV-HKU1 da HCoV-OC43 da kuma CoVs na dabbobi kamar bat SL-CoV da bat CoV-HKU9.
Hadin kan kwayar cutar da mai cutarwa dangane da yaduwar cutar.
Baya ga abubuwan da aka ambata a sama na ƙwayoyin cuta guda uku, hulɗar ƙwayoyin cuta da mai karɓa mai karɓa wani muhimmin abu ne da ke shafar yaduwar ƙwayoyin cuta tsakanin ƙabilan.
A nan, an yi la'akari da sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun, wanda kuma ya nuna shaidar zaɓin mai kyau yayin al'amuran watsawa na intergenetic.
Dangane da nazarin kwatancen masu rarrabawa tsakanin SARS-CoVs na mutum da na teku, SARS-CoV tare da maye gurbi a kan RBD na furotin S musamman, ana ganin zai iya daidaitawa cikin sauri a cikin nau'ikan masu amfani.
A yadda aka saba, RBD yana hulɗa da mai karɓar kwayar halitta a cikin S-protein na CoV kuma ana zaɓar abinci mai gina jiki ta hanyar amsawar rigakafi tare da zurfafawa.
A cikin SARS-CoV, RBD yana cikin amino acid na 318th zuwa 510th a kan s1 sashi wanda ke haɗuwa da ACE2 na ɗan adam da kuma co-receptors don shigar da kwayar cutar.
RBD na SARS-CoV na iya gano masu karɓar ACE2 na dabbobi daban-daban, gami da barayi, civet, linzamin kwamfuta, da kuma rakunin kare, wanda ke haifar da yaduwar ƙwayoyin cuta tsakanin ƙwayoyin cuta.
A zahiri, amino acid guda 6 ne kawai aka gano a cikin RBD daban da na ɗan adam da na ƙwayoyin cuta kuma 4 daga cikinsu suna cikin ƙwayoyin cuta masu ɗaure da juna don hulɗa da mai karɓar ACE2.
RBD na SARS-CoV na Sewet yana ɗauke da maye gurbin K479N da S487T waɗanda za su iya haɓaka ƙarfin haɗin sunadarin spike tare da mai ɗaukar ACE2 na ɗan adam.
A wasu kalmomin, waɗannan amino acid ɗin biyu na iya zama masu mahimmanci a cikin kwayar cutar a cikin mutane.
Yana da mahimmanci cewa SARS-CoV-2 yana da mai ɗaukar kwayar halitta ɗaya tare da SARS-CoV.
30% bambanci tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S furotin yana nuna cewa haɗin haɗin S furotin na iya zama mai canzawa tare da ACE2 na ɗan adam.
A zahiri, binciken Cryo-EM ya nuna cewa wannan haɗin yana da ƙarfin 10 zuwa 20 sau fiye da haɗin tsakanin ACE2 ɗan adam da furotin SARS-CoV S.
Hakanan zai zama mai ban sha'awa don tantance ko SARS-CoV-2 na buƙatar wani mai karɓar mai karɓa don watsawa.
Abin sha'awa, HCoV -NL63 ma yana haɗuwa da ACE2, amma ta wani ɓangaren S.
Akwai wasu masu karɓar HCoV da yawa, kamar su aminopeptidase N don HCoV-229E, da 9-O-acetylated sialic acid don HCoV-OC43.
Hakanan zasu iya zama masu alhakin nasarar daidaitawa na CoVs zuwa mutane bayan watsawa tsakanin jinsin daga dabbobi.
Harsuna na HCoVs na iya zama masu karɓar ƙwayoyin cuta, amma kuma suna da alaƙa da sauran abubuwan da ke tattare da ƙwayoyin cuta.
Bambancin waɗannan sunadarai masu gina jiki tsakanin mutane da HCoVs masu ɗaukar kwayar halitta, kamar su beyar, raƙumi mai ƙyalƙyali da sauro na iya zama cikas ga watsawa tsakanin jinsuna.
Samun nasarar watsa kwayar cutar HCoVs na iya buƙatar haɓaka abubuwan dogaro da abubuwan gina jiki da kuma jujjuya abubuwan da ke hana gina jiki.
A wannan batun, har yanzu ana bukatar a gano da kuma bayyana abubuwan da ke haifar da kwayoyin halittar a wannan muhimmin bangare na hulɗar kwayar cuta da ƙwayoyin cuta.
Gwajin SARS-CoV-2 na tushen abinci mai gina jiki da kuma abubuwan hanawa ta hanyar amfani da sabuwar fasahar CRISPR na iya zama mai amfani.
HCoVs na sabon abu: komawa zuwa asali
Bambancin bat CoVs yana ba da dama mai yawa don haifar da sabon HCoVs.
A wannan ma'anar, kwari suna aiki a matsayin kwayar halittar kwayar halittar CoVs, HCoVs.
Hakanan, HCoVs suna haɓaka saboda saurin maye gurbi da sake haɗuwa da kwayoyin halittar kuma suna aiki da matakai biyu masu mahimmanci a cikin wannan tsari.
Misali, kwayar halittar da ke samar da kwayar halittar da ke samar da kwayar halittar tana da karfin canza yanayin kwayar cutar ta hanyar samu ko rasa kwayar halittar.
Daga cikin sunadarai masu taimakawa SARS-CoV, ORF8 ya zama mai mahimmanci a cikin daidaitawa a cikin mutane, tun da aka ware ƙwayoyin cuta masu alaƙa da SARS-CoV, amma an gano cewa suna yin amfani da sunadarai daban-daban na ORF8.
An gano SARS-CoVs da ke da halayyar halayyar 29-nucleotide a cikin jinsunan da aka ware a farkon annobar mutum.
Wannan maye gurbin ya sa ORF8 ya zama ORF8a da ORF8b kuma an yi imanin cewa maye gurbin da ya dace ne wanda ke sa ƙwayoyin halitta su canza.
Bugu da ƙari, SARS-CoV yana da tarihin yiwuwar sake haɗuwa tare da alpha- da gamma-CoVs lineages, tare da gano adadi mai yawa na ƙananan yankuna na sake haɗuwa a cikin RNA-based RNA polymerase.
An kuma gano wuraren sake haɗuwa a cikin sassan nsp9, mafi yawan nsp10, da nsp14.
Haka nan, an lura cewa cutar MERS-CoV ta fuskanci abubuwan da suka faru tsakanin jinsuna daban-daban, wanda ya faru a cikin raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman ra raƙuman ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra
Ban da SARS-CoV da MERS-CoV, an kuma lura da abubuwan da suka faru na sake haɗuwa a wasu HCoVs, inda HCoVs ke sake haɗuwa da sauran CoVs na dabbobi a cikin kwayoyin halittarsu.
Hakanan ya kamata a sani cewa zaɓin na roba na iya yin canje -canje ba da gangan ba a cikin kwayar cuta, mai yiwuwa saboda ƙwayoyin cuta waɗanda ba su da ƙarancin zaɓin, kamar su tsarin garkuwar jiki.
Misali na waɗannan tasirin shine asarar ORF4 mai tsayi a cikin nau'in HCoV-229E na asali saboda ɓarkewar kwayar halittar nucleotide biyu.
Yayin da za a iya ganin ORF4 wanda ba a iya gani ba a cikin ƙwallon ƙafa da ƙwayoyin raƙumi da ke da alaƙa da HCoV-229E, Alpaca alpha-CoV yana nuna shigarwar nucleotide guda ɗaya, wanda ke haifar da frame.
A ƙarshe, amma ba mafi ƙaranci ba, ci gaba da ci gaba na HCoVs sabon abu ya faru ne ta hanyar matsin lamba na zaɓuɓɓuka a cikin ƙwayoyin halittun su.
An gano marasa alamun cutar ko kuma alamu masu sauki ne kawai lokacin da aka kamu da CoVs wanda ke nuna daidaituwa tsakanin CoVs da bats.
Ya bayyana cewa bat sun daidaita sosai da CoVs ta tsarin jiki da kuma ta jiki.
Misali, lahani a cikin kunnawar amsar pro-inflammatory a cikin ƙudaje, yana rage tasirin cututtukan da CoVs ke haifar.
Bugu da ƙari, an hana aikin kwayar halitta a cikin beyar, saboda ƙuntataccen tsarin kwayar halitta mai karɓar kwayar halitta NKG2/ CD94 da ƙananan matakan bayyana ƙwayoyin halittar ƙwayoyin halittar ƙwayoyin halittar ƙwayoyin halittar ƙwayoyin halittar ƙwayoyin halittar ƙwayoyin halittar ƙwayoyin halittar ƙwayoyin halittar ƙwayoyin halittar ƙwayoyin halittar ƙwayoyin halittar ƙwayoyin halittar ƙwayoyin cuta.
Bugu da ƙari, matakan da ke haifar da ƙwayoyin oxygen masu saurin aiki (ROS) waɗanda ke haifar da ƙarin aikin rayuwa na batuttukan na iya haifar da dakile kwayar CoV kuma ya shafi karatun shaida ta hanyar exoribonuclease, don haka samar da matsin lamba don samar da nau'ikan kwayar cutar da ke haifar da cutar yayin shiga sabon mai gina jiki.
Hakanan za a iya samar da ƙarin ƙwayoyin CoV masu cutar ta hanyar sake haɗuwa, wanda zai iya haifar da sabon furotin ko halayen furotin don daidaitawa mai gina jiki.
Saboda haka, ba daidaituwa ba ne cewa sabon HCoVs guda uku sun fito a cikin shekaru 20 da suka gabata.
CoVs ba su da cutar ko kuma suna haifar da alamun rashin lafiya a cikin masu ɗaukar hoto kamar bats da raƙumi.
Suna yin kwafi sosai ba tare da nuna ƙarfin ƙwayoyin gina jiki ba.
Wannan yana da asiri game da dalilin da ya sa ake ganin marasa cutar masu dauke da cutar da kuma dalilin da ya sa mutane ke kamuwa da cutar sosai.
Babban alamomi, galibi ana haifar da martani na rigakafi da kuma tsananin tashin hankali na cytokine, wanda mafi girman tasirin rigakafi, mafi girman lalacewar huhu.
A akasin wannan, a cikin masu ɗaukar hoto mara alama, amsar rigakafi ta rabu da kwayar CoV.
Irin wannan dabarar na ware martani na rigakafi na iya samun fa'idodi masu amfani a maganin SARS-CoV-2.
Amsar interferon tana da ƙarfi musamman a cikin bat.
Saboda haka, gudanar da Interferon na nau'in I a cikin mutane ya kamata ya zama da amfani, aƙalla a farkon farkon kamuwa da SARS-CoV-2.
Ƙari ga haka, ƙwayoyin NLRP3 a cikin ƙwari ba su da aiki sosai.
Ta wannan hanyar, hana NLRP3 inflammasome tare da MCC950 na iya zama da amfani a cikin maganin COVID-19.
Yaduwar SARS-CoV-2 ta bi tsari guda ɗaya wanda ya haifar da SARS-CoV da MERS-CoV.
Inda aka lura da daidaiton nucleotide na 95% na bat-beta-CoV tare da SARS-CoV, bat-CoV yana da daidaiton nucleotide 96% tare da SARS-CoV-2.
Duk da yake an ga cewa sewet da sauran dabbobi a kasuwanni suna ba da tsari ga ƙwayoyin cuta kamar SARS-CoV, ba a gano matsakaiciyar matsakaiciyar matsakaiciyar SARS-CoV-2 ba.
An gano Pangolin beta-CoVs masu kama da juna daga SARS-CoV-2, wanda ke nuna cewa pangolin na iya zama ɗaya daga cikin masu shiga tsakani ko kuma na iya zama bangaren bangaren beta-CoVs a cikin kwayar halittar SARS-CoV-2.
Duk da cewa akwai tambayoyi, babu wata shaida da ta nuna cewa SARS-CoV-2 an yi shi da gangan ko kuma an yi shi ne ta hanyar hadari.
CoVs sun zama abin da ake magana da shi saboda barkewar cutar SARS-CoV-2 a kwanan nan.
Nazarin CoVs a cikin beyar da sauran dabbobi ya kawo canji mai yawa a fahimtarmu game da ƙwayoyin dabbobi na HCoVs a cikin asalin dabbobi da kuma daidaitattun watsawa.
Shaidar da ta kasance ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararru.
Ganin cewa kamuwa da SARS-CoV ya samo asali ne daga hulɗa tsakanin mutane da kuma seawet a cikin kasuwanni, rufe kasuwannin ruwa da kashe seawet a can ya kamata ya kawo ƙarshen cutar SARS.
Saboda wannan dalili, dole ne a cire pangolin daga kasuwar tsakiya don hana yaduwar kwayoyin halittar saboda gano wasu zuriya da yawa na pangolin beta-CoVs da ke da alaƙa da SARS-CoV-2.
Koyaya, ko SARS-CoV-2 yana watsawa ga mutane ta hanyar pangolins da sauran dabbobi masu shayarwa kuma ta yaya ya kamata a bayyana a cikin binciken da za a yi nan gaba.
A gefe guda, MERS-CoV ya shiga cikin raƙuman raƙumi shekaru da yawa.
Waɗannan raƙuman suna da muhimmanci ga jama'ar yankin a matsayin hanyar sufuri, da kuma tushen nama, madara, fata, da kuma kayan ulu.
Sun fi yawa a Gabas ta Tsakiya da Afirka.
Saboda haka ba zai yiwu a kashe dukkan raƙuma don sarrafa MERS kamar yadda aka yi a kasuwar dabbobi ta kasar Sin don hana yaduwar SARS-CoV da SARS-CoV-2.
Dole ne a ɗauki cikakkiyar hanya don haɓaka ingantattun alluran rigakafi na MERS-CoV don raƙumi a haɗe tare da sauran matakan sarrafa kamuwa da cuta don hana barkewar sake fashewar cutar MERS.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, sababbin nau'in kwayoyin za su iya fitowa don haifar da barkewar cuta.
CoVs masu bambancin halittar kwayoyin suna yawo a cikin namun daji.
Musamman, kwayar CoVs mai iyawar kwayar halitta tana da bambanci sosai.
Akwai yiwuwar cewa waɗannan CoVs na zoonotic za su iya yin aiki da haɓaka, wanda zai haifar da sabon CoVs wanda zai iya zama mafi kamuwa da cuta da / ko kuma mai haɗari a cikin mutane a nan gaba.
A wasu yankuna na kasar Sin, ya kamata a daina cin naman namun daji domin rage hulda da ba dole ba tsakanin mutane da dabbobi.
Tare da gwajin SARS, MERS, da COVID-19, ya kamata a tsara shirye-shirye da martani mafi kyau.
A gaskiya, akwai ƙwayoyin cuta da yawa da suka daɗe suna wanzuwa a duniya.
Suna zama a cikin gidajensu na asali har sai da akwai damar da za su iya yaduwa.
Kodayake akwai wasu halaye na bat da ke taimakawa wajen yada cutar, amma idan aka ilimantar da mutane game da yadda za su guji bat, za a iya rage yiwuwar hulda da mutane da su da sauran jinsin dabbobin daji.
Kulawa na ci gaba da dabbobi masu shayarwa ya zama dole don samun kyakkyawar fahimta game da yanayin CoVs da abubuwan da ke cikin su wanda zai zama da amfani wajen hana yaduwar mutum da dabbobi da kuma barkewar barkewar cutar nan gaba.
A ƙarshe, hanya mafi inganci na hana yaduwar cututtukan da ake samu daga dabbobi ita ce nisantar da mutane daga muhallin da ƙwayoyin cutar ke da shi.
Yawancin sassan da ke cikin asirin asalin SARS - CoV-2 har yanzu sun ɓace.
Na farko, idan dabbobin kwari suna watsa kwayar SARS-CoV-2 ga pangolins, zai zama da ban sha'awa mu ga cikin wane yanayi dabbobin kwari da pangolins za su iya raba mahalli ɗaya.
Na biyu, idan da'awar cewa bats suna da hannu a cikin zirga - zirgar mutane, ya kamata a bincika yadda mutane suke hulɗa da bats.
Na uku, idan dabbobi masu shayarwa na uku suna aiki a matsayin masu gina jiki na gaskiya, ya kamata a bayyana yadda wannan ya shafi nau'in halittu daban -daban, ciki har da mutane, bat da pangolin.
A ƙarshe, tun da dabbobi masu shayarwa da yawa, ciki har da dabbobin gida, na iya zama masu saurin kamuwa da SARS-CoV-2, ya kamata a yi sa ido da kuma kamuwa da cutar ta gwaji.
Ko dai bats, pangolin ko wani dabbobi masu shayarwa, ana sa ran SARS-CoV-2 ko kuma kakanninta masu kusan iri daya za a gano su a makomarsu ta halitta.
Bincike mai gudana a wannan yanki zai fayyace hanyoyin ci gaban SARS-CoV-2 a cikin dabbobi tare da mahimman tasirin a cikin rigakafi da sarrafa COVID-19 a cikin mutane.
Ana buƙatar sabunta ƙa'idodin bincike na "abin da ake zargi" da "tabbacin" na COVID-19.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagororin tuntuba na gaggawa don ganowa da kuma magance cutar ta 2019 Novel Coronavirus (2019-nCoV), kuma wannan jagorar tana ba da kwarewarmu da kuma dacewa don yaƙi da cutar a duniya.
Ko da yake cutar Coronavirus ta 2019 (COVID-19) sabuwar cuta ce, saninmu da iliminmu a hankali yana ƙaruwa bisa ga binciken bincike da ƙwarewar aikin asibiti; don haka, dabarun bincike da magani ana ci gaba da sabunta su.
A cikin wannan wasika, mun amsa wani tsokaci kan ka'idodinmu kuma mun samar da sabbin ka'idodin bincike na "shaidar lamari" da "tabbatar da lamari" daidai da sababbin ka'idojin bincike da magani na COVID-19 (na bakwai) da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin ya fitar.
A cikin watan Disambar 2019, cutar ta 2019 Novel Coronavirus (2019-nCoV) ta barke, wanda yanzu aka sanya wa suna Coronavirus Disease 2019 (COVID-19) kuma an sanya wa kwayar cutar suna Babban Ciwon Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-19 a matsayin annoba.
Don yaƙi da kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagororin tuntuɓar gaggawa kuma an buga su akan layi a cikin binciken likitancin soja a ranar 06 ga Fabrairu, 2020.
Wannan ya jawo hankali sosai tun lokacin da aka buga shi.
Koyaya, lura cewa COVID-19 sabon cuta ne, wayar da kan mu da bayananmu suna haɓaka a hankali dangane da sakamakon binciken bincike da ƙwarewar aikin asibiti; saboda haka, dabarun bincike da magani suma ana ci gaba da sabunta su.
Misali, a tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, kwamitin lafiya na kasar Sin ya fitar da jagororin da aka tsara don ganewar asali da magani na COVID-19 (http://www.nhc.gov.cn/) wanda ya fito da nau'ikan guda bakwai tare da sauye-sauye na asali a wasu mahallin.
Zhou et al. sun yi sharhi a kan ƙa'idodinmu, suna ba da shawara mai sauƙi na alama bisa ga kwarewarsu ta asibiti.
Ayyukansa sun ba da ƙarin tabbaci ga ƙa'idodinmu kuma sun ba da ƙarin bayani game da wannan annoba a duk duniya.
Muna goyon bayan aikin su mai muhimmanci kuma muna nuna godiyar mu.
Koyaya, aikinsa yana buƙatar sabuntawa tare da sababbin jagororin bincike da magani don COVID-19 (juzu'i na gwaji na bakwai) da kuma binciken da aka yi kwanan nan.
Dangane da bugu na bakwai (3 Maris 2020), don yin cikakken bincike don tabbatar da abin da ake zargi da shi, kowane ɗayan abubuwan tarihin annoba ya buƙaci a haɗa shi da abubuwa biyu na maganganun asibiti, ko kuma idan babu tarihin annobar da ya bayyana, abubuwa uku na maganganun asibiti ya buƙaci a cika su:
Tarihin annoba: (1) Tarihin tafiya ko zama a cikin Wuhan City da kewayen yankuna, ko wasu al'ummomin da aka ba da rahoton COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) Tarihin hulɗa da SARS-CoV-2 cututtuka masu yaduwa (tare da gwajin kwayar nucleic acid mai kyau); (3) Tarihin hulɗa da marasa lafiya da zazzabi ko cututtukan numfashi daga Wuhan City da kewayen yankuna, ko sauran al'ummomin da aka ba da rahoton COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin hulɗa da rukunin lamuran da aka tabbatar (tare da ≥ 2 na cutar) da / ko kuma ƙananan yankuna kamar gida, ofis, aji na makaranta, da sauransu a cikin makonni 2 na kamuwa da cututtukan numfashi.
Bayyanar asibiti: (1) zazzabi da/ko alamun numfashi; (2) tare da alamun da ke nuna kamuwa da COVID-19; (3) jimlar adadin kwayar jinin da ke nuna al'ada, raguwa ko ƙananan lymphocytes a farkon farkon.
Tabbatar da cutar da aka tabbatar dole ne ya dogara da yanayin da ake zargi da cutar ko kuma wani abu na hujja na serial wanda ya biyo baya: (1) gwajin PCR na ainihi na SARS-CoV-2 ya tabbata; (2) kwayar kwayar cuta ta gabaɗaya ta nuna babban daidaituwa ga sanannun sabon kwayar cutar coronaviruses; (3) gwajin kwayar cutar a cikin ƙwayar cuta ya nuna tabbatacce ga IgM antibody da IgG antibody na musamman ga SARS-CoV-2; ko SARS-CoV-2-daidaitaccen IgG antibody yana canzawa daga mara kyau zuwa tabbatacce, ko kuma ƙimar ƙira ta ninka ≥ 4x a cikin lokaci mai kyau idan aka kwatanta da saurin lokaci.
Za mu iya ganin cewa an ƙara gwajin PCR na ainihin lokaci don nucleic acid a cikin hanyoyin numfashi ko samfurin jini a cikin na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
An ƙara gano cututtukan cututtukan jini a cikin na huɗu (Janairu 27, 2020) da na biyar (Fabrairu 8, 2020); sannan kuma an ƙara hujja ta serial a cikin fitowa ta bakwai.
Waɗannan bita sun dogara ne akan aikin da masu bincike ke ci gaba da yi, wanda ya gano mafi kyawun kayan gano nucleic acid don saurin ganewa, da samfuran tsarin numfashi, gami da samfuran jini, wanda ya haɓaka wadatar samfurori daban -daban, da kuma kawo tallafin ƙayyadaddun maganin rigakafin tabbatacce a cikin ƙa'idodin da aka tabbatar.
Bugu da ƙari, akwai shaidu da yawa da suka tuna mana mu yi hattara da marasa lafiya marasa alamun cutar da marasa alamun cutar.
Saboda haka, Zhou et al. ya kamata a sabunta ma'aunin da suka tsara, saboda sun sanya mutumin da ba shi da alamun cutar a matsayin "mai haɗari".
Tsarin maki yana buƙatar tabbatarwa a cikin ƙarin aikin asibiti da karatu.
A ƙarshe, muna fatan ƙarin shaidar kai tsaye za ta bayyana kuma muna gayyatar masu karatu su ba da ra'ayoyinsu.
Don gano "shahararrun lamari" da "tabbatarwar lamari", muna ba da shawarar ganowa da bin sabbin jagororin ƙasashensu na gida.
Our tawagar za ta kuma sabunta ka'idojinmu lokaci-lokaci don bayar da taimako.
Bangladesh ta sami sabbin mutuwar COVID-19 guda biyar, mafi yawa a rana guda.
A jiya, Bangladesh ta tabbatar da ƙarin mutuwar COVID-19 guda biyar a cikin kwana ɗaya.
Wannan shi ne adadi mafi yawa na mutuwar da aka samu a rana guda daga cutar.
Har zuwa jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike (IEDCR) ta Bangladesh ta ce adadin wadanda suka kamu da cutar sun hada da 114 wadanda ke aiki da kuma 33 da suka warke daga cutar yayin da suke gida.
An samu adadin mutanen da suka mutu a wannan rana 17.
A wani taron manema labarai na yanar gizo, Daraktan IEDCR, Dakta Mirzazi Sabrina Flora ta bayyana cewa maza hudu da mace daya ne suka mutu.
A cewar Dakta Mirzadi, mutum biyu daga cikin wadanda suka kamu da cutar sun wuce shekaru 60, biyu daga tsakanin shekaru 51 zuwa 60 kuma daya daga cikinsu yana tsakanin shekaru 41 zuwa 50.
Ya kuma ce biyu daga cikin wadanda suka mutu 'yan Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba ta duniya a ranar 11 ga Maris.
Wani jami'in asibitin ya shaida wa kamfanin dillancin labarai na Anadolu cewa, mutumin da aka kashe Jalal Safur Rahman ne, daraktan hukumar yaki da cin hanci da rashawa a Bengal, kuma ana kula da shi a asibitin Kuwait Mitrai.
A cikin wani sanarwar bidiyo ta yanar gizo a ranar Asabar, Ministan sufuri da tituna na Bangladesh Ubaidul Kader ya ce za a dakatar da sufurin tituna daga ranar Asabar, fiye da yadda aka tsara.
An fara wannan dokar hana zirga-zirgar jama'a ne a ranar 26 ga watan Maris, kuma an shirya za a dakatar da ita a ranar 4 ga watan Afrilu.
Ba a hana sufurin kayayyakin rayuwa kamar su kayan magani, mai da abinci ba.
An samu farkon masu dauke da cutar COVID-19 a Bangladesh a cikin mutane biyu da suka dawo daga Italiya da matar ɗaya daga cikinsu a ranar 8 ga Maris.
A ranar 19 ga Maris, dukansu uku sun warke.
A duniya, adadin mutanen da suka kamu da SARS - CoV - 2 ya zarta miliyan ɗaya.
Bayanai daga Jami'ar Johns Hopkins sun nuna cewa a ranar Alhamis, adadin masu kamuwa da cutar SARS-CoV-2 a duniya ya zarce miliyan daya.
COVID-19 da ke haifar da cutar coronavirus an danganta shi da mutuwar mutane akalla 52,000.
A ranar da aka kai wannan adadi, Malawi ta fara samun mutum na farko da ya kamu da cutar, sai kuma Zambia ta fara samun mutum na farko da ya mutu.
Koriya ta Arewa ta yi ikirarin cewa ta kasance cikin 'yan kasashen da har yanzu ba su kamu da cutar coronavirus ba.
Ya zuwa yau, Hukumar Lafiya ta Duniya ta ba da rahoton aukuwar kamuwa da cutar 10,51,635, ciki har da 79,332 a cikin awanni ashirin da hudu da suka gabata kafin karfe 10:00 na yammacin Turai a ranar 4 ga Afrilu.
An samu mutum fiye da dubu biyu da dubu arba'in da hudu da suka kamu da cutar a Amurka, inda kuma ta yi sanadiyar mutuwar mutane akalla dubu biyar da dari tara.
CBS News ta ruwaito, tana mai ambaton bayanan da jami'ar Johns Hopkins ta fitar, cewa a ranar Laraba, an samu mutuwar mutane fiye da 1,000 a Amurka sakamakon kamuwa da cutar coronavirus.
Kasashen duniya sun sanar da tsaurara matakan da za su yi don dakile yaduwar cutar.
A ranar Alhamis, magajin Moscow Sergei Sobyanin ya tsawaita dokar kulle-kulle a birnin har zuwa ranar 1 ga Mayu.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa 'yan Rasha za su ci gaba da samun albashi ba tare da sun je aiki ba har sai 30 ga Afrilu.
Majalisar dokokin Portugal ta kada kuri'ar amincewa da tsawaita dokar ta baci har tsawon kwanaki 15; an amince da wannan kudurin da kuri'a 215, 'yan majalisa goma ne ba su halarci taron ba, sai kuma guda daya da ya nuna adawa.
Saudiyya ta kafa dokar hana fita ta dare da rana a biranen Makka da Madina, inda a baya dokar ta kasance daga karfe 3 na yamma zuwa 6 na safe.
Thailand na shirin sanya dokar hana fita daga karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio Mike Duane ya sanar da cewa an tsawaita dokar hana fita a jihar har zuwa ranar 1 ga Mayu.
A Ostareliya, shaguna sun rage adadin takardar bayan gida da za a iya saya a lokaci ɗaya.
A ranar Lahadi da Asabar da yamma, Shagunan sayar da kayayyaki na Woolworths da Coles na Australiya sun rage adadin takardun wanka da za a iya saya a lokaci guda a duk shagunan su a duk fadin kasar zuwa biyu da guda daya.
ALDI ma ta aiwatar da iyakar kunshin daya a ranar Litinin.
An sanya waɗannan iyakoki a matsayin saƙonni a wuraren biya da kuma shafukan Facebook na sarƙoƙi.
An ruwaito cewa masu sayayya suna yin sayayya tare don yanayin da ake buƙatar keɓewa saboda tsoron COVID-19.
A ranar Laraba, Woolworths ya rage iyakar sayen takardar bayan gida zuwa fakiti daya a kowane tsari, har ma don isar da gida.
Kafin waɗannan canje -canje, Woolworths da Coles sun aiwatar da ƙuntatawa na sayan mafi ƙarancin fakiti huɗu a lokaci ɗaya a ranar 4 da 5 ga Maris, bi da bi.
Koles ya bayyana a cikin sanarwar da ya fitar a ranar 8 ga Maris cewa duk da dokar hana kwalliyar kwalliya, "har yanzu akwai shagunan da yawa da ke ƙarancin kaya cikin awa ɗaya bayan isarwa", kuma ya bayyana wannan a matsayin abin da ba a taɓa gani ba, yayin da ALDI ya kira shi "abin da ba a tsammani ba" a cikin wani sakon Facebook a ranar Talata.
Wani mai magana da yawun Woolworths ya ce, "Kasuwancin da ya gabata ya nuna cewa an samu ci gaba sosai.
Wani kantin sayar da abinci mai suna Costco da ke Canberra ya rage adadin zuwa fakiti biyu a makon da ya gabata.
Don rage karancin, Coles ya ba da umarni ga masu samar da kayayyaki da yawa kuma ya ƙara yawan isar da kayayyaki. Woolworths ya ba da umarnin ƙarin kaya, ALDI ya tara kaya don samar da kayan aikin Laraba da aka tsara da wuri.
Babban daraktan kungiyar masu sayar da kayayyaki ta Australiya, Russell Zimmerman, ya ce masu sayar da kayayyaki suna kokarin tara kayayyaki, amma hakan yana da wuya saboda takunkumin da majalisar dokokin yankin ta kafa a kan lokacin da za a kai kayan.
A wannan yanayin, masu samar da kayayyaki suna ƙoƙari su biya bukatunsu kuma ƙididdigar ƙididdiga ta ragu, Russell yana sa ran farashin kayan aiki zai ƙaru.
A ranar Talata ALDI ta sanar da cewa wasu shagunan ba za su iya gudanar da musamman a ranar Laraba ba, bayan an saki hannun jari da wuri.
A wani rahoto da News.com.au ya wallafa, wani masanin kasuwanci a jami'ar Queensland University of Technology, Dr. Gary Mortimer, ya ce shaguna suna cika kayayyaki a kowane dare.
Ya ce takarda na bayan gida abu ne mai nauyi, saboda haka ba a iya samun yawansa, kuma idan aka sayar da shi, sai a bar manyan ɗakuna a baya, wanda hakan na sa a ji daɗi da kuma ƙin yin amfani da shi.
Russell Zimmerman ya ce, "Hankalin Coles da Woolworths shi ne, idan akwai kayayyaki da yawa a kan shiryayye, da kayayyaki kamar takardar bayan gida da kuma na'urar wanke-wacce, da za a iya saya da yawa, da za a iya rage hayaniyar.
Kamfanin kera takarda bayan gida, Who Gives a Crap, ya sanar da cewa ya gama sayar da takardun bayan gida da aka sake amfani da su.
Kamfanin Kimbraley-Clark, wanda ke kera kayan wanka na Cleanx, da Solaris Pepper, wanda ke kera kayan wanka, sun kara da cewa suna aiki 24/7 don kiyaye wadatar.
A Melbourne, inda masu sayen gidaje ke yin hutun ranar ma'aikata, wasu masu sayar da gidaje suna ba da takarda na bayan gida kyauta ga masu yin tayin farko a gwanjo, kamar yadda wani shafin yanar gizon Domain.com ya ruwaito.
A cikin wani jarida da ake bugawa a Darwin, akwai wani shafi mai shafi takwas da aka yanka a cikin NT News na ranar Alhamis don a yi amfani da shi a matsayin takardar bayan gida.
ABC Australia a cikin wani rahoto na 3 ga Maris ya ce, a farkon, ba a son shagunan da za a hana; a cikin wannan rahoto, sun ce ba su da wani shirin hana sayayya.
Russell Zimmerman ya kara da cewa akwai bukatar wasu kayayyaki da suka hada da masks, sanitizers, dry goods, handwashes da flour.
Haka kuma a waje da Australia, a cikin babban kanti na Burtaniya da ake kira Okado a ranar Lahadi da yamma, an sanya iyaka ga sayen takardar bayan gida guda biyu.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin cutar da ta zama ruwan dare
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana cutar COVID-19 a matsayin annoba ta duniya.
Duk da cewa kalmar "annoba ta duniya" tana nufin yadda cutar ke yaduwa ne kawai, ba yadda takamaiman yanayin cutar ke da haɗari ba, WHO ta tattauna bukatar motsa gwamnatoci su ɗauki mataki.
Dukkanin ƙasashe suna da ikon kawo sauyi a wannan annoba a yanzu.
Idan kasashe suka amsa, za su iya gano cutar, su kula da marasa lafiya, su ware su, su gano su, kuma su haɗa kai, " in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO.
Muna matukar damuwa da yadda yaduwar cutar take da kuma yadda rashin aikin yi yake da matukar damuwa.
A cewar tsohon darektan cibiyar dakile cututtuka na Amurka, Dr. Tom Freeden, wannan annoba ta duniya ba ta taba faruwa ba.
A cikin wani sharhin da aka wallafa a CNN a watan Fabrairu, ya ce, "Ba a taɓa samun wata cuta ta numfashi ba, sai dai mura, a cikin yaɗuwar duniya".
Gabalaisis ya yi magana game da wannan lokacin da ya ce, "Ba mu taɓa ganin annobar da ta shafi duniya ba kamar ta kwayar cutar corona".
Ya kara da cewa, "Kuma ba mu taɓa ganin wata annoba ta duniya da za a iya shawo kanta a lokaci ɗaya ba".
Wannan sabon matsayi na annobar duniya ya biyo bayan shawarar da WHO ta yanke a watan Janairu na ayyana annobar a matsayin gaggawar lafiyar jama'a da ke da matukar muhimmanci a duniya.
Dokta Anthony Fauci, darektan cibiyar kasa ta Amurka da ke kula da cututtuka masu sa ido da kuma cututtuka, ya ce: "Abin takaici, yanayin zai kara muni".
Kamfanin dillancin labarai na Associated Press ya ruwaito cewa a ranar Alhamis, akwai aƙalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, kuma fiye da 4,600 sun mutu sakamakon haka.
2019-20 Cutar annobar cutar Korona 2019 (COVID-19) wata annoba ce mai gudana wacce ta haifar da cutar sankarar bargo mai saurin kamuwa da cutar Korona 2 (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China a watan Disamba 2019, an ayyana ta a matsayin gaggawa ta lafiyar jama'a a duniya a ranar 30 ga Janairun 2020 kuma an ayyana ta a matsayin annoba a ranar 11 ga Maris 2020.
Ya zuwa ranar 10 ga Afrilu, 2020, kusan mutane miliyan 1.61 ne suka kamu da COVID-19 a cikin kasashe da yankuna 210, wanda ya yi sanadiyar mutuwar kusan 97,000.
Kusan mutane 364,000 ne suka warke.
An kiyasta mutuwar cutar a China a 4%, yayin da a duniya ya kai daga 13.04% a Algeria zuwa 0.08% a New Zealand.
Alamun da ake yawan gani sun haɗa da zazzabi, tari, da kuma rashin numfashi.
Matsaloli na iya haɗawa da cutar nimoniya da kuma ciwon numfashi mai tsanani.
Lokacin da ake ɗauka daga lokacin da aka kamu da cutar zuwa lokacin bayyanar cututtuka yawanci kusan kwanaki biyar ne, amma zai iya zama daga kwanaki biyu zuwa 14.
Babu wata sananniyar rigakafi ko maganin rigakafin ƙwayoyin cuta.
Maganin farko shine maganin cututtuka da kuma taimako. Hanyoyin da aka ba da shawara sun haɗa da: wanke hannu, rufe fuska idan kana yin tari, nisanta daga wasu, da kuma kula da kai da kuma keɓewa ga waɗanda ake zargin sun kamu da cutar.
Hukumomi a duk duniya sun mayar da martani ta hanyar aiwatar da takunkumin tafiye -tafiye, keɓewa, dokar hana fita, sarrafa haɗarin wurin aiki da rufe wuraren aiki.
Cutar ta haifar da mummunan rikice-rikicen zamantakewar tattalin arziki a duniya, ta sa aka dage ko soke wasannin motsa jiki, na addini, siyasa da al'adu, da kuma tsananin karancin kayayyaki saboda tsananin sayen mutane.
Makarantu da jami'o'i a kasashe 193 sun rufe a matakin kasa ko na gida, wanda ya shafi kusan kashi 99.4 na yawan ɗaliban duniya.
Bayanai na karya game da cutar sun bazu a yanar gizo, kuma akwai al'amuran da suka shafi tsoron baƙi da nuna bambanci ga Sinawa, wasu mutane na Gabas da kudu maso gabashin Asiya da kuma wasu da ke da launi, da kuma wasu daga yankuna da ke da yawan kamuwa da cutar.
Rage tafiye-tafiye da rufe manyan masana'antu ya haifar da raguwar gurɓatar iska da ƙurar carbon.
Hukumomin kiwon lafiya a Wuhan (babban birnin lardin Hubei) na kasar Sin sun ba da rahoton tarin kamuwa da cutar numunoniya daga dalilai da ba a sani ba a ranar 31 ga Disamba 2019 kuma an fara bincike a farkon watan Janairun 2020.
Yawancin shari'o'in sun kasance suna da alaƙa da kasuwar sayar da abincin teku na Hunan kuma saboda haka ana ɗaukar kwayar cutar a matsayin asalin halittar.
Kwayar cutar da ke haifar da barkewar cutar, da aka sani da SARS-CoV-2, sabuwar kwayar cuta ce da aka gano, wacce ke da alaƙa da kwayar cutar coronavirus, kwayar cutar coronavirus ta pangolin, da SARS-CoV. An gano mutum na farko da ke da alamun cutar a ranar 1 ga Disamba 2019, kuma ba a ga alaƙar da ke tsakanin wannan mutumin da ƙungiyar kasuwar nama ba.
A cikin farkon rukunin shari'o'in da aka bayar da rahoton a cikin Disamba 2019, kashi biyu bisa uku suna da alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba a jaridar South China Morning Post ya ruwaito cewa wata shari'a ta 17 ga Nuwamba, 2019 ta kasance ga wani mutum mai shekaru 55 a lardin Hubei, wanda zai iya zama shari'ar farko. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa an sami kwatsam a cikin Italiya, Iran da Koriya ta Kudu tare da raguwar sabbin shari'o'i a China, tare da adadin sabbin shari'o'i a wajen China sun zarce adadin sabbin shari'o'i a cikin China a karon farko.
Ba a san yawan mutanen da suka kamu da cutar ba, musamman ma wadanda ke da alamun rashin lafiya.
Ya zuwa 26 ga Fabrairu, an ba da rahoton ƙarancin ƙwayoyin cuta a cikin matasa, waɗanda shekarunsu 19 da ƙasa da haka suka kai kashi 2.4% na ƙwayoyin cuta a duniya.Babban masanin kimiyya na Burtaniya, Patrick Valence, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya za su buƙaci kamuwa da cutar kafin samun rigakafin cutar.
Lamarin na nuni da yawan mutanen da aka gwada su da cutar COVID-19, kuma aka tabbatar da gwajin na tabbatacce, kamar yadda aka tsara a cikin tsarin gwamnati.
Har zuwa ranar 23 ga Maris, babu wata ƙasa da ta gwada fiye da 3% na yawan jama'arta, kuma ƙasashe da yawa kamar Italiya, Netherlands, Spain, da Switzerland suna da manufofin hukuma na ƙin gwada mutane masu alamun cutar.
Wani bincike da aka wallafa a ranar 16 ga Maris ya gano cewa a China, har zuwa ranar 23 ga Janairu, kimanin kashi 86% na cututtukan COVID-19 ba a gano su ba, kuma waɗannan cututtukan da ba a rubuta su ba sune tushen kamuwa da cutar ga kashi 79% na shari'o'in da aka rubuta.
Wani bincike da aka yi a ranar 30 ga watan Maris ya nuna cewa adadin mutanen da suka kamu da cutar a Italiya ya fi adadin da aka samu rahoto.
Hasashen farko na ainihin adadin haifuwa (R0) don COVID-19 ya kasance 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka ta Amurka ta wallafa ya nuna cewa, cutar ta kai 5.7 a shekara.
Yawancin mutanen da suka kamu da COVID-19 sun warke.
A cikin waɗanda ba su warke ba, lokacin da ya wuce daga bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, tare da mafi yawan kwanaki 14.
Ya zuwa 10 ga Afrilu, 2020, COVID-19 ya yi sanadiyar mutuwar kusan mutane 97,000.
A China, har zuwa ranar 5 ga Fabrairu, kusan kashi 80% na mutuwar sun kasance a cikin mutanen da suka haura shekaru 60, kuma kashi 75% na masu cutar suna da yanayin rashin lafiya, gami da cututtukan zuciya da ciwon sukari.Kudaden da aka samu daga cutar COVID-19 a hukumance yana nufin mutanen da suka mutu, waɗanda aka gano sun kamu da COVID-19 daidai da ka'idojin hukuma.
Adadin ainihin mutuwar COVID-19 na iya zama mafi girma, saboda ba zai iya haɗawa da mutanen da suka mutu ba tare da gwaji ba kamar a gida, a cikin gidajen jinya, da sauransu.
Ƙididdigar Italiya ta gano cewa ƙarin adadin mutuwar da aka samu a lokacin annobar ya ninka adadin mutuwar COVID da aka samu sau 4-5.
Wani mai magana da yawun Cibiyar Kula da Cututtuka ta Amurka (CDC) ya yarda da cewa "mun san cewa [adadin mutuwar da aka ruwaito] an rage shi", bayanin da ke da goyan baya ta hanyar bayanin bayanin ƙididdigar ƙididdiga a Amurka. Irin wannan raguwa yana faruwa sau da yawa a cikin annoba, kamar yadda ya faru a cikin annobar H1N1 ta 2009 .
Mutuwar farko a wajen kasar Sin ta faru ne a kasar Philippines a ranar 1 ga Fabrairu, kuma mutuwar farko a wajen Asiya ta faru ne a Faransa a ranar 14 ga Fabrairu.
Ya zuwa ranar 28 ga Fabrairu, a wajen babban yankin China, an sami mutuwar sama da dozin a Iran, Koriya ta Kudu da Italiya.
Ya zuwa ranar 13 ga Maris, an ba da rahoton mutuwar a cikin kasashe da yankuna fiye da arba'in a kowace nahiya ban da Antarctica. Da yawa daga cikin matakan da aka saba amfani da su don ƙididdige yawan mutuwar.
Waɗannan lambobin sun bambanta ta yanki da lokaci, kuma yawan gwaji, ingancin tsarin kula da lafiya, zaɓuɓɓukan magani, lokacin da aka yi tun farkon barkewar cutar, da kuma halayen jama'a kamar su shekaru, jinsi, da lafiyar gaba ɗaya. Halin mutuwar ya nuna yawan mutuwar da aka raba da adadin shari'o'in da aka gano a cikin wani lokaci.
Dangane da bayanan Jami'ar Johns Hopkins, rabon mutuwar duniya zuwa cutar ya kai 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Wannan adadin ya bambanta bisa ga yankin.
A China, an kiyasta cewa mutuwar ta ragu daga 17.3% (ga waɗanda suka fara bayyanar da alamun cutar a tsakanin 1-10 ga Janairu 2020) zuwa 0.7% (ga waɗanda suka fara bayyanar da alamun cutar bayan 1 ga Fabrairu 2020).Sauran matakan sun haɗa da mutuwar ta kamuwa da cutar (CFR), wanda ke nuna yawan mutanen da aka gano da ke mutuwa daga cutar, da mutuwar kamuwa da cutar (IFR), wanda ke nuna yawan mutanen da ke kamuwa da cutar da ke mutuwa (damuwa da rashin kamuwa da cutar).
Waɗannan ƙididdigar ba su da lokaci kuma suna bin takamaiman yawan jama'a daga kamuwa da cutar zuwa murmurewa.
Masana ilimi da yawa sun yi ƙoƙarin ƙididdige waɗannan lambobi don ƙayyadaddun mutane.
Cibiyar Kula da Magunguna ta Oxford ta Cibiyar Bayyanawa ta Oxford ta kiyasta cewa yawan mutuwar kamuwa da cutar a cikin annobar cutar ya kasance tsakanin 0.1% da 0.39%.
Upperididdigar sama na wannan iyaka ya yi daidai da sakamakon binciken ƙididdiga wanda ya bincika tasirin gwajin a kan gwajin bazuwar farko na COVID-19 a cikin Jamus da ƙididdigar CFR.
WHO ta ce ana iya shawo kan annobar.
Matsayi da lokacin ƙarshe na fashewar ba shi da tabbas kuma zai iya bambanta dangane da wurin.
"Idan ba a sarrafa su ba, ƙwayoyin cuta da ke yaɗuwa za su yi sanyi kuma za su soma raguwa idan aka daina samun abubuwan da ke gina jiki da ke sa cutar ta yi tsanani", in ji McKee Boney na Jami'ar Jihar Penn.
Amma a yanzu ba za mu iya sanin ainihin lokacin da hakan zai faru ba.
Babban mai ba da shawara kan harkokin lafiya na gwamnatin kasar Sin, Zhong Nanshan, ya yi jayayya cewa "za a iya kawo karshen wannan cutar a watan Yuni" idan dukkan kasashe suka bi shawarar WHO kan matakan dakile yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Lafiya da Magungunan Tsuntsu na London ya ce SARS-CoV-2 "zai yiwu ya kasance cikin zagayawa na shekara ɗaya ko biyu".
Dangane da binciken da Kwalejin Masarautar ke jagoranta, wanda Neil Ferguson ya jagoranta, nisantar jiki da sauran matakan za su zama dole "har sai an sami rigakafi (mai yiwuwa watanni 18 ko fiye)", in ji binciken.
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin cewa ba zai yiwu ba a kawar da wannan cutar ba, saboda tana yaduwa da sauƙi" kuma tana iya "juyawa zuwa wani yanayi da ke dawowa kowace shekara".
Matsayin dawowar zai dogara ne akan rigakafin rukuni da kuma girman maye gurbi.
Alamun COVID-19 na iya zama ba na musamman ba kuma mutanen da suka kamu da cutar na iya zama marasa lafiya.
Abubuwa biyu da suka fi yawa sune zazzabi (88%) da kuma tari (68%).
Ƙananan alamun da aka saba gani sun haɗa da: gajiya, ƙamshi, ƙarancin ƙanshi, rashin iskawa, ciwo a cikin tsoka da haɗin gwiwa, ciwo a cikin makogwaro, ciwon kai, sanyi, amai, zub da jini, zawo ko hawan jini. WHO ta ce kusan mutum ɗaya cikin shida yana ciwo sosai kuma yana da wahalar numfashi.
Cibiyoyin Kula da Cututtuka na Amurka (CDC) sun lissafa alamun gaggawa kamar wahalar numfashi, ci gaba da ciwo ko matsin zuciya, rikicewar kai tsaye, wahalar farkawa, da fuska ko launin lebe; ana ba da shawarar neman taimakon likita nan da nan idan waɗannan alamun sun bayyana. Ci gaban cutar na iya haifar da cutar numfashi mai tsanani, cututtukan numfashi masu tsanani, cututtukan ƙwaƙwalwa, cututtukan ƙwayar cuta da mutuwa.
Wasu daga cikin wadanda suka kamu da cutar na iya zama marasa lafiya, ba tare da alamun bayyanar cutar ba, amma sakamakon gwajin ya tabbatar da kamuwa da cutar, don haka masu binciken sun bayar da shawarar cewa ya kamata a sanya ido sosai a kan mutanen da suka yi mu'amala ta kusa da mutanen da aka tabbatar da kamuwa da cutar don kawar da cutar.
Ainihin adadin mutanen da suka yi rashin biyayya ga Allah ya kai kashi 44 cikin ɗari.
Lokacin da ake saurin kamuwa da cutar (lokacin da cutar ta kamu da cutar da bayyanar cututtuka) ya kai kwanaki 1 zuwa 14; mafi yawanci kwanaki 5. Wani misali na rashin tabbas, ƙididdigar kashi 30 cikin 100 na mutanen da ke da COVID-19 da suka rasa ƙamshi, an fara da kashi 15 cikin 100 daga baya.
Wasu bayanai game da yadda cutar ke yaduwa har yanzu ana kan tantance su.
An yi imanin cewa cutar tana yaduwa ne ta hanyar saukad da ke fitowa daga kusanci kusa da lokacin da mutum ya yi tari, tari, ko yin magana, idan kusanci ya kai tsakanin mita 1 zuwa 2.
Bincike ya nuna cewa idan mutum ya yi tari ba tare da rufe fuskarsa ba, sai ya yi digo mai tsawon kafa 15 zuwa kafa 27 (mita 4. 5 zuwa 8. 2).
Wasu sun ba da shawarar cewa za a iya yada cutar ta hanyar ƙwayoyin da ake samu yayin magana da ke cikin iska na tsawon lokaci. Ana iya samun ƙwayoyin numfashi yayin numfashi, ciki har da lokacin magana, kodayake cutar ba ta da iska.
Saukad da za su iya shiga cikin bakin ko hancin mutanen da ke kusa ko kuma za su iya shiga cikin huhu ta hanyar numfashi.
Wasu hanyoyin magani kamar su ductal and cardiopulmonary therapy (CPR) na iya haifar da lalacewar numfashi kuma ta haka ne na iya haifar da yaduwar iska.
Hakanan yana iya yaduwa lokacin da mutum ya taɓa wani abu da ya ƙazanta, gami da fata, sannan ya taɓa idanunsa, hanci ko bakinsa.
Duk da cewa akwai damuwa cewa za a iya yada shi ta hanyar kwari, amma an yi la'akari da cewa ba shi da haɗari.
Gwamnatin China ta musanta yiwuwar watsawar SARS-CoV-2 ta hanyar bakin-da-bakin. kwayar cutar ta fi kamuwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake za a iya samun yiwuwar watsawa kafin bayyanar cututtuka da kuma a matakai na gaba na cutar.
Mutane sun gwada tabbatacce ga cutar har zuwa kwanaki uku kafin fara bayyanar cututtuka, wanda ke nuna yiwuwar watsawa kafin bayyanar da alamomi masu mahimmanci.
Akwai rahotannin rahotanni kaɗan na tabbatar da yanayin rashin bayyanar a cikin dakin gwaje-gwaje, amma an gano kararraki na rashin bayyanar da wasu ƙasashe yayin binciken binciken tuntuɓar.
A cewar Cibiyar Kula da Cututtuka ta Turai (ECDC), ko da yake ba a san yadda cutar ke yaduwa da sauƙi ba, mutum ɗaya yakan kamu da mutum biyu zuwa uku. Kwayar cutar tana iya rayuwa a kan farfajiyoyi na tsawon sa'o'i ko kwanaki.
Musamman, an gano cewa ana iya gano kwayar cutar a cikin filastik (polypropylene) da kuma bakin karfe 304 har tsawon kwana uku, a cikin kwali har tsawon rana guda, kuma a cikin jan ƙarfe har tsawon sa'o'i huɗu.
Koyaya, ya bambanta dangane da zafi da zafin jiki.Dabbobin gida da sauran dabbobin sun gwada tabbatacce ga COVID-19.
Babu wata hujja da ke nuna cewa kwayar cutar za ta iya wucewa daga dabbobi zuwa mutane, duk da haka hukumomin Burtaniya sun ba da shawarar wanke hannaye bayan sun yi mu'amala da dabbobi, kamar yadda ake yi bayan sun yi mu'amala da wasu wuraren da mai cutar ya taba.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka (SARS-CoV-2) wani sabon kwayar cuta ne, wanda aka fara warewa daga mutane uku da suka kamu da cutar huhu da ke da alaƙa da rukunin masu cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka a Wuhan.
Dukkanin halayen kwayar cutar ta SARS-CoV-2 ana samun su a cikin coronaviruses masu alaƙa da ke cikin yanayi. A waje da jikin mutum, kwayar cutar tana mutuwa ne ta sabulu na gida, wanda ke lalata murfinta na kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
An yi imanin cewa wannan kwayar cutar ta zoonotic ce.
Nazarin kwayar halitta ya nuna cewa kwayar cutar ta kasance cikin rukuni na Betacoronaviruses, subgenus Cerbecoviruses (sunan B), tare da nau'ikan kwayoyin halittar bat-biri biyu.
Wannan yana da kashi 96 cikin ɗari na sauran bat coronavirus (BatCov RaTG13) a matakin cikakken kwayoyin halitta.
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambancin amino acid guda daya a wasu sassan tsarin kwayoyin halittar kwayoyin halittar tsakanin kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halitta.
A cikin kwatancen cikakken kwayar halittar har zuwa yanzu, an sami matsakaicin matsakaicin kwayar halittar jini tsakanin kwayar cutar pangolin da SARS-CoV-2 na 92%, wanda bai isa ba don tabbatar da ƙwayoyin cuta na tsaka-tsakin pangolin.
Ana iya gano kamuwa da kwayar cutar ta hanyar alamun cutar, kodayake a ƙarshe an tabbatar da cutar ta hanyar jujjuyawar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar (rRT - PCR) ko hotunan CT.
Wani bincike da aka yi a Wuhan da ya kwatanta PCR da CT ya nuna cewa CT yana da karfin fahimta fiye da PCR, duk da cewa ba shi da takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takama na takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takama.
Ya zuwa Maris 2020, Kwalejin Rediology ta Amurka ta ba da shawarar cewa "kada a yi amfani da CT a matsayin gwaji na farko don bincika ko gano COVID-19".
WHO ta wallafa wasu ladabi na gwajin RNA don SARS-CoV-2, wanda aka fara fitar da shi a ranar 17 ga Janairu.
Wannan gwajin yana amfani da Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR).
Ana iya yin gwajin ne a kan numfashin da ake yi ko kuma a kan jini.
Ana samun sakamako a cikin 'yan sa'o'i ko 'yan kwanaki.
Ana yin wannan gwajin ne a kan hanci, amma ana iya amfani da sashin hanci. Yawancin dakunan gwaje - gwaje da kamfanoni suna haɓaka gwaje - gwajen serological waɗanda ke gano antibodies.
Har zuwa 6 ga Afrilu, 2020, babu wani daga cikinsu da ya tabbatar da cewa yana da cikakkiyar daidaito don a yarda da shi don amfani da shi.
Gwajin kwayar cutar da Cellex ta haɓaka a Amurka an yarda da shi don amfani da gaggawa ta hanyar takaddun shaida kawai.
Hoton hoton da aka nuna a kan radiographs da CT na mutanen da ke da alamun sun hada da asymmetrical peripheral ground glass opacities da kuma rashin saurin saurin saurin numfashi.
Ƙungiyar Radiology ta Italiya tana tattara bayanan duniya na binciken radiation don tabbatar da lamuran.
Ba tare da tabbatarwa ta PCR ba, saboda kamanceceniya da sauran cututtukan kamar na adenovirus, hoton hoto yana da iyakantaccen ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙwarar ƙayyadaddunƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarƙwarar ƙwarar ƙwar ƙwarar ƙwarar ƙwarar ƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙƙwarar ƙwarar ƙwarƙƙƙƙwarƙƙƙƙƙwarar ƙ ƙwarar ƙ ƙ ƙ ƙwarƙƙƙƙƙwarar ƙwarƙƙ
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa kodayake hoton ba shi da ƙayyadaddun kamuwa da cuta, yana da sauri kuma ya fi dacewa, yana ba da shawarar yin la'akari da shi azaman hanyar nunawa a yankunan da ke fama da cutar.
An haɓaka hanyoyin sadarwa na jijiyoyin jijiyoyi don gano abubuwan hoto na kwayar cutar tare da radiograph da CT.
Don hana yaduwar cutar, dabarun sun haɗa da kiyaye tsabtar mutum gaba ɗaya, wanke hannuwanku, guje wa taɓa idanu, hanci, ko baki da hannayen da ba a wanke ba, da yin tari ko hancin a cikin nama da kuma jefa nama kai tsaye cikin kwandon shara.
Ana ba da shawarar mutanen da suka riga sun kamu da cutar su sanya takunkumin rufe fuska a wuraren da jama'a ke.
Ana kuma bada shawarar nisantar da jiki don hana yaduwar cutar. Gwamnatoci da dama sun hana ko kuma bayar da shawarar hana duk wata zirga-zirga da ba ta da muhimmanci a cikin kasashen da yankunan da cutar ta bulla.
Koyaya, cutar ta kai matakin watsawa a cikin al'umma a yawancin sassan duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'umma, kuma wasu daga cikin al'umma ba su san inda ko yadda suka kamu da cutar ba. Ana ba da shawarar ga masu ba da kulawa da ke kula da wanda ke da cutar su yi amfani da daidaitattun matakan kariya, matakan kariya, da kiyaye idanu.
Amfani da bayanan wurin wayoyin hannu da gwamnatoci ke yi don wannan dalili ya haifar da damuwar sirri, wanda hakan ya sa Amnesty International da sauran kungiyoyi sama da 100 suka fitar da sanarwa don iyakance irin wannan sa ido.
An aiwatar ko kuma ba da shawarar aikace-aikacen hannu daban-daban don amfani da son rai, kuma har zuwa 7 ga Afrilu, 2020, sama da ƙungiyoyin ƙwararru dozin suna aiki akan hanyoyin magance abokantaka na sirri, kamar amfani da Bluetooth don yin amfani da kusanci daga wasu wayoyin salula na mai amfani.
Masu amfani suna samun saƙo idan sun kasance cikin kusanci da wani wanda ya gwada COVID-19 tabbatacce.Rashin fahimta game da hanyoyin hana kamuwa da cuta suna yaduwa; alal misali, shafa hanci da kuma wanke baki ba su da tasiri.
Babu rigakafin COVID-19 da ke akwai, kodayake ƙungiyoyi da yawa suna aiki don haɓaka rigakafi.
Ana bada shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa akai-akai na aƙalla dakika ashirin, musamman bayan sun je banɗaki ko kuma idan hannayensu sun kasance da datti; kafin cin abinci; da kuma bayan an huda hanci, an yi hanca ko an yi atishawa.
Wannan saboda a waje da jikin mutum, ana kashe kwayar cutar da sabulun gida, wanda ke fashewa da abubuwan da ke kare ta.
Bugu da ƙari, CDC ta ba da shawarar yin amfani da na'urar tsabtace hannu mai amfani da giya wanda ke da aƙalla kashi 60% na barasa lokacin da sabulu da ruwa ba su da sauƙi.
WHO ta shawarci mutane da su guji taba idanu, hanci ko bakinsu da hannaye marasa wanka.
Za'a iya kashe kwayoyin cuta ta hanyoyi da yawa, ciki har da 6271% ethanol, 50100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone - iodine (a cikin minti ɗaya na hulɗa da maganin kashe ƙwayoyin cuta don saman ƙarfe mara tsami).
Wasu magungunan, kamar su benzalkonium chloride da crohexidin gluconate, ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan an yi zargin ko an tabbatar da wani COVID a ofishi ko wurin da ake kula da shi kamar ofishi, ya kamata a tsabtace dukkan wuraren da ake amfani da su kamar ofisoshin, dakunan wanka, wuraren jama'a, na'urorin lantarki da ake amfani da su kamar su allunan, allon taɓawa, allon rubutu, na'urorin sarrafa nesa, da na'urorin ATM da mutane masu cutar ke amfani da su.
Ƙungiyoyin kiwon lafiya sun ba da shawara cewa a rufe hanci da baki da kuma hanci da ƙwanƙwasa ko kuma wani abu da zai rufe hanci da hanci sa'ad da ake yin tari ko yin atishawa, kuma a zubar da duk wani abu da aka samu nan da nan.
Ana ba da shawarar yin amfani da abin rufe fuska na tiyata ga mutanen da za su iya kamuwa da cutar, saboda sanya abin rufe fuska na iya iyakance adadin da kuma nisan da za a iya wucewa na saukad da numfashi da ke yaduwa lokacin magana, atishawa, da tari.
WHO ta ba da umarni game da lokacin da yadda za a yi amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin cututtukan cututtukan cututtuka a Jami'ar Leeds, "Sanya abin rufe fuska na iya rage yawan mutane zuwa taɓawa fuskarsu, wanda shine babban tushen kamuwa da cuta ba tare da tsabtace hannu ba".
WHO ta ba da shawarar sanya abin rufe fuska ta mutanen da ke cikin koshin lafiya ne kawai idan suna cikin haɗari, kamar waɗanda ke kula da wanda ke da COVID-19, kodayake sun kuma yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskarsu.
Ƙasashe da yawa sun fara ƙarfafa amfani da abin rufe fuska ga talakawa.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska na likitanci wanda ba na likitanci ba wanda aka yi da yarin. China ta ba da shawarar yin amfani da abin rufe fuska na likitanci wanda ba shi da magani ta hanyar mutane masu lafiya na yau da kullun, musamman lokacin da suka kusanci mutane (1 mita (3 feet) ko ƙasa da haka).
Hong Kong ta ba da shawarar sanya abin rufe fuska yayin amfani da sufuri na jama'a ko zama a wuraren da ke cike da jama'a.
Jami'an kiwon lafiya a Thailand suna ƙarfafa mutane su yi abin rufe fuska a gida kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita a wuraren jama'a ba tare da sanya abin rufe fuska ba ko rufe hanci da fuska.
A ranar 16 ga Maris, Vietnam ta nemi kowa da kowa ya sanya abin rufe fuska yayin da yake shiga wuraren jama'a don kare kansa da na wasu.
Gwamnatin Austriya ta ba da umarnin sanya abin rufe fuska ga duk wanda ya shiga kantin sayar da kayan masarufi.
Isra'ila ta bukaci dukkan 'yan kasar da su sanya takunkumin fuska a duk lokacin da suke shiga cikin jama'a.
Taiwan, wacce ke samar da masks miliyan goma a kowace rana tun daga tsakiyar Maris, ta ba da umarnin sanya abin rufe fuska ga matafiya a cikin jiragen ƙasa da bas na birni a ranar 1 ga Afrilu.
Panama ta sanya sanya takunkumin fuska ya zama tilas yayin da ake fita waje, yayin da kuma bada shawarar yin abin rufe fuska a gida ga mutanen da ba za su iya siyan abin rufe fuska ba.
Ana amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisantar zamantakewa (wanda aka fi sani da nisantar jiki) ya ƙunshi ayyukan hana kamuwa da cuta, wanda ke nufin rage yaduwar cuta ta hanyar rage kusanci tsakanin mutane.
Hanyoyin sun haɗa da keɓewa; ƙuntatawar tafiye -tafiye; da rufe makarantu, wuraren aiki, filayen wasa, gidajen kallo, ko wuraren sayayya.
Mutane na iya amfani da hanyoyin nisantar da jama'a ta hanyar zama a gida, iyakance tafiye-tafiye, guje wa wuraren cunkoso, yin amfani da gaisuwa ba tare da tuntuɓar juna ba, da kuma nisantar da kansu daga wasu.
Gwamnatoci da yawa yanzu suna ba da umarni ko ba da shawarar kiyaye nisantar zamantakewa a yankunan da cutar ta shafa.
An rage yawan jama'a da hukumomin gwamnati da kungiyoyin lafiya suka bayar da shawarar a Amurka daga mutane 250 (idan ba a san wani cutar COVID-19 a yankin ba) zuwa mutane 50, sannan daga baya zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a na mutane fiye da biyu. Manya tsofaffi da kuma mutanen da ke da yanayin likita kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, da kuma tsarin rigakafin da ke da rauni suna da haɗarin kamuwa da cututtuka da cututtuka masu tsanani kuma CDC ta ba su shawara su zauna a gida kamar yadda ya yiwu a yankunan da ke fama da cutar. A ƙarshen Maris 2020, WHO da sauran hukumomin kiwon lafiya sun fara sauya amfani da kalmar " nisantar zamantakewa " da " nisantar jiki ", don bayyana cewa manufar ita ce ta rage hulɗa ta zamantakewa ta hanyar kiyaye hulɗa ta jiki ko dai ta jiki ko ta jiki.
Amfani da kalmar "nesa tsakanin jama'a" ya haifar da ma'anar cewa, ya kamata mutane su ɗauki cikakken keɓewar jama'a maimakon ƙarfafa su don yin hulɗa da wasu ta hanyar wasu hanyoyin. Wasu hukumomi sun ba da jagororin kiwon lafiyar jima'i don amfani da su yayin annobar.
Wadannan sun hada da shawarwarin yin jima'i ne kawai da mutumin da ke tare da kai wanda ba shi da cutar ko kuma wanda ba shi da alamun cutar.
An ba da shawarar keɓe kai a gida ga mutanen da aka gano suna da COVID-19 da kuma waɗanda ake zargin suna da cutar.
Hukumomin lafiya sun bayar da cikakkun bayanai game da keɓewar kai. Gwamnatoci da yawa sun ba da umarnin ko kuma ba da shawarar keɓewa ga dukkan mazauna yankunan da abin ya shafa.
An ba da umarnin tsaurara kai-tsare a cikin rukunin haɗari.
Duk wanda ya sadu da wani da ke dauke da COVID-19 da kuma wanda ya ziyarci wata kasa ko yanki da ke da cutar, ana ba da shawarar a killace kansa na tsawon kwanaki 14 daga lokacin da aka samu cutar.
Hanyoyin da za a bi wajen magance wata annoba su ne, hanawa ko kuma dakile, da kuma rage radadin.
An yi wannan aikin ne a farkon barkewar cutar kuma manufarsa ita ce gano mutanen da suka kamu da cutar tare da aiwatar da wasu matakan da za su iya hana cutar da kuma yin allurar rigakafi don hana yaduwar cutar a sauran al'umma.
Idan ba za a iya hana cutar ba, sai a mayar da hankali ga ragewa, wato, a ɗauki matakai don rage yaduwar cutar da kuma rage tasirin da cutar take da shi a kan tsarin kiwon lafiya da kuma al'umma.
Ana iya amfani da maganin hana yaduwa da maganin rage zafi a lokaci guda.
Tsayawa yana buƙatar ƙarin matakan da za a iya amfani da su don rage yawan adadin haihuwa zuwa 1. Wani ɓangare na gudanar da cutar ta kamuwa da cuta shine ƙoƙarin rage girman cutar, wanda aka sani da rage girman cutar.
Wannan yana rage haɗarin rashin lafiyar lafiya da kuma ba da ƙarin lokaci don haɓaka allurar rigakafi da magani.
Hanyoyin da ba na magani ba da za su iya magance barkewar cutar sun haɗa da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska da keɓewa; matakan al'umma da aka yi niyya kamar rufe makarantu da soke shirye-shiryen taro don nisantar da jiki; haɗin kan al'umma don karfafa yarda da shiga cikin irin wannan sa hannun; kazalika da matakan muhalli kamar tsabtace farfajiya. An gudanar da ayyuka masu tsaurara a China da nufin hana barkewar cutar lokacin da aka gano tsananin barkewar cutar, kamar keɓe dukkan biranen da tsauraran takunkumin tafiye-tafiye.
Sauran ƙasashe ma sun ɗauki matakan da yawa don iyakance yaduwar cutar.
Koriya ta Kudu ta fara bincike mai zurfi da kebewa a cikin gida, da kuma bayar da gargadin game da motsi na mutanen da ke da cutar.
Singapore ta ba da tallafin kuɗi ga waɗanda suka kamu da cutar waɗanda suka keɓe kansu kuma suka ba da babbar tarar ga waɗanda suka kasa yin hakan.
Taiwan ta haɓaka samar da abin rufe fuska kuma ta hukunta tara kayan aikin likita. Abubuwan da aka yi don Burtaniya da Amurka sun nuna cewa akwai ƙalubale masu yawa a cikin ragewa (ragewa amma ba a hana yaduwar cutar ba) da kuma dakile (juya ci gaban cutar).
Ka'idojin rage radadin cutar na iya rage yawan bukatar kula da lafiya da kashi biyu cikin uku, kuma ya rage yawan mutuwar da rabi, amma har ila yau, daruruwan mutane suna mutuwa kuma tsarin kiwon lafiya ya lalace.
Za a iya ba da fifiko ga dakilewa, amma ana buƙatar kiyaye shi har sai cutar ta bazu cikin yawan mutane (ko kuma har sai an sami rigakafi, idan ya kasance da wuri), in ba haka ba rashin kulawa yana haifar da saurin dawowar yaduwa.
Tsattsauran ra'ayi na dogon lokaci don magance annoba yana haifar da farashin zamantakewa da tattalin arziki.
Babu takamaiman magungunan ƙwayoyin cuta da aka amince da su don COVID-19, amma ƙoƙarin ci gaba yana gudana, gami da gwajin magungunan da ake da su.
Shan magungunan sanyi da sanyi, shan ruwa da kuma hutawa na iya taimakawa wajen rage alamun.
Dangane da tsananin, ana iya buƙatar maganin oxygen, ruwan intravenous, da taimakon numfashi.
Yin amfani da steroids zai iya sa sakamakon ya yi muni.
Ana binciken wasu magungunan da aka riga aka amince da su don magance wasu cututtukan ƙwayoyin cuta don amfani da su wajen magance COVID-19.
A cewar WHO, wasu " magungunan gargajiya da na gida " na iya taimakawa wajen rage alamun da SARS-CoV-19 ke haifarwa.
WHO ta bayyana haɓaka iyawa da daidaitawa na kiwon lafiya don bukatun marasa lafiyar COVID-19 a matsayin matakan amsawa na barkewar cutar.
ECDC da WHO Regional Office na Turai sun ba da jagorori don tura albarkatu ga asibitoci da sabis na kiwon lafiya na farko a matakai da yawa, gami da: mayar da hankali kan ayyukan dakin gwaje-gwaje akan gwajin COVID-19, soke hanyoyin zaɓuɓɓuka a duk lokacin da ya yiwu, warewa da keɓe marasa lafiya da ke da COVID-19, da haɓaka ƙarfin kulawa mai ƙarfi ta hanyar horar da ma'aikata da haɓaka adadin ventilators da gadaje da ke akwai.
Akwai ra'ayoyi da yawa game da inda al'amarin farko (wanda ake kira mai haƙuri) ya samo asali.
An gano farkon cutar da aka sani na sabon kwayar cutar coronavirus a Wuhan, Hubei, China a ranar 1 ga Disamba, 2019.
A cikin wata guda, adadin masu kamuwa da cutar a Hubei ya karu a hankali.
Wadannan sun fi yawa ne da suka danganci kasuwar sayar da kayan kifi ta Hunan, wanda kuma ake sayar da dabbobi masu rai, kuma akwai ra'ayi cewa cutar ta fito ne daga daya daga cikin wadannan dabbobi; ko kuma, a wata ma'ana, asalin dabbobi ne. An gano gungun cutar huhu da ba a san dalilinsa ba a ranar 26 ga Disamba kuma likitan Zhang Jixian ne ya yi jinyar su a asibitin lardin Hubei, wanda ya sanar da Wuhan Jiangnan CDC a ranar 27 ga Disamba.
A ranar 30 ga Disamba, wani rukuni na likitoci a asibitin Wuhan ya gargadi abokan aikinsa game da "SARS-like coronavirus".
'Yan sanda sun gargadi likitoci takwas, ciki har da Lee Wenliang, kan yada jita - jitar ƙarya, kuma wani likita, I Feng, ya sha ihu daga shugabanninsa.
Hukumar Lafiya ta Birnin Wuhan ta ba da sanarwar jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An ba da rahoton wasu maganganu na cutar nimoniya da ba a gano ba ga hukumomin lafiya a Wuhan, wanda ya sa aka fara bincike a farkon watan Janairu. A lokacin farkon barkewar annobar, adadin masu kamuwa da cutar ya ninka kusan sau biyu a kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairu 2020, cutar ta bazu zuwa wasu lardunan China saboda yawan zirga-zirga da Sabuwar Shekarar Sin da Wuhan ke da shi, cibiyar sufuri da kuma babbar hanyar musayar jiragen kasa.
A ranar 20 ga Janairu, China ta ba da rahoton kusan sabbin mutane 140 a rana guda, ciki har da mutum biyu a Beijing da mutum daya a Shenzhen.
Bayanan hukuma na baya sun nuna cewa mutane 6,174 sun riga sun kamu da cutar zuwa 20 ga Janairu 2020. Ya zuwa 26 ga Maris, Amurka ta wuce China da Italiya a matsayin masu yawan adadin da aka tabbatar da cutar a duniya. Ya zuwa 9 ga Afrilu, 2020, an ba da rahoton sama da mutane miliyan 1.61 a duniya; fiye da mutane 97,000 sun mutu kuma fiye da mutane 364,000 sun warke.
Aƙalla akwai ɗaya daga cikin waɗannan a cikin kusan ƙasashe da yankuna 200.
Saboda barkewar cutar a Turai, kasashe da yawa a yankin Schengen sun takaita zirga-zirgar 'yanci kuma sun kafa iyakokin kan iyakoki.
Amsoshin ƙasa sun haɗa da matakan hanawa kamar su keɓewa (wanda aka fi sani da umarnin zama a gida, umarnin zama a wurin zama, ko kuma kulle-kulle) da kuma dokar hana fita. A ranar 2 ga Afrilu, kusan mutane miliyan 300 a Amurka, ko kusan kashi 90% na yawan jama'a suna cikin wani nau'i na kulle-kulle, fiye da mutane miliyan 50 a Philippines suna cikin kulle-kulle, kusan mutane miliyan 59 a Afirka ta Kudu suna cikin kulle-kulle, kuma mutane biliyan 1.3 a Indiya suna cikin kulle-kulle.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya sun shiga wani irin kulle-kulle, wanda ya karu zuwa biliyan 2.6 bayan kwana biyu - kusan kashi daya bisa uku na jama'ar duniya.
An gano farkon cutar COVID-19 a Wuhan a ranar 1 ga Disamba, 2019; wani rahoto da ba a tabbatar da shi ba ya nuna cewa an sami cutar a ranar 17 ga Nuwamba.
Likita Zhang Jixian ya lura da tarin cututtukan cutar huhu da ba a san dalilin su ba a ranar 26 ga Disamba, bayan haka asibitin sa ya sanar da Wuhan Jiangnan CDC a ranar 27 ga Disamba.
Gwajin kwayar halitta na farko na samfuran mai haƙuri a ranar 27 ga Disamba, 2019 ya nuna kasancewar kwayar cutar SARS-like.
A ranar 31 ga Disamba, Hukumar Kiwon Lafiya ta Birnin Wuhan ta ba da sanarwar jama'a.
WHO ta sanar da ita a wannan ranar.
Bayan wadannan rahotannin, 'yan sanda a Wuhan sun gargadi likitoci da su "yi jita-jita" game da barkewar cutar.
Hukumar lafiya ta kasar Sin ta ce babu wata "hujja" da ta nuna cewa cutar ta yadu daga mutum zuwa mutum.
A ƙarshen watan Janairu, gwamnatin China ta fara wani mummunan aiki don dakile yaduwar cutar, wanda Sakatare Janar na Jam'iyyar Kwaminis ta China Xi Jinping ya kira "yakin mutane".
An bayyana a matsayin "mafi girma a cikin tarihin ɗan adam", an ba da sanarwar a yankin da aka kewaye don hana zirga-zirga a Wuhan a ranar 23 ga Janairu, wanda aka faɗaɗa zuwa birane 15 a cikin Hubei, wanda ya shafi mutane miliyan 57.
An hana amfani da motoci masu zaman kansu a cikin birni.
An soke bukukuwan sabuwar shekara ta Sinanci (Janairu 25) a wurare da yawa.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, asibitin Hosensen, wanda aka kammala a cikin kwanaki 10.
An gina wani asibitin, asibitin Leishensen, don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, China ta kuma canza wasu wurare 14 a Wuhan kamar cibiyoyin taro da kuma filayen wasa zuwa asibitocin wucin gadi.A ranar 26 ga Janairu, gwamnati ta kafa ƙarin matakan hana barkewar COVID-19, gami da fitar da sanarwar lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
An kuma rufe makarantu da jami'o'i a duk faɗin ƙasar.
Yankunan Hong Kong da Macau sun kafa matakan da yawa, musamman dangane da makarantu da jami'o'i.
An kafa hanyoyin yin aiki daga nesa a yankuna da yawa na China.
An sanya takunkumin hana zirga -zirga a ciki da wajen Hubei.
An sake sauya sufuri na jama'a, kuma an rufe gidajen tarihi na ɗan lokaci a duk ƙasar Sin.
An sanya takunkumi kan zirga-zirgar jama'a a birane da yawa, kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu nau'ikan ƙuntatawa na waje.Bayan barkewar cutar a cikin watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana cutar "zuwa" daga wasu ƙasashe.
A misali, Beijing ta sanya dokar keɓewa ta kwanaki 14 ga duk matafiya na duniya da ke shiga birni. A ranar 23 ga Maris, shari'ar guda daya ce kawai aka samu a cikin gida a cikin kwanaki biyar da suka gabata a cikin babban yankin China, a wannan misalin ta hanyar wani matafiyi da ke dawowa daga Istanbul zuwa Guangzhou.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya sanar da cewa an dakatar da yaduwar masu yaduwar cutar a gida kuma an shawo kan barkewar cutar a kasar Sin.
A wannan rana, watanni biyu bayan an fara kulle, an sassauta takunkumin tafiye-tafiye a Hubei ban da Wuhan. Ma'aikatar Harkokin Waje ta kasar Sin ta sanar a ranar 26 ga Maris, 2020, cewa za a dakatar da shiga kasar Sin ga masu biza ko takardar izinin zama daga ranar 28 ga Maris, ba tare da wani bayani na musamman game da lokacin da wannan manufar za ta ƙare ba.
Duk wanda ke son shiga China dole ne ya nemi takardar izinin shiga kasar Sin a ofishin jakadancin kasar Sin ko ofishin jakadancin kasar Sin.
Gwamnatin China ta ƙarfafa kasuwanci da masana'antu su sake buɗewa a ranar 30 ga Maris kuma ta ba da kunshin ƙarfafa tattalin arziki ga kasuwancin. Majalisar Jiha ta ba da sanarwar ranar makoki a ranar 4 ga Afrilu da karfe 10:00 na safe, ta fara da minti uku na nutsewar ƙasa, wanda ya zo daidai lokacin bikin Qingming, duk da cewa gwamnatin tsakiya ta nemi iyalai da su yi biyayya ta hanyar yin nesa ta hanyar yin amfani da yanar gizo don kauce wa sabon barkewar COVID-19.
An tabbatar da barkewar cutar COVID-19 a Koriya ta Kudu daga China a ranar 20 ga Janairu, 2020.
Hukumar lafiya ta kasar ta yi rahoton karuwar wadanda suka kamu da cutar a ranar 20 ga watan Fabrairu, wanda ya danganta da yadda mutane suka taru a Daegu, wani sabon addini da ake kira Cocin Yesu na Shinchigi.
Masu bautar Shinchyoji da suka zo Daigu daga Wuhan sun kasance masu shakkar asalin cutar.
Ya zuwa ranar 22 ga Fabrairu, 1,261 ko kusan 13% na mabiyan cocin 9,336 sun ba da rahoton alamun.Koriya ta Kudu ta ba da sanarwar matakin gargadi mafi girma a ranar 23 ga Fabrairu 2020.
A ranar 28 ga Fabrairu, an samu fiye da mutum 2,000 da suka kamu da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin sojan Koriya ta Kudu bayan da aka tabbatar da cewa sojoji uku sun kamu da cutar.
Shirin da Koriya ta Kudu ta gabatar, wanda aka ɗauka a matsayin mafi girma kuma mafi kyawun tsari a duniya don bincika yawan jama'a don cutar da kuma ware duk wani wanda aka kamu da cutar, da kuma ganowa da keɓe waɗanda suka zo tare da su.
Hanyoyin binciken sun hada da tilasta kai tsaye na bayyanar cututtuka ta hanyar sabbin masu shigowa na duniya ta hanyar aikace-aikacen wayar hannu, saurin gwaji don kwayar cutar tare da sakamakon da ake samu a rana mai zuwa, da kuma kara karfin gwaji don gwada mutane 20,000 a kowace rana.
Shirin Koriya ta Kudu ana ɗaukar sa a matsayin nasara a cikin sarrafa barkewar cutar duk da cewa ba a kebe biranen gaba ɗaya ba.Koriya ta Kudu ta kasance mai rarrabuwa a kan yadda Shugaba Moon Jae-in ya mayar da martani ga rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a yi wa Moon tsige, suna zargin gwamnati da yin ba daidai ba a lokacin barkewar cutar, ko kuma suna yabawa a kan yadda ya mayar da martani.
A ranar 23 ga Maris, an ba da rahoton cewa Koriya ta Kudu tana da karancin lokuta a cikin kwanaki hudu.
A ranar 29 ga Maris, an sanar da cewa daga ranar 1 ga Afrilu, duk sabbin baƙi da suka shigo ƙasar za a keɓe su na tsawon makonni biyu.
A ranar 1 ga Afrilu, kafofin watsa labarai sun ba da rahoton cewa Koriya ta Kudu ta karbi buƙatun taimako na gwajin ƙwayoyin cuta daga ƙasashe 121.
Iran ta ba da rahoton farkon kamuwa da cutar SARS-CoV-2 a Kom a ranar 19 ga Fabrairu, inda mutane biyu suka mutu daga baya a ranar, a cewar Ma'aikatar Lafiya da Ilimin Likita.
Matakan farko da gwamnati ta sanar sun hada da rufe kide kide da wake-wake da sauran shirye-shiryen al'adu, wasannin motsa jiki, da sallar Juma'a, da rufe jami'o'i, manyan makarantu da makarantu.
Iran ta ware Riyal tiriliyan biyar don magance cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairun 2020 babu wani shiri na kebe yankunan da cutar ta shafa kuma za a kebe mutane ne kawai.
An ba da sanarwar shirin rage tafiye-tafiye tsakanin biranen a watan Maris, duk da cewa zirga-zirgar ababen hawa tsakanin biranen ya ci gaba da yawa kafin sabuwar shekara ta Farisa.
Har zuwa 16 ga Maris, 2020, wuraren bautar Shi'a a Qom sun kasance a buɗe ga masu bautar Allah.A lokacin Fabrairu, Iran ta zama cibiyar watsa cutar bayan China.
A cikin da'awar boyewa da'awar kamuwa da cutar a Iran, sama da kasashe goma sun gano cewa akwai alakar da ke tsakanin cutar da Iran a ranar 28 ga Fabrairu, wanda ke nuna cewa kamuwa da cutar na iya zama mafi tsanani fiye da adadin mutane 388 da gwamnatin Iran ta rubuta a ranar.
An rufe majalisar dokokin Iran bayan da 23 daga cikin mambobinta 290 suka kamu da cutar a ranar 3 ga watan Maris.
A ranar 12 ga Maris, Human Rights Watch ta yi kira ga hukumomin gidan yari na Iran da su saki masu kare hakkin dan adam da aka tsare saboda zanga-zangar lumana ba tare da wani sharadi ba, da kuma sakin dukkan fursunonin da suka cancanta a wani lokaci.
Ya kara da cewa, akwai hadarin kamuwa da cutar a wuraren da aka rufe, kamar wuraren da ake tsare, inda kuma ba a samun isasshen kulawar likitoci.
A ranar 15 ga Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana guda, wanda shi ne adadi mafi girma da aka samu a cikin ƙasar tun bayan barkewar cutar.
A kalla 'yan siyasa 12 da tsofaffin jami'an gwamnatin Iran sun mutu a sakamakon cutar a ranar 17 ga watan Maris.
Har zuwa 23 ga Maris, ana samun sabbin kamuwa da cutar a kowace sa'a guda 50 a Iran, kuma a kowane minti goma ana samun sabon mutuwar cutar.
Wani jami'in WHO ya ce, Iran na da adadin wadanda suka kamu da cutar fiye da sau biyar na wadanda ake samun rahoton su.
An kuma ba da shawarar cewa takunkumin da Amurka ta sanya wa Iran na iya shafar karfin kudi na kasar don mayar da martani ga barkewar cutar.
Babban Kwamishinan Majalisar Dinkin Duniya na kare hakkin bil'adama ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da wasu 'yan yawon bude ido biyu' yan kasar Sin da ke Roma suka kamu da cutar SARS-CoV-2.
Lamarin ya karu da sauri, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa da kuma daga China kuma ta ayyana dokar ta baci.
An gano wani rukuni na COVID-19 da ba su da alaƙa, wanda ya fara da 16 da aka tabbatar a Lombardy a ranar 21 ga Fabrairu.A ranar 22 ga Fabrairu, majalisar ministoci ta ba da sanarwar sabuwar dokar shari'a don dakile barkewar cutar, tare da keɓe mutane fiye da 50,000 daga 11 daban-daban a cikin arewacin Italiya.
"A cikin wuraren da cutar ta bullo, ba za a ba da izinin shiga da fita ba", in ji Firayim Minista Giuseppe Conte.
An riga an ba da umarnin dakatar da ayyukan aiki da shirye-shiryen wasanni a cikin waɗancan yankuna. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar, bayan mutuwar 100 a Italiya.
Duk manyan wasannin motsa jiki, gami da wasannin ƙwallon ƙafa na Serie A, ya kamata a yi su ba tare da shaidu ba har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da dukkan wasannin gaba ɗaya na aƙalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan duk ayyukan kasuwanci, ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Italiya ta Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) ta buga shawarwarin ɗabi'a game da ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin
A ranar 19 ga Maris, Italiya ta fi ta China yawan masu kamuwa da cutar coronavirus a duniya bayan ta ba da rahoton mutuwar mutane 3,405 daga cutar.
A ranar 22 ga watan Maris, an ba da rahoton cewa Rasha ta tura jiragen sama guda tara zuwa Italiya dauke da kayan aikin likita.
Ya zuwa 5 ga Afrilu, Italiya tana da mutane 128,948 da aka tabbatar, 15,887 suka mutu, da 21,815 da suka warke, tare da yawancin al'amuran da ke faruwa a yankin Lombardy.
Wani rahoton CNN ya nuna cewa haɗuwa da yawan tsofaffin mutanen Italiya da rashin iyawar yin gwajin mutanen da suka kamu da cutar a lokacin na iya ba da gudummawa ga yawan mace - ta - mace.
Martanin Birtaniya game da cutar ya kasance na farko a cikin ƙasashen da suka fi fama da cutar, kuma har zuwa ranar 18 ga Maris, 2020, gwamnatin Burtaniya ba ta aiwatar da duk wani nau'in nisantar zamantakewar jama'a ko matakan keɓewa ga 'yan ƙasa ba.
A sakamakon haka, gwamnati ta sami suka saboda rashin saurin da take da shi da kuma gaggawar da take nunawa wajen mayar da martani ga damuwar da jama'a ke fuskanta. A ranar 16 ga Maris, Firaminista Boris Johnson ya ba da shawarar dakatar da duk wata tafiya da ba ta da muhimmanci da kuma hulɗar jama'a, tare da ba da shawarar cewa mutane su yi aiki daga gida inda ya yiwu kuma su guji wuraren da ake da jama'a a ciki kamar wuraren shan giya, gidajen abinci da gidajen sinima.
A ranar 20 ga Maris, gwamnatin ta sanar da cewa duk wuraren nishaɗi kamar wuraren shakatawa da wuraren motsa jiki za a rufe su da wuri-wuri, kuma ta yi alkawarin biyan ma'aikata har zuwa kashi 80% na albashin su har zuwa £ 2,500 a wata don hana rashin aikin yi a cikin rikici. A ranar 23 ga Maris, firaministan ya sanar da tsauraran matakan nisantar da jama'a, ya hana tarurruka sama da mutane biyu da kuma iyakance tafiye-tafiye da ayyukan waje zuwa ayyukan da aka ɗauka da mahimmanci.
Ba kamar matakan da suka gabata ba, an tilasta waɗannan ƙuntatawa ta hanyar hukunta 'yan sanda da kuma tarwatsa taron.
An umarci rufe yawancin kasuwancin, ban da kasuwancin da aka ɗauka "mai mahimmanci", wanda ya haɗa da manyan kantunan, magunguna, bankuna, shagunan kayan masarufi, tashoshin mai da kuma gareji.
A ranar 20 ga Janairu, jihar Pacific Northwest ta Washington ta tabbatar da farkon wanda aka sani da COVID-19 a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar ta White House Coronavirus Task Force a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana matsalar lafiyar jama'a, kuma ta hana matafiya shiga kasar Sin.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka - babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka - ta sanar da cewa ta samar da kayan gwajin nata.
Duk da yin hakan, Amurka ta fara gwajin ne a hankali, wanda hakan ya sa ya zama da wuya a fahimci ainihin yanayin barkewar cutar a lokacin.
Gwajin ya kasance yana da matsala saboda ƙarancin kayan gwaji da gwamnatin tarayya ta yi a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan gwaji na ba da tallafi (ta masana ilimi, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma ƙuntataccen ƙa'idodin da ke hana mutane su cancanci yin gwaji har zuwa farkon Maris (wanda bayan haka ya buƙaci umarnin likita).
Ya zuwa ranar 27 ga Fabrairu, The Washington Post ta ba da rahoton cewa an yi gwajin kasa da 4,000 a Amurka.
A ranar 13 ga watan Maris, The Atlantic ta ba da rahoton cewa an yi kasa da gwaje-gwaje 14,000.
A ranar 22 ga Maris, The Associated Press ta ba da rahoton: "Mutane da yawa da ke da alamun cutar kuma suna da umarnin likita sun jira na sa'o'i ko kwanaki don a gwada su". A Amurka, bayan da aka ba da rahoton mutuwar farko a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Insley ya ba da sanarwar gaggawa, matakin da sauran jihohi suka bi ba da daɗewa ba.
Makarantun yankin Seattle sun soke azuzuwan a ranar 3 ga Maris kuma tun daga tsakiyar Maris, ana rufe makarantu a duk faɗin ƙasar. A ranar 6 ga Maris, 2020, ƙungiyar ƙwararrun masana ilimin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka a Kwalejin Imperial College London sun ba da shawara ga Amurka game da hasashen tasirin sabon coronavirus a ƙasar.
A wannan ranar ne kuma, Shugaba Trump ya rattaba hannu kan dokar da aka yi wa karin tanadi don shirye-shiryen da za a yi don magance annobar, wadda ta ba da dala biliyan 8.3 don ba da tallafin gaggawa ga hukumomin tarayya da za su yi aiki a kan cutar.
Kamfanoni sun sanya takunkumin tafiye tafiye, sun soke taro, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
A ranar 11 ga Maris, wanda ya fara aiki a ranar 13 ga Maris, Trump ya ba da sanarwar dakatar da tafiye-tafiye na tsawon kwanaki 30 ga yawancin Turai, ban da Burtaniya.
Washegari, ya kara takunkumin kuma ya kara da Birtaniya da Ireland.
A ranar 13 ga Maris, ya ba da sanarwar gaggawa ta ƙasa, wanda ya ba da kuɗin tarayya don amsa rikicin.
Tun daga ranar 15 ga Maris, yawancin kasuwancin sun daina aiki ko rage lokacin aiki a duk faɗin Amurka don ƙoƙarin rage yaduwar cutar.
Ya zuwa ranar 17 ga watan Maris, an tabbatar da cewa an samu annobar a dukkan jihohi 50 da kuma gundumar Columbia.A ranar 23 ga watan Maris, an bayar da rahoton cewa akwai mutane 10,700 da suka kamu da cutar coronavirus a birnin New York, wanda ya fi yawan adadin da aka samu a Koriya ta Kudu.
A ranar 25 ga Maris, gwamna ya ce nisantar da jama'a yana aiki, yayin da adadin da ake tsammani ya ninka daga kwanaki 2.0 zuwa kwanaki 4.7.
Ya zuwa ranar 28 ga Maris, an tabbatar da mutane 32,308 da suka kamu da cutar a birnin New York, kuma mutane 672 sun mutu sanadiyyar cutar. A ranar 26 ga Maris, Amurka ta ba da rahoton ƙarin mutane da suka kamu da cutar coronavirus fiye da kowace ƙasa a duniya, ciki har da China da Italiya. Ya zuwa ranar 8 ga Afrilu, Amurka ta ba da rahoton mutane 400,335 da suka kamu da cutar, kuma mutane 12,841 sun mutu.
A ranar 30 ga watan Maris, shugaban Amurka Donald Trump ya tsawaita umarnin hana nisantar da jama'a har zuwa ranar 30 ga watan Afrilu, kamar yadda rahotanni suka ruwaito.
A wannan ranar ne jirgin ruwan USNS Comfort, wanda ya zama asibiti mai gadaje 1,000, ya sauka a New York.
A ranar 3 ga Afrilu, an sami adadin mutuwar 884 a Amurka a cikin awanni 24.
A jihar New York, adadin masu kamuwa da cutar ya haura 100,000 a ranar 3 ga Afrilu.An soki Fadar White House saboda rage girman hadarin da kuma sarrafa sakonni ta hanyar umarnin jami'an kiwon lafiya da masana kimiyya su hada kai da ofishin mataimakin shugaban kasa Mike Pence don yin maganganu da wallafe-wallafen da suka shafi cutar.
Dukan zaɓen da Trump ya yi na magance matsalar ya yi daidai da na ƙiyayya.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayayyaki masu mahimmanci daga China, ciki har da kayayyakin kiwon lafiya masu mahimmanci.
An yi amfani da tsarin nazarin tafiye-tafiye don yin taswira da hasashen yaduwar kuma an buga shi a cikin Jaridar Maganin Tafiya a tsakiyar Janairun 2020.
Bisa ga bayanan 2018 daga Transportungiyar Sufurin Jiragen Sama ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei suna da mafi yawan fasinjoji daga Wuhan.
Dubai, Sydney da Melbourne sun kasance sanannun wurare don mutanen da ke tafiya daga Wuhan.
An bayyana Bali a matsayin mafi ƙarancin ƙarfi daga cikin biranen da aka fi sani da 20 a cikin yanayin shiri, yayin da aka gano biranen Australia a matsayin mafi ƙarfi. Ostiraliya ta fitar da shirin ta na gaggawa don cutar Korona (COVID-19) a ranar 7 ga Fabrairu.
Wannan ya nuna cewa ba a san da yawa game da COVID-19 ba, kuma Ostiraliya za ta mai da hankali kan kula da kan iyakoki da sadarwa a cikin martanin cutar.
A ranar 21 ga Maris, an ayyana dokar ta-baci ta tsaron lafiyar dan Adam a Ostereliya.
Saboda ingantaccen keɓewar jigilar jama'a a Wuhan da Hubei, ƙasashe da yawa sun shirya fitar da 'yan ƙasa da ma'aikatan diflomasiyya daga yankin, galibi ta jiragen haya na gida, wanda hukumomin China suka ba da izini.
Kasashen farko da suka fara shirin fitar da 'yan kasarsu sun hada da Canada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand.
Pakistan ta ce ba za ta fitar da wani dan kasar daga China ba.
A ranar 7 ga Fabrairu, Brazil ta fitar da 'yan Brazil 34 ko danginsu, ban da 'yan kwaminis hudu, da wani dan kasar China da kuma wani dan kasar Indiya.
'Yan kasar Poland, China, da Indiya sun sauka a Poland, inda jirgin na Brazil ya koma kan hanyarsa ta zuwa Brazil bayan ya tsaya.
'Yan Brazil da suka je Wuhan an kebe su a wani sansanin soji da ke kusa da Brasilia.
A wannan ranar, 'yan ƙasar Kanada 215 (176 daga jirgin farko, 39 daga jirgin na biyu da gwamnatin Amurka ta yi haya) an kwashe su daga Wuhan zuwa CFB Trenton kuma an keɓe su na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama dauke da 'yan Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Ostiraliya sun kwashe 'yan kasar 277 a ranar 3 da 4 ga Fabrairu zuwa Cibiyar Kula da Tsibirin Kirsimeti, wanda aka sake gina shi a matsayin wurin keɓewa, inda suka zauna har tsawon kwanaki 14.
Jirgin da aka kai New Zealand ya isa Auckland a ranar 5 ga Fabrairu; an kebe fasinjojinsa (ciki har da wasu daga Australia da kuma yankin Pacific) a wani sansanin sojin ruwa a Wangaiparoa, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa daga jirgin ruwan Diamond Princess.
A ranar 21 ga Fabrairu, wani jirgin sama ya sauka a Trenton, Ontario, dauke da fasinjoji 129 'yan Kanada da aka kwashe daga jirgin Diamond Princess.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, wani jirgin saman kamfanin South African Airways da gwamnatin Afirka ta Kudu ta ba da lasisi ya dawo da' yan Afirka ta Kudu 112.
An yi gwajin likita kafin tashi, kuma an bar 'yan Afirka ta Kudu huɗu da ke nuna alamun cutar coronavirus a baya don rage haɗarin.
An mayar da 'yan Afirka ta Kudu da suka yi gwaji mara kyau ne kawai.
Sakamakon gwajin ya nuna cewa dukkan 'yan Afirka ta Kudu ba su da cutar, ciki har da ma'aikatan jirgin, matukan jirgin, ma'aikatan otal, 'yan sanda da sojoji a cikin aikin agaji, duk sun kasance a karkashin kulawar kariya kuma an kebe su a Ranch Resort na tsawon kwanaki 14.
A ranar 20 ga Maris, Amurka ta fara janye dakarunta daga Iraki saboda cutar.
A ranar 5 ga Fabrairu, Ma'aikatar Harkokin Wajen China ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimakon agaji zuwa China.
Wasu daliban kasar Sin daga jami'o'in Amurka sun hada kai don taimakawa wajen aika da taimako zuwa yankunan da cutar ta shafa a kasar Sin, inda aka ce wata kungiya a yankin Chicago ta tura takunkumin N95 50,000 zuwa asibitocin lardin Hubei a ranar 30 ga Janairu.Kungiyar agajin jin kai ta Direct Relief, a cikin hadin kai da FedEx, ta tura takunkumin fuska 200,000 tare da wasu kayan kariya na sirri, ciki har da safar hannu da gashi, zuwa asibitin Wuhan Union ta hanyar jirgin gaggawa har zuwa ranar 30 ga Janairu.
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don kare "mutanan da ke cikin hadari a Afirka da Kudancin Asiya", da kuma tallafawa binciken allurar rigakafi da kuma kokarin warkarwa.
Interactions ya ruwaito cewa gwamnatin China ta ba da kyautar masks 200,000 ga Filipin a ranar 6 ga Fabrairu, lokacin da Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga Fabrairu, Red Cross na Singapore ya ba da sanarwar cewa zai aika da taimakon dala miliyan 2.26 zuwa China.
Japan ta ba da kyautar abin rufe fuska miliyan daya a Wuhan, Turkiyya ta tura kayan aikin likitanci, Rasha ta tura tan 13 na kayan kiwon lafiya zuwa Wuhan, Malaysia ta sanar da ba da gudummawar safofin hannu miliyan 18 ga China, Jamus ta ba da gudummawar kayan kiwon lafiya daban-daban ciki har da kayan aikin 10,000, kuma Amurka ta ba da gudummawar tan 17.8 na kayan aikin kiwon lafiya zuwa China da kuma alkawarin dala miliyan 100 a cikin ƙarin taimakon kuɗi ga ƙasashen da abin ya shafa.
A watan Maris, China, Cuba da Rasha sun tura kayan aikin likita da kwararru zuwa Italiya don taimakawa wajen magance barkewar cutar ta coronavirus.
Jack Ma ya aika da kayan gwaji miliyan ɗaya da dubu ɗari, da abin rufe fuska miliyan shida, da kuma kayan kariya dubu 60 zuwa Addis Ababa, Habasha don rarraba ta Tarayyar Afirka.
Daga baya, ya tura Panama kayan gwaji 5,000, da abin rufe fuska 100,000 da kuma na'urar sanyaya jiki 5.
Ma ya kuma ba da gudummawar kayan aikin likita ga Kanada. Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech sun bayyana damuwarsu kan abin rufe fuska da kayan gwaji da aka yi a China.
Misali, Spain ta dawo da kayan gwajin cutar coronavirus 58,000 da aka yi a China tare da daidaito kashi 30% kawai, yayin da Netherlands ta dawo da abin rufe fuska na China 600,000 wanda ke da lahani.
Belgium ta dawo da kayan rufe fuska 100,000 da aka yi amfani da su, wadanda aka dauka sun fito ne daga China, amma a zahiri sun fito ne daga Colombia.
A gefe guda, an samu karɓuwa sosai ga taimakon da China ke bayarwa a wasu ɓangarorin Latin Amurka da Afirka. A ranar 2 ga Afrilu, Bankin Duniya ya ƙaddamar da ayyukan ba da agajin gaggawa ga ƙasashe masu tasowa.
WHO ta yaba da kokarin hukumomin China na gudanar da kuma hana yaduwar cutar.
WHO ta yi nuni da bambanci tsakanin barkewar cutar SARS a 2002-2004 inda aka zargi hukumomin kasar Sin da yin boye-boye wanda ya kawo cikas ga kokarin hanawa da kuma maganin, da kuma rikicin na yanzu inda gwamnatin tsakiya ta "ba da sabuntawa a kai a kai don guje wa fargaba kafin hutun sabuwar shekara".
A ranar 23 ga watan Janairu, a cikin martani ga shawarar da hukumomin tsakiya suka yanke na aiwatar da takunkumin safarar a Wuhan, wakilin WHO Gauden Galia ya yi sharhi cewa yayin da "ba shakka WHO ba ta ba da shawarar ba" wannan "ainihin alama ce mai mahimmanci na sadaukar da kai don dakile cutar a wurin da ta fi yawa" kuma ya kira shi "wanda ba a taɓa gani ba a tarihin lafiyar jama'a". A ranar 30 ga Janairu, WHO ta ayyana barkewar a matsayin matsalar gaggawa ta lafiyar jama'a ta damuwar kasa da kasa (PHEIC) bayan tabbatar da yaduwar mutum-zuwa-mutumin a wajen kasar Sin da kuma wannan karuwar adadin sauran shari'o'in, wanda shi ne karo na shida da PHEIC ta dauki matakan farko tun bayan barkewar cutar ta ɓeraye a shekarar 2009.
Babban Daraktan WHO Tedros Adhanom ya ce PHEIC ya haifar da "haɗarin yaduwar cutar a duniya, musamman a ƙasashe masu ƙarancin kuɗi da matsakaici ba tare da ingantaccen tsarin kiwon lafiya ba".
A cikin martani ga aiwatar da takunkumin tafiye -tafiye, Tedros ya ce "babu wani dalili na matakan da ke tsoma baki cikin tafiye -tafiye da cinikayya na ƙasa da ƙasa ba tare da wata bukata ba" kuma "WHO ba ta ba da shawarar iyakance kasuwanci da motsi".
A ranar 5 ga Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da gudummawar dala miliyan 675 don shirye-shiryen da za a yi a cikin ƙasashe masu ƙarancin kuɗi, inda ta yi kira da a taimaka wa ƙasashen da "ba su da tsarin da za su iya gano mutanen da suka kamu da cutar, ko da kuwa za a iya samun cutar. "
Tedros ya kara da cewa a cikin sanarwa, "mu ne kawai karfi kamar yadda mu mafi raunin mahada" da kuma kira ga kasa da kasa al'umma "don zuba jari a yau ko biya more daga baya". A ranar 11 ga Fabrairu, WHO a wani taron manema labarai kafa a matsayin cutar na COVID-19.
A wannan ranar, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya amince ya ba da "ikon tsarin Majalisar Dinkin Duniya gaba daya a cikin martani".
Sakamakon haka ya sa aka kunna wata rundunar UN ta kula da rikicin da ta hada kai da dukkan bangarorin UN, wanda a cewar WHO zai ba su damar "daidaita kan aikin kiwon lafiya, yayin da sauran hukumomin za su iya amfani da kwarewarsu wajen magance tasirin annobar".
A ranar 14 ga Fabrairu, an kunna wata tawagar hadin gwiwa da WHO ke jagoranta tare da China don ba da tabbacin ƙasa ga masana a China da kuma na duniya WHO don taimakawa cikin gudanar da gida da kuma gudanar da bita da kuma gudanar da taro tare da manyan cibiyoyin ƙasa don tantance "tsaurin cutar da yaduwar cutar" da kuma "tasirin ayyukan mayar da martani a matakin lardi da na gunduma, gami da birane da yankuna". A ranar 25 ga Fabrairu, WHO ta sanar cewa "ya kamata duniya ta ƙara yin ƙoƙari don shirya don yiwuwar annobar coronavirus", yana mai cewa duk da cewa da wuri, amma ya kamata ƙasashe su "kasance a cikin wani matakin shiri na yanzu".
Dangane da barkewar cutar a Iran, WHO ta tura wata tawagar hadin gwiwa don tantance halin da ake ciki.A ranar 28 ga Fabrairu, hukumomin WHO sun ce za a tantance barazanar cutar ta duniya daga "mai girma" zuwa "mai girma", matakin mafi girman faɗakarwa da ƙimar haɗari.
Mike Ryan, darektan gudanarwa na shirin gaggawa na kiwon lafiya na WHO, ya yi gargadin a cikin wata sanarwa cewa "Wannan gwajin gaskiya ne ga kowace gwamnati a duniya: lokaci ya yi da za a farka.
Wannan kwayar cutar na iya zuwa kuma kuna buƙatar kasancewa a shirye ", yana mai da hankali cewa matakan da suka dace na iya taimakawa duniya ta guji "mafi munin abin da ya faru".
Ryan ya ci gaba da cewa alkaluman da ake da su a yanzu ba su tabbatar da hukumomin kiwon lafiya na jama'a su ayyana cutar a matsayin annoba ta duniya ba, yana mai cewa irin wannan ayyanawar na nufin "ba za mu iya yarda da cewa kowane mutum a duniya zai kamu da wannan cutar ba".
A ranar 11 ga Maris, WHO ta ayyana annobar cutar korona a matsayin annoba.
Darakta Janar ya ce WHO "ta damu matuka game da haɗarin da ke tattare da yaduwa da kuma matakan haɗari na rashin aiki". WHO ta fuskanci babban zargi saboda rashin isasshen kula da annobar, gami da jinkirin da ta yi na ayyana dokar ta baci ta kiwon lafiya da kuma rarraba cutar a matsayin annoba.
Sakamakon ya haɗa da takardar neman murabus na Daraktan WHO Tedros Adhanom, wanda mutane 733,000 suka sanya hannu har zuwa 6 ga Afrilu.
A ranar 26 ga Maris, 2020, daruruwan masanan kare hakkin bil'adama na Majalisar Dinkin Duniya sun yi kira ga girmama haƙƙin kowane mutum a yayin annobar COVID-19.
Kungiyar ta ce kowa na da hakkin samun ceton rai kuma gwamnati ce ke da alhakin hakan.
Kungiyar ta jaddada cewa, bai kamata a yi amfani da karancin albarkatu ko rashin inshorar lafiya a matsayin hujja don nuna bambanci ga wani rukuni na musamman.
Masana sun jaddada cewa kowane mutum, gami da nakasassu, kungiyoyin marasa rinjaye, tsofaffi, masu hijira a cikin gida, marasa gida, mutanen da ke cikin matsanancin talauci, mutanen da ke cikin keɓewa, da 'yan gudun hijira da sauran rukunin da ba a bayyana ba waɗanda ke buƙatar taimakon gwamnati, suna da' yancin samun lafiya.
Kungiyoyin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewar jama'a na rikicin COVID-19.
Kungiyar Tattalin Arzikin Duniya ta kafa wani dandamali don samar da cikakken bayani, hangen nesa da shawarwari kan martani na siyasa a kasashe a duniya.
Daga manufofi zuwa karfafa tsarin kiwon lafiya da kuma magance tasirin hanawa da takunkumi a kan tafiye-tafiye a cikin tattalin arzikin duniya, Digital Hub ya ƙunshi mai bin diddigin manufofin ƙasa, kuma yana da nufin taimaka wa ƙasashe su koya daga juna da kuma sauƙaƙa da haɗin gwiwar duniya don magance ƙalubalen cutar ta Korona.
Amurka, Ministan Burtaniya na Ofishin Ministan, Michael Gove, da ɗan Shugaban Brazil, Jair Bolsonaro, Eduardo Bolsonaro, sun soki gwamnatin China kan yadda ta magance cutar a lardin Hubei na China.
An kori wasu masu gudanar da ayyukan lardin a jam'iyyar kwaminis ta Sin (CPC) saboda yadda suka yi aiki a kokarin da ake yi na killace mutane a tsakiyar kasar Sin, wanda ke nuna rashin gamsuwa da yadda hukumomin siyasa ke mayar da martani ga barkewar cutar a yankunan.
Wasu masu sharhi sun yi imanin cewa an yi wannan ne don kare babban sakataren jam'iyyar kwaminis ta Sin Xi Jinping daga fushin da jama'a ke yi kan barkewar cutar coronavirus.
Wasu jami'an China, kamar Zhao Lijian, sun yi watsi da yarda da cewa barkewar cutar coronavirus da ta fara a Wuhan, suna ba da shawara game da makircin da ke faruwa game da COVID-19 wanda ya samo asali daga Amurka ko Italiya.
Gwamnatin Donald Trump ta Amurka ta yi la'akari da kwayar cutar ta "Chinese virus" ko "Wuhan virus", tana mai cewa "tsarin sarrafawa na China ya juya kwayar cutar zuwa ga cutar da ta zama annoba a duniya", wanda wasu masu suka suka suka a matsayin "rashin nuna bambancin launin fata da kuma gazawar gwamnatin sa wajen hana cutar".
Jaridar Daily Beast ta samu wani sakon gwamnatin Amurka da ke nuna cewa an kafa wani shingen sadarwa a cikin kwamitin tsaro na kasa, inda aka bayyana dabarar cewa "duk abin da ya shafi kasar Sin ne.
Ana tambayar mu mu yi kokarin isar da wannan sakon ta kowace hanya, gami da taron manema labarai da kuma bayyanar da talabijin. "Hotunan kamar Politico, Foreign Policy da Bloomberg sun yi iƙirarin cewa ƙoƙarin China na aika da taimako ga ƙasashen da cutar ta shafa wani ɓangare ne na farfaganda don ƙara girman tasirin duniya.
Shugaban harkokin wajen Tarayyar Turai, Josep Borrell, ya yi gargadin cewa yana da "abubuwa na siyasa da suka haɗa da gwagwarmaya don tasiri ta hanyar juyawa da 'siyasa na sassaucin ra'ayi.' "
Borrell ya kuma ce, "China tana tura sakon cewa ba kamar Amurka ba, ita ce mai alhakin da za a iya amincewa da ita".
China ta kuma yi kira ga Amurka da ta cire takunkumin da ta sakawa kan Syria da Venezuela da kuma Iran, inda aka ce an tura kayan agaji ga kasashen biyu na baya.
A ranar 3 ga Afrilu, an dakatar da tallafin masks 100,000 na Jack Ma ga Cuba saboda takunkumin Amurka.
An kuma zargi hukumomin Amurka da karkatar da taimakon da aka yi niyya ga wasu kasashe zuwa kasarsu.
Kuma akwai rikice-rikice game da abin rufe fuska tsakanin wasu ƙasashe kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da kari, Turkiyya ta kwace daruruwan na'urorin sanyaya numfashi da aka shirya za a tura Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kan Tarayyar Turai da Italiya da ke fama da cutar ta coronavirus.
Mai magana da yawun jakadan Italiya a Tarayyar Turai, Maurizio Massari, ya ce "China ce kawai ta yi martani a kan al'amuran da suka shafi kasashen biyu".
Babu shakka, wannan ba alama ce mai kyau ba ta haɗin kan Turai".
A ranar 22 ga Maris, bayan wani kiran waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya aikawa da likitocin soja, motocin kwantar da cuta na musamman da sauran kayan aikin likita zuwa rundunar sojan Rasha.
Jaridar La Stampa ta Italiya ta yi kaulin wani "babban dan siyasa" wanda ba a bayyana sunansa ba, wanda ya ce kashi 80 na taimakon da Rasha ta bayar "ba shi da amfani ko kuma bai yi wa Italiya amfani ba".
Wannan majiyar ta zargi Rasha da yin "ta'addanci da diplomasiyya".
Shugaban Lombardy Atillio Fontana da Ministan Harkokin Wajen Italiya Luigi Di Maio sun musanta rahotannin kafofin watsa labarai kuma sun nuna godiya.
Rasha ta aika da kayan agaji na likita zuwa Amurka ta jirgin sama.
Da yake ba da taimakon ga abokan Amurka, mai magana da yawun Kremlin Dmitry Peskov ya ce, "Suna da tabbacin cewa idan Amurkawa masu kera kayayyakin kiwon lafiya da kayan aiki suka kara yawan kayayyakin da suke kerawa, za su iya biyan diyyarsu idan ya zama dole".
Za a gudanar da babban wasan motsa jiki na NATO mafi girma tun bayan karshen yakin Cold War, wato wasan motsa jiki na NATO "Defender 2020" a kan kasa a Jamus, Poland, da kuma kasashen Baltic.
Sakatariyar Janar na Nuclear Disarmament Kate Hudson ta soki atisayen Defender 2020: "A cikin rikicin lafiyar jama'a na yanzu, yana jefa rayuwar sojojin Amurka da na ƙasashen Turai da yawa cikin haɗari, har ma da mazauna ƙasashe masu halarta inda suke aiki". Gwamnatin Iran ta yi fama da cutar, tare da kusan 'yan majalisa da yawa da suka kamu da cutar, da kuma wasu' yan siyasa goma sha biyar na yanzu ko na baya.
Shugaban Iran Hassan Rouhani ya rubuta wasikar jama'a ga shugabannin duniya a ranar 14 ga Maris, 2020 don neman taimako, yana mai cewa kasarsa tana fama da fama da barkewar cutar saboda rashin samun damar zuwa kasuwannin duniya sakamakon takunkumin Amurka da aka sanyawa Iran. Wannan barkewar cutar ta haifar da kira ga Amurka da ta rungumi manufofin zamantakewa a cikin sauran ƙasashe masu arziki, ciki har da kula da lafiya ta duniya, kula da yara ta duniya, hutun iyali da aka biya, da kuma babban matakin kudade ga lafiyar jama'a.
Manazarta siyasa sun yi hasashen cewa hakan na iya yin tasiri a kan sake zaben Donald Trump a zaben shugaban kasa na 2020. Rashin jituwa tsakanin Japan da Koriya ta Kudu ya sa dangantakar diflomasiyya ta yi tsami.
Koriya ta Kudu ta soki Japan saboda "kokarin da ba a bayyana ba kuma ba a yi aiki ba" lokacin da Japan ta ba da sanarwar cewa duk wanda ya zo daga Koriya ta Kudu za a keɓe shi a makonni biyu a wuraren da gwamnati ta tsara.
Da farko, jama'ar Koriya ta Kudu sun rabu saboda yadda Shugaba Moon Jae-in ya mayar da martani game da rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takaddun neman a gurfanar da Moon, suna zargin gwamnati da aikata laifin da ya shafi barkewar cutar, ko kuma suna yabawa da yadda ta mayar da martani. Wannan annobar ta sa ƙasashe suka zartar da dokokin gaggawa don mayar da martani.
Wasu masu sharhi sun nuna damuwa cewa hakan na iya taimaka wa gwamnatoci su karfafa ikon su.
A Hungary, majalisar dokokinta ta kada kuri'ar ba da damar firaminista, Viktor Orban, ya yi mulki ba tare da bata lokaci ba, tare da dakatar da majalisar da kuma zabuka, da kuma hukunta duk wanda aka samu yana yada labaran karya game da yadda ake magance cutar da kuma rikicin da gwamnati ke ciki.
An zargi barkewar cutar coronavirus da misalai da yawa na ƙarancin wadatar da aka samu, wanda ya samo asali daga amfani da kayan aiki don yaƙar cutar a duniya, sayayya ta hanyar tsoro, da kuma rushewar masana'antu da ayyukan dabaru.
Hukumar Kula da Abinci da Magunguna ta Amurka ta yi gargadin game da karancin magunguna da na'urorin kiwon lafiya saboda karuwar bukatar masu amfani da kuma katsewar masu samar da kayayyaki.
An ga wasu yankuna da yawa suna yin sayayya cikin tsoro, wanda ya sa kayan masarufi kamar abinci, takardar bayan gida, da ruwan kwalba suka ragu daga kan shelves, wanda hakan ya rage wadatar.
An gargadi masana'antar fasaha musamman game da jinkirin jigilar kayayyakin lantarki.
A cewar Tedros Adhanom, Darakta Janar na WHO, bukatar kayan kariya ta mutum ya karu sau 100.
Wannan bukatar ya sa farashin na yau da kullum ya karu har sau ashirin, kuma ya sa an yi jinkiri wajen isar da kayayyakin kiwon lafiya na tsawon watanni hudu zuwa shida.
Wannan ya haifar da karancin kayan kariya na mutum a duniya, wanda WHO ta yi gargadin cewa zai jefa ma'aikatan lafiya cikin haɗari.
A Ostiraliya, cutar ta ba da sabuwar dama ga masu sayar da kayan da ke da gida don sayar da kayayyakin Australiya a China.
Wannan aikin ya haifar da karancin kayan abinci na jarirai a wasu manyan kasuwannin kuma daga baya gwamnatin Ostiraliya ta hana shi. Duk da yawan masu cutar COVID-19 da kuma tsananin bukatar kayayyakin abinci a yankin arewacin Italiya da Wuhan, yankuna biyu na fuskantar karancin abinci.
Matakan da China da Italiya suka ɗauka don hana yin amfani da kayayyaki masu mahimmanci da kuma cinikin haramtacciyar hanya sun yi nasara, sun hana ƙarancin abinci da aka yi hasashen a Turai da kuma Arewacin Amurka.
Arewacin Italiya ba ta ga babban raguwa a cikin muhimmin aikin gona ba, amma farashin na iya tashi bisa ga wakilan masana'antu.
An kuma ga shelves na abinci a cikin garin Wuhan na wucin gadi, yayin da jami'an gwamnatin kasar Sin suka saki wadatattun kayan abinci na shukar-nama don tabbatar da wadataccen abinci ga yawan jama'a.
A Italiya, irin wannan dokar ta wajabta wa masu noman abinci su ajiye abinci don irin wannan yanayi na gaggawa.
An ji rauni a tattalin arzikin duniya a China: Matakan gwamnati don dakile yaduwar cutar, da kuma faduwar tallace-tallace da kashi 20.5 cikin dari, ya yi mummunan tasiri a kan tattalin arzikin kasar Sin a farkon watanni biyu na 2020, a cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris.
Tunda China ta zama babbar tattalin arziki da cibiyar masana'antu, barkewar cutar ana ganin babbar barazanar kawo cikas ga tattalin arzikin duniya.
Agathe Demaris na sashen binciken tattalin arziki na Economist Intelligence Unit ya yi hasashen cewa kasuwannin za su ci gaba da yin tururuwa har sai an sami cikakken haske game da sakamakon da ake tsammanin.
A cikin Janairu 2020, wasu manazarta sun yi hasashen cewa tasirin tattalin arzikin cutar a kan ci gaban duniya na iya zama mafi girma fiye da barkewar SARS na 2002-2004.
Wani ƙwararren masani daga Jami'ar Washington a St. Louis ya yi hasashen cewa tasirin da ya kai dala biliyan 300 a kan sarkar samar da kayayyaki a duniya zai iya kaiwa shekara biyu.
Kungiyar Kasashen da ke Fitar da Man Fetur ta OPEC ta yi ta "fada" bayan da farashin mai ya fadi saboda karancin bukatar da ake samu daga China.
Kasuwannin hannayen jari na duniya sun yi tashin gwauron zabi a ranar 24 ga Fabrairu saboda karuwar adadin masu cutar COVID-19 a wajen kasar Sin.
A ranar 27 ga Fabrairu, saboda karuwar damuwa game da barkewar cutar coronavirus, wasu alamomin hada-hadar hannayen jari na Amurka da suka hada da NASDAQ-100, S&amp;P 500 index, Dow Jones Industrial Average sun ba da rahoton raguwa mafi sauri tun daga 2008, inda Dow ya fadi da maki 1,191, wanda shi ne mafi girma a cikin rana guda tun bayan rikicin kudi na 2007-08.
Dukkanin alamun sun yi kasa da kashi 10 cikin 100 a wannan makon.
A ranar 28 ga Fabrairu, Scope Ratings GmbH ya tabbatar da kimantawa na cinikayya na China, amma ya ci gaba da kasancewa mai mummunan fata.
A sakamakon wannan, hannun jari ya sake faduwa, tare da raguwa mafi girma a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai iya yin kasala.
Masanin tattalin arziki, Mohammed Al-Erian, ya yaba wa babban bankin da jihohi saboda matakan gaggawa da suka dauka.
Bankunan tsakiya na kasar sun fi karfin da suka yi a lokacin da aka fuskanci matsalar kudi a shekara ta 2008.
Yawon shakatawa na ɗaya daga cikin yankuna da suka fi fama da cutar saboda ƙuntata zirga-zirgar ababen hawa, rufe wuraren jama'a, gami da wuraren yawon shakatawa, shawarwarin gwamnatoci na dakatar da duk wata tafiya a duk faɗin duniya.
A sakamakon haka, kamfanonin jiragen sama da dama, ciki har da British Airways, China Eastern Airlines da Qantas, sun soke zirga-zirgar jiragen sama saboda karancin bukatar, yayin da kamfanin jiragen sama na yankin Burtaniya Flybe ya fadi.
Wannan shi ne karo na farko da aka taɓa ganin irin wannan mummunar sakamako a kan jiragen ruwa.
An kuma rufe tashar jirgin kasa da tashar jiragen ruwa da yawa.
Wannan lokacin ya zo daidai da lokacin da ake yin manyan tafiye-tafiye, wato lokacin hutun Sabuwar Shekara ta China.
Gwamnatocin ƙasa da na yanki sun soke yawancin abubuwan da suka faru, gami da bikin Sabuwar Shekara na shekara-shekara, tare da kamfanoni masu zaman kansu da kansu suna rufe shagunan su da wuraren yawon shakatawa kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe wasu bukukuwan sabuwar shekara da wuraren yawon bude ido a Beijing don hana taron jama'a da suka hada da Forbidden City da bukukuwan gargajiya na gidajen ibada.
A cikin 24 daga cikin larduna 31, birane da yankuna na kasar Sin, hukumomi sun tsawaita hutun Sabuwar Shekara zuwa 10 ga Fabrairu, tare da umarnin mafi yawan wuraren aiki kada su sake buɗewa har zuwa wannan ranar.
Waɗannan yankuna sun wakilci kashi 80 na GDP da kashi 90 na fitar da kayayyaki na ƙasar.
Hong Kong ta kara yawan matakan rigakafin cutar ta kamuwa da cutar zuwa mafi girma kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa Maris kuma ta soke bikin sabuwar shekara. An yi tasiri a kan ɓangaren tallace-tallace a duniya, tare da ragewa ko rufe shagunan na ɗan lokaci.
A Turai da Latin Amurka, ziyarar masu siyarwa ta ragu da kashi 40 bisa dari.
Masu siyar da kaya a Arewacin Amurka da Gabas ta Tsakiya sun ga raguwar 50-60%.
Masu tafiya zuwa shagunan kasuwanci sun ragu da kashi 33 zuwa 43 cikin dari a watan Maris idan aka kwatanta da na watan Fabrairu.
Masu gudanar da cibiyoyin kasuwanci a duk duniya sun ɗauki ƙarin matakan, kamar ƙara tsaftacewa, shigar da na'urori masu auna zafi don bincika yanayin zafin jiki na masu cin kasuwa, da soke abubuwan da suka faru. A cewar wani kwamiti na tattalin arziki na Majalisar Dinkin Duniya don Latin Amurka, raguwar da cutar ta haifar na iya barin tsakanin mutane miliyan 14 da 22 a Latin Amurka cikin talauci mai tsanani wanda ba zai kasance ba a cikin wannan yanayin ba tare da annobar ba.
A watan Janairu da Fabrairun 2020, a lokacin da annobar ta yi kamari a Wuhan, kusan mutane miliyan 5 a China sun rasa ayyukansu.
Yawancin ma'aikatan gudun hijira na karkara kusan miliyan 300 na kasar Sin sun makale a gida a lardunan cikin gida ko kuma sun makale a lardin Hubei.A watan Maris na 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar ta coronavirus na iya haifar da raguwar ayyuka miliyan 47 a Amurka kuma ƙimar rashin aikin yi na iya sauka zuwa 32%, kamar yadda Babban Bankin Tsaro na Saint Louis ya kiyasta. A Indiya, an kori miliyoyin ma'aikata masu ƙaura (wanda ake biyan su ta hanyar albashin yau da kullun).
A lokacin da ake yin rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi a ba su tallafin rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 na Birtaniya sun nemi a ba su tallafin bashi na duniya. A Jamus, kusan kamfanoni miliyan rabin sun tura ma'aikatansu zuwa wasu tsare-tsaren biyan albashi na gajeren lokaci da gwamnati ta bayar, wanda ake kira Kurzarbet.
Faransa da Birtaniya sun yi amfani da tsarin biyan diyyar aiki na gajeren lokaci na Jamus.
Ayyukan wasan kwaikwayo da al'adun gargajiyar al'adu sun sha wahala sosai daga annobar, wanda ya shafi ayyukan ƙungiyoyi a duk duniya, da kuma mutane masu aiki da masu zaman kansu.
Kungiyoyin al'adu da al'adu sun yi ƙoƙari su ci gaba da aikinsu (wanda aka ba da kuɗin jama'a) don ba da damar al'umma zuwa al'adun al'adu, don kiyaye lafiyar ma'aikatanta da jama'a, kuma, inda ya yiwu, don tallafawa masu zane -zane.
Ya zuwa watan Maris na 2020, a duk faɗin duniya da kuma a wurare daban-daban, an rufe gidajen tarihi, dakunan karatu, wuraren nunawa, da sauran cibiyoyin al'adu har abada, tare da soke ko jinkirta nune-nunen su, taron su, da kuma wasan kwaikwayon su.
A cikin martani, an yi ƙoƙari sosai don samar da wasu ayyuka ta hanyar dandamali na dijital. Wani sabon abu kuma da ke daɗa saurin kamuwa da cutar shine soke ayyukan addini, manyan al'amuran wasanni, da sauran al'amuran zamantakewa, kamar bukukuwan kiɗa da taron fasaha da nune-nunen kayan kwalliya.
Masana'antar fim ma ta fuskanci cikas. Vatican ta ba da sanarwar cewa an soke kiyayewar mako mai tsarki a Rome, wanda ke faruwa a makon ƙarshe na lokacin azumin Kirista na Lent.
Yawancin bishopo-a-jihohi sun ba da shawarar cewa Kiristoci tsofaffi su zauna a gida maimakon halartar taro a ranar Lahadi; wasu majami'u sun samar da sabis na coci ta hanyar rediyo, raye-raye ta yanar gizo ko talabijin, yayin da wasu ke ba da bautar motsa jiki.
Yayin da Roman Katolika na Rome suka rufe majami'unsu da wuraren ibadarsu da kuma kwashe Kiristoci daga St. Peter's Square, sauran addinai ma sun soke hidimomin coci, masallatai, majami'u, gidajen ibada, gidajen ibada da gurdauna, tare da takaita taron jama'a.
Ma'aikatar Kiwon Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da annobar ta shafa kuma daga baya ta rufe wuraren bautar, yayin da Saudi Arabia ta kuma hana shiga baƙi na ƙasashen waje da kuma 'yan ƙasa zuwa wurare masu tsarki a Makka da Madina.
Wannan annoba ta haifar da babbar matsala a kalandar wasanni a duniya tun bayan yakin duniya na biyu.
An soke ko jinkirta yawancin manyan abubuwan wasanni, gami da 2019-20 UEFA Champions League, 2019-20 Premier League, UEFA Euro 2020, 2019-20 NBA Season, da kuma 2019-20 NHL Season.
Fitowar cutar ta katse shirin gasar Olympics ta bazara ta 2020, wanda da farko aka shirya za a fara a ƙarshen Yuli; Kwamitin Olympics na kasa da kasa ya sanar a ranar 24 ga Maris cewa za a sake tsara wannan taron "zuwa wani kwanan wata bayan 2020 amma ba bayan lokacin bazara na 2021 ba". An rufe gidajen caca da sauran wuraren wasannin caca a duniya kuma an dage ko soke wasannin karta kai tsaye.
Wannan ya sa 'yan caca da yawa suka koma kan layi, tare da rahoton ƙaruwar ƙimar sabbin sa hannu a cikin rukunin caca da yawa. Masana'antar nishaɗi ma ta shafa, tare da ƙungiyoyin kiɗa da yawa sun dakatar ko soke kide kide da wake-wake.
Yawancin manyan gidajen wasan kwaikwayo, kamar na Broadway, sun dakatar da duk wasan kwaikwayo.
Wasu masu zane-zane sun nemi hanyoyin da za su ci gaba da raba aiki a kan intanet a matsayin madadin yin wasan kwaikwayo na gargajiya, kamar yin wasan kwaikwayo na wasan kwaikwayo na wasan kwaikwayo ko ƙirƙirar "aukuwa" na yanar gizo don nunawa, rarrabawa da kuma inganta aikin su.
A kan layi, yawancin labaran intanet masu taken kwayar cutar sun zama abin dariya da damuwa a cikin rashin tabbas.
Tun bayan barkewar COVID-19, an lura da karuwar nuna wariya, tsattsauran ra'ayi da wariyar launin fata ga mutanen da suka fito daga China da gabashin Asiya, da kuma mutanen da ke da wuraren da aka fi sani a Turai, Amurka da sauran ƙasashe.
An ga al'amuran tsoro, shakku da kuma nuna adawa a kasashe da dama, musamman a Turai, Gabashin Asiya, Arewacin Amurka da Asiya-Pacific.
Rahotanni daga watan Fabrairu (lokacin da yawancin lamura har yanzu suka kasance a cikin China) sun yi rubuce-rubuce game da tunanin wariyar launin fata na mutanen China a cikin ƙungiyoyi daban-daban a duniya, waɗanda suka cancanci samun cutar ko kuma a hukunta su.
Wasu ƙasashen Afirka ma sun ga ƙaruwar ƙiyayya da Sin.
Yawancin mazauna Wuhan da Hubei sun ba da rahoton nuna bambanci dangane da asalin yankin su.
Akwai taimako na kan layi da wajen layi ga mutanen China da kuma mutanen da ke cikin yankunan da cutar ta shafa.
Bayan ci gaban barkewar cutar a cikin sabbin kasashe masu zafi, mutanen Italiya, ƙasar farko a Turai da ta fuskanci mummunan barkewar COVID-19, na iya fuskantar shakku da ƙiyayya da baƙi. 'Yan ƙasa daga ƙasashe da suka haɗa da Malaysia, New Zealand, Singapore da Koriya ta Kudu sun sanya hannu kan takaddama don hana Sinawa shiga ƙasashensu a ƙoƙarin hana cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama abin birgewa a shafin Twitter.
'Yan kasar Sin da wasu' yan Asiya a Burtaniya da Amurka sun ba da rahoton karuwar cin zarafin wariyar launin fata da hare-hare.
Shugaban Amurka Donald Trump ya fuskanci suka saboda ya ambaci cutar ta coronavirus a matsayin "kwayar cutar China", wanda masu sukar suka yi la'akari da wariyar launin fata da kuma adawa da China.
A Ukraine, masu zanga - zangar sun kai hari kan motocin bas da ke ɗauke da 'yan gudun hijirar Ukraine da na ƙasashen waje daga Wuhan zuwa Novi Sanjari.
Dalibai daga arewa maso gabashin Indiya, wanda ke da iyaka da China, waɗanda ke karatu a manyan biranen Indiya, sun sami matsala game da cutar ta Coronavirus.
Shugaban jam'iyyar BJP a jihar Bengal, Dilip Ghosh, ya ce, "Allah ya hukunta mu saboda yadda 'yan China suka lalata muhalli".
Ofishin jakadancin China a Kolkata daga baya ya yi tir da wannan kalami, yana mai cewa "rashin gaskiya ne". A China, cutar ta haifar da tsattsauran ra'ayi da wariyar launin fata ga mazauna da ba Sinawa ba, tare da bayyana baƙi a matsayin "baƙin ƙasashen waje" da kuma "dawowa".
Yawancin jaridun da ke da Pevales sun cire su don wani ɓangare ko duka ɗaukar hoto na coronavirus.
Yawancin masu wallafa kimiyya sun ba da takardun kimiyya game da cutar tare da samun damar buɗewa.
Wasu masana kimiyya sun zaɓi su yi saurin raba sakamakon su a kan sabobin da aka riga aka buga kamar bioRxiv.
Cutar da ake samu daga wata cuta - cuta da ake samu daga wata cuta, sau da yawa sabon abu ne a yanayin cutar ko kuma yadda ake kamuwa da ita
Duniya da cututtuka - Dubi duniya da cututtuka
Jerin annoba da annoba - Jerin mutanen da suka mutu saboda cutar
Fataucin namun daji da cututtuka masu yaduwa - haɗarin kiwon lafiya da ke tattare da cinikin namun daji na ƙasashen waje.
Binciken dakin gwaje-gwaje na cutar coronavirus ta 2019 (COVID-19) da na SARS-CoV-2 da ke da alaƙa ya haɗa da hanyoyin gano bayyanar cutar da kuma gano ƙwayoyin rigakafin da aka samar a matsayin martani ga kamuwa da cuta.
Ana tabbatar da kasancewar ƙwayoyin cuta a cikin samfuran ta hanyar RT-PCR, wanda ke gano RNA na kwayar cutar.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na kwayar cutar SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da cututtukan da ke gudana ko na yanzu.
Ana iya amfani da bincike na rigakafi (hematopsychology) don tantancewa da kuma sa ido kan mutane.
Binciken rigakafi yana nuna yawan mutanen da suka kamu da cutar, har da waɗanda suke da alamun da ba su da alamun cutar ko kuma waɗanda ba su da alamun cutar.
Sakamakon wannan gwajin zai iya ƙayyade ainihin mutuwar cutar da matakin rigakafin jama'a a cikin mutane.
Saboda karancin bincike, babu wata kasa da ta samu sahihin alkaluman yaduwar cutar a cikin mutane har zuwa watan Maris na 2020.
Har zuwa 23 ga Maris, babu wata ƙasa da ta yi gwajin fiye da 3% na yawan jama'arta kuma akwai bambance-bambance da yawa a cikin ƙasashe daban-daban kan yawan gwajin da aka yi.
Wannan bambance -bambancen na iya yin tasiri sosai ga adadin mutuwar da aka ruwaito, wanda a wasu ƙasashe ana iya yin la'akari da shi sosai.
Ana iya bincika samfuran numfashi da aka samo ta hanyoyi daban -daban, gami da samfurin hanci ko mucous, ta amfani da Real - time Reverse Transcription Polymerase Chain Reaction (rRT - PCR).
Sakamakon bincike yakan kasance a cikin 'yan sa'o'i zuwa kwanaki 2.
RT - PCR tare da labule na makogwaro yana da inganci a farkon mako na cutar.
Daga baya, kwayar cutar za ta iya ɓacewa daga makogwaro, yayin da take ci gaba da ƙaruwa a cikin huhu.
Ga waɗanda aka gano suna da cutar a cikin mako na biyu, za a iya yin amfani da samfurin da aka ɗauka daga cikin iska ta hanyar catheter na tsotsa ko kuma amfani da abin da aka samu daga cough (ballagam).
Daya daga cikin farkon gwajin PCR da aka yi amfani da Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) an ci gaba a Charité a Berlin a watan Janairun 2020, kuma ya zama tushen rarraba kayan aiki 250,000 da Hukumar Lafiya ta Duniya (WHO) ta yi.
United Kingdom ma sun haɓaka kayan bincike a ranar 23 ga Janairu, 2020. Kamfanin KoganBioTech na Koriya ta Kudu ya haɓaka nau'in bincike na SARS-CoV-2 (PowerCheck Coronavirus) mai ƙwarewa, mai ƙwarewa a kan PCR, a ranar 28 ga Janairu, 2020.
Yana gano "E" gene da aka raba ta dukkan beta coronaviruses da kuma RdRp gene da aka samo a cikin SARS-CoV-2 musamman. A China, BGI Group ita ce ɗaya daga cikin kamfanoni na farko da suka sami izinin amfani da gaggawa na PCR-tushen SARS-CoV-2 kit kit daga National Medical Products Administration na China. A Amurka, Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) suna ba da sabon kwayar cutar ta 2019-nCoV (2019-nCoV) Real-Time RT-PCR Diagnostic Panel zuwa dakunan gwaje-gwajen kiwon lafiya ta hanyar Reagent Research International.
Tsoffin juzu'in gwajin na gwajin sun sami sakamako mara kyau saboda ƙarancin reagents a cikin ɗayan gwajin kwayar halitta guda uku, kuma ya haifar da matsala a cikin gwajin a CDC a Atlanta; wannan ya haifar da matsakaicin matsakaicin samfuran da aka sarrafa cikin nasara a cikin duka Fabrairu 2020 na ƙasa da samfuran 100 a kowace rana.
Gwaje-gwajen da ke amfani da abubuwa biyu ba su da tabbas har zuwa 28 ga Fabrairu 2020 kuma ba a ba da izinin ci gaba da gwaji ba har zuwa lokacin da aka ba da izinin ci gaba da gwajin.
An ba da izinin gwajin ta Hukumar Kula da Abinci da Magunguna ta Hukumar Amfani da Gaggawa, kuma masu binciken masana'antu na Amurka sun fara gwajin a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ya sanar da samun gwajin COVID-19 na RT-PCR a duk fadin kasar.
Quest Diagnostics ya ba da damar gwajin COVID-19 a duk fadin kasar nan da 9 ga Maris, 2020.
Babu iyakance iyaka da aka sanar; dole ne a tattara da sarrafa samfuran daidai da bukatun CDC.
A Rasha, gwajin COVID-19 ya haɓaka kuma Cibiyar Nazarin Gida ta Virology da Biotechnology VECTOR ta samar.
A ranar 11 ga Fabrairu 2020, Hukumar Kula da Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris 2020, Mayo Clinic ya samu labarin kirkirar gwajin don gano cutar COVID-19. A ranar 13 ga Maris 2020, Roche Diagnostics ya sami izinin FDA don gwajin da za a iya yi a cikin sa'o'i 3.5 a cikin babban girma, wanda ya haifar da kimanin gwaje-gwaje 4,128 a cikin awanni 24 daga na'ura ɗaya.
A ranar 19 ga Maris 2020 FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don yin gwaji a kan tsarin Abbott na m2000; FDA ta ba da izini iri ɗaya ga Holologic, LabCorp, da ThermoFisher Scientific.
A ranar 21 ga Maris, 2020, Sheffield ta karɓi EUA daga FDA don binciken da ke ɗaukar kimanin minti 45.
FDA ta amince da gwajin da ke amfani da isothermal nucleic acid amplification maimakon PCR.
Tun da yake ba ya bukatar jerin canje -canje na zafin jiki, wannan hanyar tana iya ba da sakamako mai kyau a cikin ƙasa da minti biyar da kuma mummunan sakamako a cikin minti 13.
A halin yanzu akwai kimanin 18,000 na'urori a Amurka kuma Abbott yana son haɓaka masana'antu don gwajin 50,000 a kowace rana. An haɓaka kayan gwajin a Taiwan wanda ke amfani da rigakafin monoclonal wanda ke haɗuwa da sunadarin nucleocapsid na kwayar cutar coronavirus (N protein), tare da fatan zai iya ba da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin mura mai saurin gaske.
Wani bita na wallafe-wallafe na Maris 2020 ya kammala cewa "Radiograph na kirji a farkon matakan yana da ƙarancin mahimmancin bincike, yayin da CT [komputaccen tomography] na iya samun sakamako tun kafin bayyanar bayyanar cututtuka".
Abubuwan da ke cikin CT sun haɗa da bilateral multilobar ground - glass opacification tare da kewaye, asymmetrical da post - distribution.
Yayin da cutar take ci gaba, tasirin subplural, madding, da kuma haɗuwa suna tasowa.
Nazarin da ya kwatanta PCR da CT a Wuhan, asalin cutar ta yanzu, ya ba da shawarar cewa CT yana da mahimmancin hankali fiye da PCR duk da cewa ba shi da ƙayyadadden ƙayyadadden ƙayyadaddun ƙwayoyin cuta, tare da yawancin halayen hoto iri ɗaya da na wasu cututtukan huhu da hanyoyin cutar.
Ya zuwa Maris 2020, Kwalejin Rediyo na Amurka ta ba da shawarar cewa kada a yi amfani da CT a matsayin gwaji ko gwajin farko don gano COVID-19. Ya zuwa Maris 2020, CDC ta ba da shawarar PCR don gwajin farko.
Sashe na amsar rigakafi ga kamuwa da cuta ya ƙunshi samar da ƙwayoyin rigakafi, gami da IgM da IgG.
Ana iya amfani da su don gano kamuwa da cutar a cikin mutane da kuma lura da mutane bayan kwanaki 7 ko makamancin haka bayan bayyanar cututtuka. Ana iya yin gwajin a cikin dakunan gwaje-gwaje na tsakiya (CLT) ko ta hanyar gwajin kulawa (PoCT).
Tsarin atomatik mai yawan zafin jiki a cikin dakunan gwaje - gwaje na asibiti da yawa zai iya yin waɗannan gwaje - gwajen amma kasancewar su zai dogara ne akan ƙimar samar da kowane tsarin.
Ana amfani da samfurin jini guda ɗaya na yau da kullun don CLT, kodayake ana iya amfani da jerin samfuran don duba amsar rigakafi.
Ana samun samfurin jini guda don PoCT daga allurar fata.
Ba a buƙatar matakin farko na cirewa na gwaji wanda ya bambanta da hanyoyin PCR. A ranar 26 ga Maris, 2020, FDA ta zaɓi cibiyoyi 29 waɗanda ke ba da bayanai ga hukumar idan an buƙata kuma ta haka ne yanzu za su iya rarraba allurar rigakafin kansu.
Har zuwa 7 ga Afrilu, 2020, FDA ta amince da gwaji guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmune Medical Laboratory Diagnostics & Aptotope Diagnostics ya sami izinin Turai don kayan gwajinsa wanda zai iya gano IgG da IgA na rigakafin ƙwayoyin cuta a cikin samfurin jini.
Yana da damar bincika ɗaruruwan samfurori a cikin 'yan sa'o'i kuma saboda haka ya fi sauri fiye da gwajin PCR na gargajiya na kwayar cutar RNA.
Ana iya gano rigakafi a cikin kwanaki 14 bayan farawar kamuwa da cutar. A farkon watan Afrilu, UK ta gano cewa babu wani kayan gwajin rigakafin da ta saya da ya isa a yi amfani da shi.
Hong Kong ta tsara wani tsari wanda a ciki marasa lafiya masu shakku zasu iya zama a gida,  sashen gaggawa zai ba da bututun samfurin ga mai haƙuri, za su tofa shi a ciki kuma su dawo da sakamakon gwajin a cikin ɗan lokaci. NHS na Burtaniya ya ba da sanarwar cewa suna fara shirin don bincika marasa lafiya a gida, wanda ke kawar da haɗarin kamuwa da wasu marasa lafiya idan sun je asibiti ko kuma an yi amfani da motar motar asibiti. ƙwararren likita a cikin tafiye-tafiyen da ake zargi da cutar COVID-19 ya ɗauki samfurin tare da kiyayewa.
Cibiyoyin binciken motsa jiki sun taimaka wa Koriya ta Kudu ta gudanar da bincike mafi sauri, mafi yawa daga kowace ƙasa.A Jamus, National Association of Statutory Health Insurance Physicians a ranar 2 ga Maris sun ce suna da damar yin bincike kusan 12,000 a kowace rana a cikin asibiti kuma sun gudanar da bincike 10,700 a makon da ya gabata.
Amma idan likita ne ya ba da umarnin yin gwajin, inshorar lafiya ce za ta biya kuɗin.
A cewar shugaban Cibiyar Robert Koch, Jamus tana da damar yin gwajin mutum 160,000 a mako.
An ba da gwajin gwaji ta hanyar tuki a cikin manyan birane da yawa har zuwa 19 ga Maris.
Har zuwa 26 ga Maris, 2020, ba a san adadin adadin gwajin da aka gudanar a Jamus ba, saboda kawai an ba da rahoton sakamako mai kyau.
Binciken dakin gwaje-gwaje na farko ya nuna cewa aƙalla an gwada samfura 483,295 a cikin duka, har zuwa mako 12/2020, wanda ya haɗa da mako 12/2020, kuma an gwada samfura 33,491 (6.9%) waɗanda suka ba da halayen SARS-CoV-2. A Isra'ila, masu bincike a asibitin Technion da Renbaum sun haɓaka da kuma gwada samfurin ta hanyar haɗa samfuran tare da bincika samfuran daga marasa lafiya 64 a lokaci guda idan samfurin haɗin ya ba da halayen. A Wuhan, BGI ya ƙaddamar da wani lab na gaggawa na mita 2000 na "Huo-Yan" (sunan harshen Me: 火眼, ko "Fire Eye" a Turanci) wanda zai iya sarrafa samfuran sama da 10,000 a rana.
Tare da kulawar BGI, Wang Jian, wanda ya kafa BGI kuma ya ɗauki kwanaki 5, samfurin ya nuna cewa idan ba a ƙaddamar da wannan damar gwajin ba, yawan lamura a Hubei zai kasance 47% mafi girma kuma farashin da ya danganci magance keɓewa zai ninka.
Labarin Wuhan ya biyo bayan Laboratories Hu-Yen a Shenzhen, Tianjin, Beijing da Shanghai, jimlar birane 12 a duk fadin kasar Sin.
Har zuwa 4 ga Maris, 2020, jimlar yawan yau da kullun na yau da kullun ya kai bincike 50,000 kowace rana. Origami Asse ya fitar da tsarin bude tushen da aka yi amfani da shi wanda zai iya bincika samfurori na COVID19 har zuwa 1122 marasa lafiya ta amfani da gwaji 93.
Kafin watan Maris, rashin isasshen sinadarin da kuma rashin isasshen sinadarin sun zama matsala a manyan gwaje-gwajen da aka gudanar a kasashen EU, UK da kuma Amurka.
Wannan ya sa wasu marubutan neman hanyoyin tsara samfuri wanda ya haɗa da dumama samfuran a 98 ° C (208 ° F) na mintina 5 don sakin RNA don ƙarin bincike. A ranar 31 ga Maris, an ba da sanarwar cewa Hadaddiyar Daular Larabawa yanzu tana gwada yawan jama'arta don cutar kwayar cutar ta fiye da kowace ƙasa, kuma tana kan hanya don ƙara yawan gwajin don isa ga yawan jama'a.
Wannan ya kasance saboda haɗuwa da ikon gudanar da gwajin gwaji da kuma sayen ɗakunan gwaje-gwaje na yawan jama'a daga Group 42 da BGI (wanda ya dogara da ɗakunan gwaje-gwaje na gaggawa na "Huo - Yan" a China).
An gina shi cikin kwanaki 14, dakin gwaje-gwaje na iya yin dubban RT-PCR a kowace rana kuma shi ne na farko a duniya da aka yi aiki a irin wannan babban matakin a wajen kasar Sin.
An haɓaka hanyoyin bincike daban -daban da ke niyya ga sassa daban -daban na bayanan halittar kwayar cutar a China, Faransa, Jamus, Hong Kong, Japan, da Amurka.
WHO ta ɗauki hanyar Jamus ta samar da kayan don ƙasashe masu ƙarancin kuɗi waɗanda ba su da albarkatu don haɓaka kansu.
An wallafa dokar ta Jamus a ranar 17 ga Janairu, 2020; ba a samu takardar da Cibiyar Kula da Cututtuka ta Amurka ta samar ba har zuwa ranar 28 ga Janairu, wanda ya haifar da jinkirin samar da gwajin a Amurka. A farkon barkewar cutar akwai matsaloli tsakanin China da Amurka kan amincin gwajin gwajin, kuma kasashen biyu da Australia ba su iya samar da isassun kayan aikin da za su iya biyan bukatun gwaji da shawarwarin da kwararrun likitocin suka bayar.
Akasin haka, masana sun nuna cewa yawan gwajin da ake yi a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar.
Ikon gwaji, musamman a dakunan gwaje-gwaje masu zaman kansu, ya kasance a cikin shekaru da yawa da gwamnatin Koriya ta Kudu ta haɓaka.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta ce, kara yawan shirye-shiryen gwaji shi ne hanya mafi kyau na rage saurin cutar COVID-19. Babban bukatar yin gwaji ya haifar da tarin dubban gwaje-gwaje a cikin dakunan gwaje-gwaje na Amurka masu zaman kansu, tare da matsin lamba kan samar da allurar rigakafi da masu binciken sunadarai.
A watan Maris na 2020, kasar Sin ta ba da rahoton matsalolin daidaito a cikin kayan gwajin ta.
A Amurka, akwai karancin kayan gwajin da CDC ta samar; gwamnati ta sake cire shingayen da ke hana masu zaman kansu yin gwajin. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Biogeek Biotechnology Co. Ltd. na kasar Sin, amma ta gano cewa sakamakon bai yi daidai ba.
Kamfanin ya bayyana cewa sakamakon da bai dace ba na iya faruwa ne saboda rashin iya tattara samfuran ko kuma rashin amfani da kayan aikin yadda ya kamata.
Ma'aikatar Spain ta ce za ta cire kayan gwajin da ba su dace ba kuma ta maye gurbin su da wasu kayan gwajin da Shenzhen BioEgy ta samar. Jamhuriyar Czech ta sayi kayan gwaji daga China 80% sun ba da sakamakon da ba daidai ba. Slovakia ta sayi kayan gwaji miliyan 1.2 daga China, wanda ba a gano daidai ba.
Firayim Minista Matovič ya ba da shawarar cewa ya kamata a jefa su cikin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da "babban kuskure kuma ba su yi amfani da su ba". UK wanda ya sayi kayan gwaji miliyan 3.5 daga China a farkon Afrilu 2020, ya ba da sanarwar cewa ba za a iya amfani da su ba.
An gano masu dauke da cutar daga mutanen da suka kamu da cutar bayan an yi musu gwaji kuma an gano wadanda suka kamu da SARS-CoV-2.
A wurin da aka fara samun mutuwar COVID-19 a Italiya, masu bincike da ke aiki a garin Vò, Italiya sun yi gwaji sau biyu a kan duka mutanen da suka kai kusan 3,400 a cikin kwanaki goma.
Kusan rabin mutanen da suka kamu da cutar ba su da wata alama, kuma duk wadanda aka gano da cutar an killace su.
Taƙaitawar tafiye -tafiye a kan wuraren da ake zuwa da dawowa ya kawar da sabbin kamuwa da cuta.
Cutar annobar cutar coronavirus ta 2020 ta bazu cikin sauri a Singapore fiye da sauran ƙasashe masu tasowa, ta hanyar gano ma'amala, hana tafiye -tafiye na cikin gida, bincikawa, da keɓewa, amma ba tare da tsauraran matakai kamar rufe gidajen abinci da wuraren sayarwa ba.
An soke wasu abubuwan da suka faru, kuma Singapore ta fara ba da shawarar mazauna su zauna a gida daga 28 ga Maris, amma makarantu sun sake buɗewa a ranar 23 ga Maris bayan hutun.
Sauran kasashe da yawa, kamar Iceland da Koriya ta Kudu, sun kuma shawo kan cutar ta hanyar gano mutanen da suka kamu da cutar, hana tafiye-tafiye na cikin gida, bincike, da kuma killacewa, amma ta hanyar kulle-kulle da ba ta da karfi.
Nazarin ƙididdiga ya nuna cewa ƙasashen da ke da yawan bincike fiye da adadin mutuwar suna da ƙananan adadin mutuwar, mai yiwuwa saboda waɗannan ƙasashe sun fi dacewa wajen gano mutanen da ke da sauƙi ko marasa alamar.
WHO ta ba da shawarar cewa ƙasashen da ba su da ƙarfin gwaji kuma waɗanda ke da ƙarancin ƙwarewa a cikin COVID-19 a cikin dakunan gwaje-gwaje na ƙasa su aika da samfuran COVID-19 na farko biyar masu kyau da na farko goma mara kyau zuwa ɗaya daga cikin dakunan bincike na WHO 16 don tabbatarwa.
Daga cikin dakunan gwaje-gwaje 16 da aka ambata, bakwai suna Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostareliya.
A cikin jadawalin da ke ƙasa, kashi na 100 na gwaji masu kyau an tsara su ne bisa ga manufofin gwaji na ƙasar.
Kamar sauran abubuwa, a cikin ƙasa inda ake gwada waɗanda ke asibiti kawai, yawan gwajin da ke nuna cewa sun kamu da cutar zai fi na ƙasa da ke gwada dukkan 'yan ƙasa, ko suna da alamun cutar ko a'a.
Wanke hannu (ko wanke hannu), wanda aka fi sani da tsabtace hannu, shine aikin tsabtace hannayen mutum da nufin cire datti, mai, microorganisms ko wasu abubuwan da ba a so.
Wanke hannu da sabulu a wasu "lokacin" a cikin rana yana hana yaduwar cututtuka da yawa, kamar zawo da zawo, waɗanda ake ɗauka ta hanyar hanyar mucous.
Mutane kuma za su iya kamuwa da cututtukan numfashi kamar mura ko kuma zazzabi idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci, ko kuma baki (watau, membranes na mucous).
A cikin rana, akwai lokuta guda biyar da wanke hannu da sabulu ya zama dole: kafin da bayan wanka, bayan wanke bayanku ko canza kayan jariri, kafin ciyar da jariri, kafin cin abinci da kuma kafin cin nama, kifi ko kaza da kuma bayan cin abinci.
Idan babu sabulu da ruwa, za a iya wanke hannu da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu a lokuta kamar haka:
Kafin, lokacin, da kuma bayan an gama shirya abinci.
Kafin kula da marar lafiya da kuma bayan kula da shi.
Bayan an canja diapers ko an wanke jaririn da yake amfani da gidan wanka.
Bayan ka sha ruwa a hanci, ka tari, ko ka yi atishawa.
Bayan mutum ya taɓa dabba, ko abinci, ko kuma dattin dabba.
Sanin hannu na likitanci yana nufin ayyukan tsabta da suka shafi hanyoyin kiwon lafiya.
Wanke hannu kafin a ba da magani ko kulawar likita na iya hana ko rage yaduwar cutar.
Babban manufar wanke hannu shine a tsabtace hannayen daga cututtukan cututtuka (kwayoyin cuta, ƙwayoyin cuta, ko wasu kwayoyin da zasu iya haifar da cuta) da kuma sunadarai waɗanda zasu iya haifar da lahani ko cututtuka.
Wannan yana da mahimmanci ga mutanen da suke sarrafa abinci ko kuma masu aikin kiwon lafiya, amma kuma yana da mahimmanci ga talakawa.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, gami da: rage yaduwar mura, coronavirus da sauran cututtukan cututtuka; hana kamuwa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka;
Kuma rage mutuwar jarirai a gida.
Wani bincike da aka yi a 2013 ya nuna cewa yara 'yan kasa da shekara biyar da suke wanke hannayensu sosai za su iya samun ci gaba a tsawo.
A ƙasashe masu tasowa, sauye-sauyen halayya masu sauƙi, kamar fara wanke hannu da sabulu, na iya rage mutuwar yara da ke da alaƙa da cututtukan numfashi da na zawo.
Wannan aiki mai sauƙi zai iya rage mutuwar da ke tattare da waɗannan cututtuka da kusan kashi 50 cikin ɗari.
Matakan da ke inganta wanke hannu za su iya rage yawan masu cutar gudawa da kusan kashi ɗaya cikin uku, kuma hakan yana da muhimmanci kamar yadda samar da ruwa mai tsafta a yankunan da ba sa samun kuɗin shiga.
Za a iya danganta raguwar kashi 48 cikin ɗari na cututtukan zawo ga wanke hannu da sabulu. Wanke hannu da sabulu a matsayin halayyar kai tsaye a gidaje, makarantu da al'ummomi a duk duniya, shine hanya mafi inganci da arha don hana zawo da cututtukan cututtukan cututtukan numfashi (ARI).
Wani babban ARI, cutar nimoniya ita ce babbar hanyar mutuwa a cikin yara 'yan kasa da shekara biyar, tare da kashe yara miliyan 18 a kowace shekara.
Kusan yara miliyan 35 ke mutuwa a kowace shekara saboda cutar na zawo da na huhu.
Bisa ga Unicef, wanke hannu da sabulu kafin cin abinci da kuma bayan amfani da bayan gida zai iya ceton rayuka fiye da duk wani allurar rigakafi ko magani guda, wanda zai iya rage mutuwar da ke tattare da zawo da kusan rabi da kuma mutuwar da ke tattare da cututtukan numfashi mai zurfi da kashi ɗaya cikin huɗu.
Wanke hannu yawanci ana haɗa shi da sauran matakan tsaftacewa a matsayin ɓangare na shirye -shiryen ruwa, tsaftacewa da tsaftacewa (WASH).
Wanke hannu yana kuma kare mutum daga cutar sankara wadda ke yaduwa ta hanyar saduwa kai tsaye.
Wani ƙananan illa na wanke hannu shine cewa wanke hannu akai -akai na iya haifar da lalacewar fata saboda bushewar fata.
Wani binciken Danish na 2012 ya gano cewa yawan wanke hannu na iya haifar da yanayin fata mai laushi, wanda aka sani da hand eczema ko dermatitis, wanda ya zama ruwan dare musamman a tsakanin ma'aikatan kiwon lafiya.
Ana kuma ganin cewa yawan wanke hannu alama ce ta OCD.
Akwai lokuta guda biyar a rana da wanke hannu da sabulu ke da muhimmanci wajen rage yaduwar cutar a cikin al'umma: bayan amfani da bayan gida (shari'a, zubar da jini), bayan wanke bayan jaririn (bayan canza kayan wanki), kafin ciyar da jariri, kafin cin abinci da kuma shirya abinci ko kafin / bayan cin nama, kifi, ko kaji.
Sauran lokutan da ya kamata a yi amfani da hanyoyin wanke hannu don hana yaduwar cutar sune: kafin da bayan an yi wa mutum rauni ko kuma a yi masa rauni; bayan an yi atishawa, an yi amai ko kuma an yi hanci; bayan an yi amfani da najasa ko kuma dabbobi; da kuma bayan an yi amfani da datti.
A ƙasashe da yawa, an yi amfani da sabulu wajen wanke hannu sosai.
Wani bincike na 2015 ya gano cewa a cikin kasashe 54 a shekara ta 2015, an samu kimanin kashi 38.7 cikin dari na iyalai da suka yi amfani da sabulu don wanke hannayensu. Wani binciken na 2014 ya nuna cewa Saudi Arabia tana da kashi mafi girma na 97 cikin dari; a Amurka, kashi 77 cikin dari; kuma a China, kashi 23 cikin dari.
"Tsarin Kula da Kiwon Lafiya na Musamman" da Ma'aikatar Ilimi ta Philippines ta aiwatar misali ne na babban aiki don inganta lafiyar yara da ilimi.
Ainihin shirin na kasa ya hada da tsaftace hakora da fluoride a kullum, da kuma wanke hannu da sabulu a kullum, da kuma maganin anti - worm sau biyu a shekara.
An kuma yi nasarar aiwatar da shi a Indonesia.
Za a iya inganta cire kwayoyin cuta daga fata ta hanyar hada sabulu ko kayan wanki da ruwa.
Babban aikin sabulu da na'urar wankewa shi ne rage shinge da kuma kara yawan narkewa.
Ruwa shi kaɗai ba shi da ƙwarewa wajen tsarkake fata domin kitsi da furotin, waɗanda suke cikin ƙasan ƙasa, ba sa narkewa cikin ruwa.
Duk da haka, tsaftacewa yana da amfani idan akwai isasshen ruwa.
Saboda amfani da shi akai -akai, sabulu mai ƙarfi na iya ƙunsar ƙwayoyin cuta da suka rage daga amfani da su a baya.
Wasu nazarin da ke duba canja wurin kwayoyin cuta daga sabulu mai laushi sun kammala cewa ba za a iya samun canja wurin ba saboda an wanke kwayoyin cuta tare da foam.
Amma CDC ta ce "sabon da ke da kayan aikin da ke sa a rika zuba sabulu a hannu ba tare da an taɓa hannuwa ba ya fi kyau".
An yi wa'azin sabulu masu hana ƙwayoyin cuta ga jama'a masu hankali.
Zuwa yau, babu wata shaida da ta nuna cewa amfani da maganin antiseptic ko maganin kashe kwayoyin cuta na iya haifar da kwayoyin da ke jure kwayoyin cuta a yanayi.
Koyaya, sabulu na antibacterial suna ƙunshe da kayan aikin antibacterial na yau da kullun kamar triclosan, wanda ke da cikakken jerin tsire-tsire masu juriya na kwayoyin.
Saboda haka, ko da yake sabulun antibacterial ba sa haifar da ƙwayoyin cuta masu tsayayya, ba za su iya zama masu tasiri kamar yadda ake nuna su ba.
Baya ga moisturizing da kare fata, ingantattun kayan aiki na iya haɗawa da acid (acetic acid, ascorbic acid, lactic acid), benzoic acid mai aiki da ƙwayoyin cuta da sauran abubuwan da ke inganta fata (alovera, bitamin, menthol, tsantsa na tsire -tsire). Wani bincike na musamman na Jami'ar Oregon School of Public Health ya nuna cewa sabulu mai saurin amfani da trichloroacid yana da tasiri fiye da sabulu na kwastomomi na kwastomomi a hana cututtuka da cire ƙwayoyin cuta daga hannaye.
Ruwa mai zafi don wanke hannu ba shi da zafi sosai don kashe ƙwayoyin cuta.
Bacteria suna girma da sauri a yanayin zafin jiki (digiri 37 Celsius).
Duk da haka, ruwan sabulu mai ɗumi ya fi ruwan sabulu mai sanyi tasiri wajen cire ƙasa da kuma ƙwayoyin halitta masu ƙwayoyin cuta.
Koyaya, akasin yarda da yarda, binciken kimiyya ya nuna cewa amfani da ruwan zafi ba shi da tasiri a rage yawan ƙwayoyin cuta a hannaye.
Sanitizer na hannu shine mai tsabtace hannu wanda ba shi da ruwa.
A ƙarshen 1990s da farkon ƙarni na 21, abubuwan tsabtace hannu marasa ruwa marasa ruwa (wanda aka fi sani da rubs na hannu, rubs na hannu mai tsabta ko masu tsabtace hannu) sun fara samun karɓuwa.
Yawancin waɗannan suna dogara ne akan isopropyl alcohol ko ethanol, waɗanda aka tsara tare da glycerin a cikin wani gel kamar carbomer (mai yawa na acrylic acid), ko wani mai danshi kamar ruwa ko kumfa, don sauƙin amfani da rage tasirin bushewa na barasa.
Haɗa hydrogen peroxide mai sauƙi yana ƙara ƙarfin antimicrobial. 60 zuwa 95% na masu tsabtace hannu suna da ƙwayoyin cuta masu ƙwayoyin cuta.
Alcohol rubs suna kashe kwayoyin cutar sanitizer, kwayoyin cuta masu tsayayyar magani (MRSA da VRE), tarin fuka da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinoviruses, vaccinia, influenza da hepatitis) da kuma kwari.
Alcohol Rub Sanitiser wanda ke dauke da kashi 70% na barasa yana kashe 99.97% na kwayoyin bayan dakika 30 da amfani (3.5 rage log, daidai da 35 decibel rage) da kuma 99.99% zuwa 99.999% na kwayoyin bayan minti 1 da amfani (4 zuwa 5 rage log). Sanitiser na hannu sun fi tasiri akan kwayoyin cuta kuma sun fi tasiri akan wasu ƙwayoyin cuta.
Sanitizers na hannu na barasa kusan ba su da tasiri ga nau'in ƙwayoyin cuta na Norovirus (ko Norwalk) wanda shine mafi yawan sanadin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka. Ya kamata a yi amfani da sanitizer na hannu ko kuma ruwan giya mai isa don rufe ko rufe duka hannayen biyu.
Rubbing a gaba da baya da tsakiya da kuma dukkan yatsun hannu a cikin kusan 30 seconds har sai da ruwa, foam ko gel ya bushe.
Hakanan, yakamata a wanke yatsun hannu sosai ta hanyar shafawa a cikin hannu biyu. Cibiyar Kula da Cututtuka da Rigakafin Amurka ta ba da shawarar wanke hannu maimakon wankin na hannu, musamman idan hannaye sun zama datti.
Amfani da waɗannan abubuwan da aka yi amfani da su yana da sauƙi da kuma saurin kashe kwayoyin cuta; duk da haka, bai kamata a yi amfani da su a matsayin maye gurbin wanke hannu daidai ba sai dai idan sabulu da ruwa ba su da amfani.
Yin amfani da na'urar tsabtace hannu ta barasa sau da yawa na iya haifar da bushewar fata sai dai idan an haɗa kayan shafawa da / ko moisturizer na fata a cikin tsari.
Ana iya rage ko kawar da tasirin bushewar giya ta hanyar haɗa glycerin da / ko wasu abubuwan shafawa a cikin tsari.
A cikin gwaji na asibiti, sabulu da sabulu masu amfani da giya sun rage ƙonewar fata da bushewa fiye da sabulu ko magungunan kashe kwayoyin cuta.
Alcohol ko Alcohol Hand Rubs suna da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka, cututtukan cututtukan cututtukan cututtuka ko kuma rashin lafiyar jiki.
Ƙananan karuwa na saurin saurin saurin saurin cututtukan fata ya zama abin jan hankali fiye da wanke hannu da sabulu da ruwa.
Duk da ingancin su, masu cire ruwa ba sa wanke hannaye da sinadarin da ke cikin jiki, sai dai su yi musu maganin kashe cututtuka.
Wannan shine dalilin da yasa sabulun hannu ba su da tasiri kamar sabulu da ruwa wajen hana yaduwar cututtuka, saboda cututtuka har yanzu suna kan hannaye.
Tasirin na'urar tsabtace hannu ba tare da barasa ba ya dogara sosai kan kayan da aka haɗa da kuma yadda aka tsara su, kuma a tarihi, sun yi ƙasa da na'urar tsabtace hannu da na'urar wanke hannu.
Kwanan nan, ba kamar barasa ba, wanda aka nuna yana rage inganci bayan amfani da shi akai - akai wanda zai iya haifar da mummunan halayen fata, an nuna cewa benzalkonium chloride yana da ci gaba da kuma tarawa antimicrobial aiki bayan an sanya sunadarai masu amfani da shi.
Mutane da yawa a cikin ƙananan al'ummomin da ba su da kuɗin sabulu kuma suna iya amfani da toka ko ƙasa.
Ash ko laka na iya zama mafi tasiri fiye da ruwa kadai, amma ba sa iya yin tasiri kamar sabulu.
Damuwa ɗaya ita ce idan ƙasa ko toka sun ƙazantu da ƙwayoyin cuta, za su iya ƙara yawan kamuwa da cuta maimakon ragewa.
Kamar sabulu, ash yana da maganin kashe kwayoyin cuta saboda yana samar da wani bayani mai ma'adanai idan ya zo da ruwa.
WHO ta ba da shawarar ash ko yashi a matsayin madadin sabulu idan sabulu ba a samuwa.
Ainihin dabarun wanke hannu da Cibiyar Kula da Cututtuka ta Amurka ta ba da shawara don hana yaduwar cutar ta ƙunshi waɗannan matakai:
Rigar hannu da ruwan sanyi ko mai dumi.
Ana bada shawarar ruwa mai gudana saboda wuraren da ruwa mai tsayayye zai iya zama mai gurɓataccen, kodayake zafin ruwan ba shi da mahimmanci.
Yi amfani da adadin sabulu mai dacewa a hannayenka, gami da bayan hannu, tsakanin yatsun hannu da ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu sosai idan suka yi amfani da sabulu maimakon ruwa.
Ka yi ta shafawa aƙalla na sakan 20.
Yin gogewa yana haifar da ƙura, wanda ke taimakawa wajen kawar da ƙwayoyin cuta daga fata, kuma yawan gogewa yana fitar da ƙwayoyin cuta.
Wanke sosai a ƙarƙashin ruwa mai gudu.
Wankewa a cikin kwandon ruwa na iya sake gurɓata hannaye.
Ka wanke da tawul mai tsabta ko ka bari a iska.
Hannun da ke da laushi da ɗumi suna da saurin sake gurɓatawa. Yankunan da aka fi rasawa sune yatsun hannu, wuyan hannu, yankin tsakanin yatsun hannu da kuma ƙarƙashin ƙusa.
Nails da kuma ƙusa na ƙusa na iya zama mafaka ga ƙwayoyin cuta.
Ana ba da shawarar maganin shafawa mai laushi don hana hannaye bushewa; bushewar fata na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin kamuwa da cuta.
A kasashe masu tasowa inda babu ruwan famfo da/ko sabulu, za a iya yin amfani da hanyoyin da ba su da tsada don sauƙaƙa wanke hannu, kamar su zuba ruwa a cikin kwano ko kwanon rufi da aka saka da ramuka da aka yi amfani da su, da kuma/ko amfani da toka. A cikin yanayin da ake da karancin ruwan sha (kamar a makarantu ko yankunan karkara a kasashe masu tasowa), ana iya yin amfani da hanyoyin adana ruwa, kamar su "Tippi-tap" da sauran hanyoyin da ba su da tsada.
Tippy-tap wata fasaha ce mai sauki wacce ta kunshi amfani da wani mai amfani da sanda don zuba ruwa a kan hannaye da kuma sabulu.
Drying hannu yadda ya kamata wani bangare ne na tsarin tsabtace hannu, amma akwai wasu rikice-rikice kan mafi inganci na bushewa a cikin gidajen wanka na jama'a.
Bincike mai zurfi ya nuna cewa tawul na takarda ya fi na'urar bushewa da ake samu a gidajen wanka yawa.
A cikin 2008, an gudanar da bincike ta Jami'ar Westminster, London, wanda masana'antar tawul ɗin takarda ta tallafawa The European Tissue Symposium, wanda ke da niyyar kwatanta matakan tsabtace da aka bayar ta tawul ɗin takarda, masu bushewar hannu masu zafi da kuma na'urorin bushewa na jet-air.
Bayan wanke hannu da bushewa da busassun iska, yawan kwayoyin cuta ya karu da kashi 194 bisa dari a kan matsakaiciyar yatsun hannu da kuma kashi 254 bisa dari a kan dabino.
Ta hanyar bushewa da jet-air dryers, an sami ƙaruwa a yawan adadin kwayoyin cuta a matsakaicin kashi 42 cikin dari a kan yatsun hannu da kuma kashi 15 cikin dari a kan hannayen hannu.
Bayan wanke hannu da bushewa da tawul na takarda, an rage adadin kwayoyin cuta a matsakaita na 76% a kan matattarar yatsa da 77% a kan dabino. Masana kimiyya sun kuma gwada don tabbatar da ko kowane nau'in hanyoyin bushewa yana da damar gurɓata sauran masu amfani da gidan wanka da kuma yanayin gidan wanka.
Jirgin iska mai iska, wanda ke fitar da iska daga cikin rukunin a kimanin saurin 180 m / s (650 km / h; 400 mph), ya sami damar busa kwayoyin cuta daga hannaye da naúrar kuma mai yiwuwa ya gurɓata yanayin sauran masu amfani da gidan wanka da kuma na gidan wanka har zuwa mita 2.
Yin amfani da na'urar bushewa da iska mai zafi ya sa kwayar cuta ta bazu daga na'urar bushewa har zuwa mita 0. 25.
Takarda tawul ɗin ba ta nuna mahimmancin yaduwar ƙwayoyin cuta ba. A cikin 2005, wani binciken da TÜV Produkt und Umwelt ya yi, an kimanta hanyoyin bushewa daban -daban.
An sami canje -canje masu zuwa a ƙididdigar ƙwayoyin cuta bayan an bushe hannu:
Akwai masu sana'ar busar hannaye da yawa, kuma an kwatanta busar hannaye da bushewa da tawul.
A yayin tafiya, wanke hannu ta amfani da wankin hannu mai tsabtace hannu wani zaɓi ne idan babu sabulu da ruwa.
Sanitizer na hannu na barasa ya kamata ya ƙunshi aƙalla kashi 60% na barasa.
Wanke hannu ya zama dole ne a cikin asibiti, ba da daɗewa ba bayan likitan Hungary Ignaz Semmelweis ya gano (a shekara ta 1846) yadda yake da tasiri wajen hana cutar a asibiti.
Akwai na'urorin lantarki da ke ba da amsa don tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya nuna cewa amfani da su ya rage yawan kamuwa da cutar.
A hanyar magani, ana wanke hannuwan aƙalla na daƙiƙa 15, ana amfani da sabulu da ruwa ko kuma gel da aka yi da ƙwanƙwasawa, ana kuma shafa kowane ɓangaren hannu.
Ya kamata a rub da yatsun hannu biyu a hade.
Idan akwai tarkace a ƙarƙashin ƙusoshi, za a iya amfani da goga mai gashi mai tsauri don cire shi.
Tun da ƙwayoyin cuta na iya rayuwa a cikin ruwa a hannaye, yana da mahimmanci a wanke sosai kuma a goge shi da tawul mai tsabta.
Bayan bushewa, ya kamata a yi amfani da tawul ɗin takarda don rufe ruwan (kuma a buɗe kowane ƙofar fitarwa idan ya cancanta).
Wannan yana hana hannaye sake gurɓatawa daga waɗancan saman.
Wanke hannu a cikin tsarin kiwon lafiya yana nufin kawar da ƙwayoyin cuta masu saurin kamuwa da cuta ("ƙwayoyin cuta") da kuma hana su daga yaduwa.
Jaridar New England Journal of Medicine ta ba da rahoton cewa rashin wanke hannu ya kasance a matakan da ba za a iya yarda da su ba a cikin mafi yawan wuraren kiwon lafiya, tare da adadi mai yawa na likitoci da ma'aikatan jinya da ke mantawa da wanke hannayensu a kai a kai kafin su taɓa marasa lafiya, wanda ke haifar da watsa kwayar cuta.
Wani binciken ya nuna cewa wanke hannu yadda ya kamata da sauran hanyoyin tsafta na iya rage yawan cututtukan da ke tattare da catheter da kashi 66 cikin dari. Hukumar Lafiya ta Duniya ta wallafa wata takarda da ke nuna yadda za a rika wanke hannu da kuma shafawa a wuraren da ake samun kula da lafiya.
Hakanan ana iya samun jagororin tsabtace hannu na ƙungiyar akan gidan yanar gizon don ra'ayoyin jama'a.
Wani bincike da ya dace da wannan ya yi da Witby da wasu.
Kayan kasuwanci na iya auna da kuma tabbatar da tsabtace hannu idan ya zama dole don nuna bin ƙa'idodi.
Ƙungiyar Lafiya ta Duniya ta ba da "hannu biyar" don wanke hannu:
Bayan sun haɗu da jini / ruwa na jiki
kafin aikin kashe kwayoyin cuta, da
Bayan kula da mai haƙuri. Haɗa sinadarai masu kashe ƙwayoyin cuta a cikin sabulu (sabon "magani" ko "antibacterial") yana ba da ikon kashewa ga wakilin wanke hannu.
Don 'rubbing' hannaye don tsagewar tiyata, yana da mahimmanci a sami bututun da za a iya kunnawa da kashewa ba tare da taɓa hannaye ba, wasu chlorhexidine ko iodine wanka, towel mai tsabta don bushe hannaye bayan wanka, da kuma buroshi mara tsabta don tsaftace tsutsa da kuma sauran kayan aikin tsabtace tsabta don tsabtace ƙusa.
Ya kamata a cire kayan ado.
Wannan aikin yana buƙatar wanke hannu da wuyan hannu a cikin minti 2-6.
Ba a buƙatar yin tausa na dogon lokaci (minti 10) ba.
A lokacin wanka, dole ne a hana ruwa daga hannun hannuwanka zuwa wuyan hannu.
Bayan an gama wanke hannu, sai a wanke hannu da rigar da ba ta da ƙwayoyin cuta kuma a sa rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu kafin da bayan kula da mutum mai rashin lafiya ko kuma amfani da na'urar wanke hannu.
Don sarrafa kamuwa da cuta na staphylococcal a asibitoci, an gano cewa mafi girman fa'ida daga tsabtace hannu ya zo ne daga 20% na wanka na farko, kuma ƙaramar fa'idar da aka samu lokacin da yawan tsabtace hannu ya ƙaru sama da 35%.
Wanke hannu da sabulu mai tsabta ya ninka sau uku yawan kamuwa da cututtukan cututtukan ƙwayoyin cuta fiye da wanke hannu da sabulu mai ƙwayoyin cuta. Idan aka kwatanta wankin hannu da ruwan giya da wankin hannu da sabulu mai ƙwayoyin cuta don matsakaicin lokacin wanke hannu na mintina 30, an gano cewa wankin hannu da giya ya rage gurɓatar ƙwayoyin cuta da kashi 26% fiye da wanke hannu da sabulun ƙwayoyin cuta.
Amma sabulu da ruwa sun fi na hannuwan amfani da giya tasiri wajen rage H1N1 influenza A virus da Clostridium difficile spores. Matakan da za a bi a cibiyoyin kiwon lafiya don inganta tsaftace hannuwan hannu na iya haɗawa da ilimantar da ma'aikata game da wanke hannu, ƙara yawan wadatar giya mai amfani da giya, da kuma rubutaccen da kuma tunatarwa ga ma'aikata.
Ana buƙatar ƙarin bincike kan waɗanne daga cikin waɗannan hanyoyin ne suka fi tasiri a cikin tsarin kiwon lafiya daban-daban.
A ƙasashe masu tasowa, wanke hannu da sabulu an ɗauke shi hanya mai araha, mai muhimmanci wajen samun koshin lafiya, har ma da abinci mai gina jiki.
Koyaya, rashin wadataccen ruwa, sabulu ko kayan wanke hannu a gidajen mutane, makarantu da wuraren aiki yana haifar da ƙalubale don cimma nasarar wanke hannu a duniya.
Misali, a yawancin yankunan karkara na Afirka, kusan kowane gidan wanka na jama'a ko na masu zaman kansu yana da famfo na wanke hannu, duk da cewa akwai wasu hanyoyin da za a iya wanke hannu da su.
Koyaya, ƙananan ƙimar wanke hannu na iya zama saboda halaye da aka kafa maimakon ƙarancin sabulu ko ruwa.
Tallafawa da tallafawa wanke hannu da sabulu na iya yin tasiri ga yanke shawara kan manufofi, haɓaka wayar da kan jama'a game da fa'idodin wanke hannu da kawo sauye - sauye a cikin halayen jama'a na dogon lokaci.
Don yin aiki yadda ya kamata, ana buƙatar saka idanu da kimantawa.
Binciken nazari na nazari na 70 ya gano cewa hanyoyin da aka kafa na al'umma suna da tasiri wajen haɓaka wanke hannu a cikin LMICs, yayin da kamfen na watsa labarun ya zama ba shi da tasiri. Misali na tallafi na wanke hannu a makarantu shine "Hanyar Tauraruwa Uku" ta UNICEF wanda ke ƙarfafa makarantu don ɗaukar matakai masu sauƙi, marasa tsada don tabbatar da cewa ɗalibai suna wanke hannu da sabulu tare da sauran bukatun tsabtace jiki.
A lokacin da aka cimma matsakaicin matsayi, makarantun za su iya samun daraja daga tauraro ɗaya zuwa uku.
Gina tashoshin wanke hannu na iya zama wani ɓangare na kamfen na wanke hannu da aka yi don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wata misali ce ta kamfen din wayar da kan jama'a da ke da nufin kawo sauyi a cikin halayyar mutane. A sakamakon annobar cutar Korona ta 2019-20, UNICEF ta ba da shawarar karɓar wani emoji na wanke hannu.
Wasu nazarin sun yi la'akari da tasirin tsadar wanke hannu a kasashe masu tasowa dangane da kariya daga DALYs.
Koyaya, wani bita ya nuna cewa inganta wanke hannu da sabulu ya fi sauran ruwa da matakan tsaftacewa tsada.
Muhimmancin wanke hannu ga lafiyar dan adam - musamman ga mutanen da ke cikin yanayi mai rauni, kamar uwaye da suka haihu ko sojoji da suka ji rauni a asibiti - an fara gano su ne a tsakiyar karni na 19 ta hanyar masu ba da shawara biyu na tsabtace hannu: likitan Hungary Ignaz Semmelweis wanda ya yi aiki a Vienna, Austria da Florence Nightingale, 'yar Ingila wacce ta zama "mabuwar jinya ta zamani".
A lokacin, yawancin mutane sun gaskata cewa ƙamshi ne ke haddasa ƙazanta, wanda ake kira miasmos.
A cikin shekarun 1980, barkewar cutar da ke tattare da abinci da cututtukan da ke da alaƙa da lafiya sun sa Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ƙara ƙarfafa tsabtace hannu a matsayin babbar hanyar hana yaduwar cutar.
Cutar annobar swine flu a shekarar 2009 da kuma cutar COVID-19 a shekarar 2020 sun kara wayar da kan mutane a kasashe da dama game da muhimmancin wanke hannu da sabulu don kare kai daga irin wadannan cututtukan cututtuka.
Misali, an rataye alluna mai taken "daidai dabarun wanke hannu" a kusa da sinks na wanke hannu a cikin gidajen wanka na jama'a da gidajen ofishi da kuma gidajen wanka na tashoshin jiragen sama a Jamus.
Furucin nan "wanke hannunka" daga wani abu yana nufin ka ƙi yarda da alhakin ko kuma yin tarayya da shi.
An samo shi ne daga babi na Matta a cikin Littafi Mai Tsarki inda Bilatus Ba-Bunti ya ware kansa daga hukuncin da aka yanke na gicciye Yesu Kristi, amma ya zama wani jumla da aka fi amfani da shi a wasu yankunan Ingilishi.
A cikin Macbeth na Shakespeare, Lady Macbeth ta fara wanke hannayenta a cikin ƙoƙarin wanke wani ƙazamar ƙazanta, wanda ke nuna lamirin ta game da laifin da ta aikata da kuma sa mijinta ya aikata laifi.
An kuma gano cewa mutane sukan wanke hannayensu sau da yawa fiye da sauran mutane bayan sun tuna ko sun yi tunanin ayyukan lalata, kuma suna ba da muhimmanci ga kayan wanke hannu.
Bugu da ƙari, mutanen da aka ba su damar wanke hannayensu bayan irin wannan tunani ba su da wataƙila su shiga cikin wasu ayyukan "tsabtace" kamar su aikin sa kai.
Addini yana ba da shawarar wanke hannu don tsabta da kuma dalilai na alama. Wanke hannu na alama da ruwa ba tare da sabulu ba don wanke hannu yana da wani ɓangare na wanke hannu na al'ada da aka bayyana a cikin addinai da yawa, ciki har da Bahai, Hindu, Tevila da Netilaat Ya'daim a cikin Yahudanci, Lavabo a cikin addinin Kirista, da Wazhu a cikin Islama. Addinin ya kuma ba da shawarar wanke hannu don samar da tsabta musamman bayan wasu ayyuka.
A addinin Hindu, Yahudanci, da Islama, wanke hannu bayan an yi amfani da banɗaki wajibi ne.
Kuma, a addinin Hindu, Buddha, Sikh, Yahudanci, da Islama, wanke hannu kafin cin abinci da kuma bayan cin abinci wajibi ne.
Kula da haɗarin COVID-19 a wurin aiki
Kula da haɗarin yaɗuwar COVID-19 a wurin aiki, don hana cutar Coronavirus 2019 (COVID-19) aikace -aikacen hanyoyin kula da lafiya da lafiya na aiki ne don kula da haɗarin.
Ingantaccen sarrafa haɗarin kamuwa da cuta a wurin aiki ya dogara da wurin aiki da ayyukan da ake yi, ƙididdigar haɗarin tushen tushen haɗari, tsananin cutar a cikin al'umma, da kuma haɗarin haɗarin ma'aikata na mutum waɗanda ke da haɗarin kamuwa da cutar COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ke da haɗarin haɗari suna da ƙarancin hulɗa na kasuwanci tare da mutane da sauran abokan aiki, wanda aka ba da shawarar matakan rigakafin kamuwa da cuta na asali, gami da: wanke hannaye, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, bi ƙa'idodin numfashi, da tsabtace yanayi na aiki akai-akai da kuma gurɓata su.
Ayyukan haɗarin haɗari na haɗari sune waɗanda ke buƙatar maimaitawa ko kusanci da mutane waɗanda ba a sani ba ko ake zargi da cutar COVID-19 amma waɗanda ƙila sun kamu da cutar saboda yaduwar al'umma da ke gudana ko kuma balaguron ƙasa da ƙasa.
Wannan ya haɗa da ma'aikatan da ke hulɗa da jama'a kamar makarantu, yanayin aiki mai yawan jama'a, da kuma wasu wuraren sayar da kayayyaki masu yawa.
Baya ga matakan rigakafin kamuwa da cuta, matakan sarrafa haɗari ga wannan rukunin sun haɗa da: yin amfani da matatun iska mai inganci, amfani da masu tsinkayen rigakafi, da kuma samar da kayan kariya na mutum don yanayin idan mutum mai COVID-19 ya kamu da cutar.
OSHA ta yi la'akari da ma'aikatan kiwon lafiya da ma'aikatan gawawwaki a matsayin waɗanda ke da haɗarin haɗarin haɗari, waɗanda suka zo a cikin hulɗa da mutumin da ke da cutar COVID-19 ko wanda ake zargi, kuma wannan haɗarin ya haɓaka zuwa haɗarin haɗarin haɗari idan ma'aikatan suka yi ayyukan da ke haifar da aerosol a kan mutumin da ke da cutar COVID-19, ko wanda ake zargi, ko tattara ko sarrafa samfurori daga gare su.
Abubuwan haɗari da suka dace da waɗannan ma'aikatan sun haɗa da ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙaran ƙarancin ƙarancin ƙarancin ƙaran ƙarancin ƙ ƙ ƙarancin ƙaran ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙaranƙarin ƙaran ƙ ƙarancin ƙarancin ƙarancin ƙ ƙ ƙaran ƙ ƙ ƙ ƙ ƙ ƙarancin ƙaran ƙ ƙ ƙarancin ƙ ƙaran ƙaran ƙaranƙarin ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙarancin ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙaran
Akwai abubuwa da yawa da suka shafi COVID-19 a wuraren aiki.
Ma'aikata za su iya yin rashin aiki domin rashin lafiya, ko don bukatar kula da wasu, ko kuma don tsoron haɗuwa da wasu.
Abubuwan da ake buƙata, da kuma hanyoyin samun waɗannan abubuwan (kamar lokacin buƙata ko sayayya ta hanyar isarwa ko sabis na juyawa), na iya canza yanayin kasuwanci.
A ƙarshe, zirga-zirgar kayan daga yankunan da COVID-19 ya shafa na iya shafar. Za a iya amfani da shirin shiryawa da amsawa don cutar mai saurin kamuwa da cuta don jagorantar ayyukan kariya.
Shirye-shiryen sun magance matakan haɗarin da ke tattare da wurare daban-daban da ayyukan aiki, gami da tushen haɗarin, abubuwan haɗarin da ke tasowa daga gida da kuma tsarin al'umma, da kuma abubuwan haɗarin ma'aikata daban-daban kamar tsufa ko yanayin kiwon lafiya na yau da kullun.
Sun kuma bayyana abubuwan da ake bukata don magance hadarin da kuma shirye-shiryen gaggawa don yanayin da ka iya tasowa a sakamakon barkewar cutar.
Shirye -shiryen cutar da kuma shirin mayar da martani na iya zama batun shawarwarin ƙasa ko ƙasa.
Manufofin mayar da martani ga barkewar cutar sun hada da: rage yaduwar cutar tsakanin ma'aikata, kare mutanen da ke da hadarin kamuwa da cututtukan kiwon lafiya, ci gaba da ayyukan kasuwanci da kuma rage illa ga sauran rukunin a cikin sarkar samar da su.
Matsanancin cutar a cikin al 'ummar wurin kasuwanci yana shafar amsoshin da za a ɗauka.
Tsarin sarrafa haɗari tsari ne wanda aka yi amfani dashi sosai don rukuni na sarrafa haɗari bisa ga tasirinsa a cikin lafiyar lafiya da lafiya.
Inda ba za a iya kawar da haɗarin COVID-19 ba, mafi ingancin sarrafawa shine sarrafa injiniya, sannan sarrafawa na gudanarwa, kuma a ƙarshe kayan kariya na mutum.
Gudanar da aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin da ke da alaƙa da aiki ba tare da dogaro da halayyar ma'aikaci ba, kuma wannan na iya zama mafi kyawun maganin kuɗi don aiwatarwa.
Gudanarwa na Gudanarwa canje -canje ne a cikin manufofin aiki ko hanyoyin da ke buƙatar aiki daga ma'aikaci ko mai aiki.
Kayan kariya na mutum (PPE) an dauke shi da rashin tasiri fiye da na injiniya da kuma na gudanarwa, amma zai iya taimakawa wajen hana wasu hulɗa.
Ya kamata a zaɓi kowane nau'in PPE ga ma'aikata bisa haɗari, a sanya shi yadda ya kamata (misali, injin numfashi), a ci gaba da sawa da kyau, a bincika shi akai -akai, a kiyaye shi kuma a sauya shi kamar yadda ake buƙata, kuma a cire shi, a tsabtace shi kuma a adana shi ko a kawar da shi yadda ya kamata don gujewa gurɓatawa.
A cewar Hukumar Kula da Lafiya da Kula da Lafiya ta Amurka (OSHA), ayyukan da ke da haɗarin haɗari suna da ƙananan hulɗar kasuwanci tare da mutane da sauran abokan aiki.
Ka'idojin kare kamuwa da cuta da aka bayar ga dukkan wuraren aiki sun hada da: wanke hannaye sosai kuma akai -akai, ƙarfafa ma'aikata su zauna a gida idan sun kamu da rashin lafiya, ka'idojin numfashi don rufe tari da harba, samar da kayan aiki da kwandon shara, shirya canji na nesa ko na wucin gadi idan ya zama dole, hana ma'aikata amfani da kayan aiki da kayan aikin wasu, da tsabtace yanayin aiki a kai a kai da kuma kashe kwari.
Gano da ware mutanen da za su iya kamuwa da cutar a wurin aiki tun da wuri, mataki ne mai muhimmanci na kare ma'aikata, abokan ciniki, baƙi da sauran su.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun ba da shawarar cewa ma'aikatan da ke da alamun cututtuka na cututtuka na cututtuka na cututtuka na cututtuka su kasance a gida har sai sun kasance ba tare da zazzabi ba, alamun zazzabi, ko wasu alamun bayyanar cututtuka ba tare da magani mai rage zazzabi ko wasu magungunan da ke canza alamun ba aƙalla awanni 24 da suka gabata, kuma cewa manufofin hutun rashin lafiya su zama masu sassauƙa, waɗanda ke ba ma'aikata damar zama a gida don kula da dangin da ke rashin lafiya, kuma cewa ma'aikata sun san waɗannan manufofin.
A cewar OSHA, ayyukan haɗarin haɗari na matsakaici sun haɗa da ayyukan da ke buƙatar maimaitawa ko kusanci na kusa da mutane a cikin ƙafa shida (1.8 m) waɗanda ba a san ko ake zargin suna da COVID-19 ba, amma na iya kamuwa da SARS-CoV-2 saboda yaduwar al'umma da ke kewaye da wurin aiki, ko kuma saboda mutumin ya yi balaguro na ƙasa da ƙasa zuwa wurin da aka sami yaduwar COVID-19.
Waɗannan sun haɗa da ma'aikatan da ke da hulɗa da jama'a kamar makarantu, yanayin aiki mai yawan jama'a, da kuma wasu wuraren sayar da kayayyaki masu yawa. Ayyukan sun haɗa da shigar da matattarar iska mai inganci a cikin injiniyan sarrafawa, ƙara yawan haɗarin haɗari, shigar da shingen jiki kamar masu kare kayan kwalliyar filastik, da kuma shigar da windows masu gudana don sabis na abokin ciniki. Wannan kuma ya haɗa da ƙarfafa ma'aikatan kula da jama'a da ke cikin ƙungiyoyin haɗari don barin gida, sauya tarurrukan ganawa da na'urorin sadarwa na gida, kafa masu rabawa, hana tafiye-tafiye zuwa wuraren da aka kamu da COVID-19.
Ma'aikata a cikin wannan rukunin haɗarin suna buƙatar amfani da na'urar numfashi a wani lokaci.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da: nisantar da mara lafiya daga wasu da nisan ƙafa 6, sanya ma'aikacin jirgin sama don kula da mara lafiya, da kuma ba wa mara lafiya abin rufe fuska ko kuma gaya wa mara lafiya ya rufe bakinsa da hancinsa da nama idan ya yi tari ko atishawa.
Masu aikin jirgin suna bukatar sa safofin hannu na likitanci da za a iya amfani da su a lokacin da suke kula da mai cutar ko kuma suna taba ruwan jiki ko kuma gurbataccen wuri, kuma suna bukatar sa ƙarin kayan kariya idan mai cutar yana da zazzabi, yana yawan yin tari, ko kuma yana da matsalar numfashi.
Dole ne a kwashe safofin hannu da sauran abubuwan amfani a cikin jaka mai haɗari, kuma a tsabtace da kuma gurɓata wuraren da suka gurɓata daga baya. Don jiragen ruwa na kasuwanci, gami da jiragen ruwa masu jigilar kaya da sauran jiragen ruwa masu jigilar kaya, dakatar da tafiya idan akwai rashin lafiya a cikin matakan kula da haɗari da keɓewa da sanar da cibiyar likitanci ta jirgin nan da nan idan wani ya sami zazzabi ko wasu alamun yayin da yake cikin jirgin.
Ainihin, ya kamata a bi diddigin likita a cikin ɗakin da aka keɓe. Don makarantu da wuraren kula da jarirai, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsaftacewa ko kashe ƙwayoyin cuta idan wani mai kamuwa da cuta ya kasance a cikin ginin makaranta ba tare da yaduwar al'umma ba.
Lokacin da akwai matsakaicin matsakaiciyar watsawar al'umma, ana iya aiwatar da dabarun nisantar da jama'a, kamar soke ziyarar filin, taro da sauran manyan tarurruka kamar na ilimin motsa jiki ko karatun murya ko cin abinci a cikin gidajen abinci, ƙara nesa tsakanin tebur, daidaita lokacin isowa da lokacin hutu, iyakance baƙi marasa mahimmanci, da amfani da sararin ofishin kiwon lafiya na musamman ga yara masu nuna alamun cutar kamar mura.
Lokacin da akwai isasshen yaduwa a cikin al'ummar yankin, za a iya yin la'akari da hutun makaranta mai tsawo ban da dabarun nisantar da jama'a. Ga jami'an tilasta bin doka da ke yin ayyukan yau da kullun, CDC ta ɗauki haɗarin kiwon lafiya na gaggawa kamar haka.
Ana ba da shawarar ga jami'an tsaro da ke hulɗa da mutanen da aka tabbatar ko waɗanda ake zargi da COVID-19 su bi ƙa'idodi iri ɗaya kamar na likitocin gaggawa, gami da kayan kariya na mutum.
Idan akwai kusanci yayin kamawa, ma'aikata yakamata su tsabtace da kuma kashe masu amfani da bel ɗin aikinsu da kayan aikin su, amfani da matattarar tsabtace gida ko gogewa, da kuma bin ka'idojin aiki na yau da kullun don gurɓata da zubar da PPE da kuma tsabtace da wanke tufafi kafin sake amfani da bel ɗin aikinsu.
OSHA ta ɗauki wasu ma'aikatan kiwon lafiya da ma'aikatan gidan mutuƙar a matsayin haɗarin haɗari ko haɗari.
Ayyukan haɗarin haɗari sun haɗa da samar da kiwon lafiya, taimako, ma'aikatan dakin gwaje-gwaje da jigilar likita waɗanda ke hulɗa da waɗanda aka sani ko waɗanda ake zargi da cutar COVID-19.
Waɗannan suna da haɗarin haɗari sosai idan ma'aikata suna yin ayyukan samar da aerosol akan waɗanda aka sani ko waɗanda ake zargi da COVID-19, tattara ko sarrafa samfura daga gare su.
Tsarin da ke haifar da aerosol sun haɗa da shigarwar jijiya, hanyoyin shigar da hanci, bronchoscopy, wasu hanyoyin hakori da gwaje - gwaje, ko tattara samfurin ta hanyar tsagewa.
Ayyukan gidan gawawwakin haɗarin haɗari sun haɗa da waɗanda ke shirya jikin mutane waɗanda aka sani ko kuma waɗanda ake zargi da COVID-19 a lokacin mutuwarsu; waɗannan sun zama masu haɗarin haɗari sosai idan suka yi gwajin gawa. Additionalarin matakan sarrafa injiniya ga waɗannan rukunin haɗarin sun haɗa da ɗakunan keɓewa ga marasa lafiya da aka sani ko waɗanda ake zargi da COVID-19 , gami da yayin aiwatar da hanyoyin samar da aerosol.
Wasu na'urorin gyaran hawan jini na iya zama da amfani a wasu wuraren kiwon lafiya da kuma gidajen gawa.
Ya kamata a bi da samfuran da matakan kariya na 3 na kariya.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a ware marasa lafiya masu shigowa a wuraren jira daban-daban, gwargwadon ko sun kasance abin da ake zargi da cutar COVID-19. Baya ga sauran PPE, OSHA ta ba da shawarar masu amfani da na'urar numfashi ga mutanen da ke aiki a tsakanin ƙafa 6 na marasa lafiya da aka sani ko ake zargi da kamuwa da SARS-CoV-2, da kuma waɗanda ke gudanar da ayyukan samar da aerosol.
A Amurka, NIOSH ya amince da N95 Filter Facepiece respirators ko mafi kyau don amfani a cikin mahallin mai zurfi, rubutaccen shirin kariya na numfashi wanda ya haɗa da fit-testing, horo, da kuma gwajin likita.
Sauran nau'ikan na'urar numfashi na iya samar da ƙarin kariya da kuma inganta kwanciyar hankalin ma'aikaci. WHO ba ta ba da shawarar rufewa, saboda COVID-19 cuta ce ta numfashi maimakon a watsa ta cikin ruwan jiki.
WHO ta ba da shawarar a sanya abin rufe fuska na tiyata kawai ga ma'aikatan da ke yin binciken a wurin shiga.
WHO ta ba da shawarar rufe fuska, tabarau, rigar rigakafi da safar hannu ga waɗanda ke tattara, kula da, ko jigilar samfuran numfashi daga marasa lafiyar COVID-19 ba tare da aiwatar da hanyoyin samar da aerosol ba.
Idan aka yi wani aikin da zai haifar da aerosol, ana maye gurbin abin rufe fuska da N95 ko FFP2 respirator.
Ganin cewa wadatar PPE ta duniya ba ta isa ba, WHO ta ba da shawarar rage buƙatar PPE ga mutane ta hanyar telemedicine, hana shingen jiki kamar windows masu haske, ba da izinin waɗanda ke da alaƙa da kulawa kai tsaye su shiga ɗaki tare da mai cutar COVID-19, amfani da PPE kawai da ake buƙata don takamaiman aikin, amfani da na'urar numfashi ɗaya ba tare da cirewa ba yayin kula da marasa lafiya da yawa tare da ganewar asali ɗaya, dubawa da daidaita sarkar samar da PPE, da kuma karfafa gwiwa amfani da masks don kulawa.
Katherine Mayer, Shugaba na Gidauniyar Wikimedia
Ta: Dukan ma'aikatan Gidauniyar Wikimedia
Jigo: [Covid-19] Sauƙaƙa da shirya don nan gaba
Ranar aikawa da lokacin aikawa: 14 ga Maris, 2020, 00:24 UTC
CC0: Babu haƙƙoƙi
Akwai yanayi na musamman a wannan watan.
Cutar COVID-19 ta nuna mana alaƙarmu da alhakinmu ga juna.
Kalubalen da muke fuskanta ba a taɓa yin irinsu ba, amma ya kamata mu san cewa mafi kyawun maganinmu ya dangana ne ga tausayin duniya, haɗin kai, da kuma ƙarfafa al'umma, wanda shi ne ainihin abin da ke zuciyar wannan ƙungiyar.
Irin sadaukarwar da muka gani a tsakanin abokan aikinmu ta hanyar imel, ta waya, da kuma taɗi, ya ba da tabbaci cewa muna da gata na yin aiki tare da mutane na musamman.
Ina matukar godiya da alfahari da ku a matsayin abokan aiki, ban san yadda zan iya bayyana muku ba.
A makon da ya gabata, wani ya yaba mana sosai.
Ya tunatar da ni yadda yake da ma'ana a gare ni a wannan lokacin da duniya ta juya zuwa Wikipedia, da kuma yadda yake da karfi wajen nuna cewa wannan muhimmiyar hanya ta kasance a yanar gizo kuma ga kowa da kowa.
Aikinku ne ya sa hakan ya yiwu, ko kuna kula da shafukan yanar gizonku ko kuna biyan abokan aikinmu ko kuma ku kare al'ummominmu.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa, kuma yanzu ne take bukatarsa fiye da kowane lokaci.
Lokaci ne da aikin da muke yi da kuma yadda muke yin sa zai yi tasiri a duniya.
Saboda wannan manufa, da kuma muhimmancin rawar da kuke takawa a ciki, za mu yi wasu canje-canje masu muhimmanci a yadda muke aiki tare da ku a wannan makon mai zuwa.
A wannan lokacin, na yi baftisma a matsayin mai kula da da'ira.
Kamar yadda Robin ya ambata a baya, ƙungiyar C ta haɗu a daren jiya don tattauna yadda muke aiki da kuma tsara jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun tattauna game da yadda za mu bi da yanayin da muke ciki, da kuma yadda za mu ci gaba da kasancewa da haɗin kai a wannan lokacin.
Mun yi mamaki sosai, kuma muna so mu rage damuwa kuma mu ba da gudummawa ga aikinmu na dogon lokaci.
Idan ka rage aikinka, babu laifi.
Ga ma'aikata, 'yan kwangila, da kuma ma'aikatan kwangila:
Burinmu na yau da kullum zai kasance awa 4 a rana, ko kuma awa 20 a mako, har sai an daɗa.
Ba mu ba da izinin hutu ba - idan kuna iya yin aiki fiye da yadda aka saba, to, aikin yana bukatar taimakonku.
Ko da yake, duniya ba ta da tabbas a yau, kuma ko kuna kula da ƙaunatattunku, ko ku je cin kasuwa, ko kuma ku je wurin likita, lafiyarku ita ce abin da muka sa kan gaba.
Ba mu da wani lokaci.
Idan ba ka da lafiya, kada ka yi aiki.
Ba lallai ba ne a faɗi haka, amma muna faɗin hakan.
Babu buƙatar hutun rashin lafiya ko PTO - kawai sanar da manajan ku kuma taimaka wa ƙungiyar ku ta hanyar gyara kalandar da jadawalin don tabbatar da cewa babu wanda ya ga manyan wuraren aiki.
(Idan an tabbatar da cewa kana da COVID-19, don Allah ka sanar da Brian na T&amp;C Ops domin T&amp;C ta taimake ka kuma ta tabbatar da cewa an kula da yanayin yadda ya dace.)
Ma'aikatan da suke aiki a kan lokaci za su sami cikakken albashi.
Mun riga mun faɗa, kuma muna sake tabbatar da cewa za mu cika alkawuran da muka yi wa 'yan kwangila da kuma abokan aikinmu na sa'o'i.
Kowa zai sami albashi bisa ga yawan sa'o'in da ya yi a lokacin da ya yi aiki a yanayi na al'ada.
Za a biya ku ko da kun yi rashin lafiya kuma ba za ku iya yin aiki ba.
Idan kuna son yin aiki, muna tare da ku.
Mutane da yawa suna amfani da aikinsu a matsayin hanyar da za su fita daga damuwa da ke kewaye da su.
Abin da za mu iya yi zai zama abin farin ciki, musamman a irin wannan lokacin.
A nan ma, kula da kanka shi ne abin da ya fi muhimmanci.
Muna gaya muku ku yi magana da manajanku, don mu san abin da za mu yi tsammani, kuma mu yi gyara daidai da haka.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da ba za mu iya bari su daina ba.
SRE, HR Ops, Trust & Safety, da kuma Grant Collecting Teams (da sauransu) suna da mahimman ayyuka waɗanda ke buƙatar ƙarin taimako.
Za mu fara wani tsari tare da dukkan sassan don tantance manufofin da ke akwai da kuma mayar da hankali ga abubuwan da ke da muhimmanci ga aikinmu.
Dukanmu muna da abubuwa da yawa da za mu yi, kuma za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Idan muka rage gudu yanzu, hakan zai hana mu yin rauni a nan gaba.
Babu wani shiri da zai ninka lokacin da muke da shi na kula da lafiyarmu bayan annobar ta wuce.
Ba za a bukaci ka yi aiki na sa'o'i da yawa don cika lokacin da ya wuce ba.
Mun yarda cewa yanayi ya canza, kuma za mu yi aiki don kafa sabbin manufofi da kuma lokacin da ya dace.
Mene ne zai faru da APP?
Don daidaitawa da sabon gaskiyarmu da tsammanin sa'o'in aiki na yau da kullun, muna son sake fasalin lokacin da za mu kammala shirinmu na shekara - shekara na 2020 - 2021.
Muna da niyyar bayar da shawarar fadada shirinmu na 2019-2020 don ba mu ƙarin lokacin yin kasafin kuɗi, don ba da damar ma'aikata su ba da fifiko ga mahimman ayyukan su, kula da kansu, da kula da ƙaunatattun su, da kuma daidaita waɗanda suke buƙata ko suke son yin aiki a kan jadawalin da aka rage a cikin makonni masu zuwa.
Wannan tsawaitawa na lokaci zai kawo sauƙin aiki da matsin lamba a kan tsarinmu na yanzu a cikin ƙungiyar.
Za mu gabatar da mu ƙ oƙarin ga hukumar gudanarwa a mako mai zuwa, kuma za mu sanar da wakilanmu da kuma ƙungiyoyinmu game da matakan da za mu ɗauka nan da nan bayan an tabbatar da mu.
Godiya ga ƙungiyar APP don jagorancinku a cikin wannan.
Matsayi, Saduwa, da Tsabtace ofishi
A makon da ya gabata, mun gano cewa wani abokin aikinmu da ke SF ya kamu da kwayar COVID-19.
Amma, a matsayin mai kula da mu, mun tura ma'aikatan tsabtace mu na rigakafin cutar zuwa ofisoshinmu da ke San Francisco don su tsabtace dukkan bangarorin.
Ta yi amfani da maganin kashe ƙwayoyin cuta na asibiti ta kashe ƙwayoyin cuta a kowane waje, a cikin falon, da kuma cikin akwatin ɗagawa da ke kaiwa zuwa bene.
Ginin yana aiwatar da tsarin kula da kansa ta amfani da kayayyakin da ke taimakawa wajen kiyaye lafiyar mazauna.
Mun tabbata cewa ofishin zai kasance a shirye sa'ad da muka dawo.
Ofishinmu na DC yana cikin WeWork wanda ya raba mana da duk ma'aikatan DC-based ƙa'idodin COVID-19.
A makon da ya gabata, ofishinmu na DC ya ɗauki cikakken tsari na nesa, daidai da jagorar da aka raba daga San Francisco.
Kamar yadda wasu daga cikin abokan aikinmu a New York suka sani, an kuma tattauna batun yin hayar wani wuri a Brooklyn.
Waɗannan tattaunawar suna ci gaba amma za a iya jinkirta su.
Wasu daga cikin abokan aikinmu suna aiki daga gida/nesa da gida a karon farko.
Abokanmu da suka daɗe suna aiki daga gida sun san cewa hakan na bukatar gyara, kuma suna son su ba ka shawara:
Ka rage tsawon lokacin tarurruka zuwa awa ɗaya ko biyu.
Idan kana bukatar ƙarin lokaci, ka yi amfani da lokaci mai tsawo don ka tattauna da shi.
Ka tsara tarurruka a bayyane, ka tsara jadawalin abubuwan da za a tattauna, kuma ka aika da littattafan da za a karanta a gaba.
Yi amfani da kayan aikin kamar Google Docs da Zoom don sauƙaƙa haɗin kai da haɗuwa kai tsaye, saita bidiyo a matsayin tsoho.
Ka ɗauki matakin da ya dace don gudanar da kowane taro, mutum ɗaya ya kula da hira don tambayoyi da kuma lissafin masu magana, kuma wani ya taimaka wajen yin rubutu (ko kuma a haɗa kai don yin rubutu)
Idan kana bukatar wani sa na'urar kai mai kyau, ka aika imel zuwa ga masu goyon bayan fasaha.
Ku yi amfani da kuɗin da aka ba ku don ku ci abinci.
Haɗa zuwa tashar #remoties a Slack don yin magana da abokan aikinka game da aikin da aka rarraba.
HR Operations Team na binciken Webinar-based Work Skill Guidance don tallafawa haɓaka aikin da aka rarraba a duk faɗin Foundation.
A makon da ya gabata, mun nemi duk masu amfani da tallafin al'umma su soke duk wani taron jama'a da Wikimedia ke tallafawa, kamar editaathon, da sauransu, har sai WHO ta ce an kawo karshen annobar.
Mun gaya musu cewa mun fahimci cewa buƙatunmu na sokewa da sauran ƙuntatawa na iya sa ba za a iya aiwatar da ayyukan tallafin da suka amince da juna ba, kuma ba za a hukunta kowa ba saboda jinkirta ko tilasta yin gyare - gyare ga waɗannan burin.
A cikin wannan mako mai zuwa, za mu ci gaba da bin ƙarin jagora game da Wikimania da sauran taron al'umma na yanki da na al'ada.
Akwai baƙin ciki a cikin al'ummar duniya saboda wannan cikas, amma kuma akwai nutsuwa daga ƙwarewa da cancantar mayar da hankali ga al'ummomin su, da kuma Wikimedia, da sauransu.
A ci gaba, CRT tana aiki don shirya shafi a kan Mat - wiki da nufin samar da wani wuri ga al'umma don sa ido kan tasirin da kuma bin hanyoyin sadarwa da mu.
Tattaunawa kan al'amura da suka shafi COVID-19
Za mu aika da gayyata zuwa taron ma'aikata na musamman a cikin kalandarku ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT.
Za mu yi amfani da wannan lokacin don ba da ƙarin sabuntawa, amsa tambayoyinku, da kuma ɗan lokaci don haɗuwa da juna.
Muna tare a wannan lokacin kuma muna nan don taimakawa ta kowace hanya da za mu iya.
A halin yanzu, zaku iya ci gaba da nemo bayanai daga wannan imel ɗin, da duk sauran bayanan da suka dace game da COVID-19 akan wiki na Office.
CRT za ta ci gaba da sabunta waɗannan shafuka kuma za ta adana duk bayanan a wuri guda.
Muna kuma aiki don ci gaba da sadarwa ta yau da kullun tare da ma'aikata waɗanda ke zaune a cikin ƙasashen da abin ya shafa sosai.
Idan kana da tambaya game da tafiya, abubuwan da suka faru, wani muhimmin aiki, ko ƙalubalen ɗaukar hoto, ko kuma kana bukatar taimako game da wani abu, ka yi jinkirin sanar da CRT kuma ka yi aiki tare da su.
Muna nan don taimakawa wajen samar da tallafi da kuma taimakawa wajen kafa dangantaka.
Idan shari'arku ta kasance sirri ko kuma mai mahimmanci, don Allah aika imel zuwa ga Brian Judan, Daraktan Ayyukan Duniya na HR International.
Babu wani daga cikin wadannan canje -canje da ya kamata a yi la'akari da watsi da aikinmu da kuma alhakinmu.
Maimakon haka, sun yarda cewa a wannan lokaci, ayyukanmu da kuma alhakinmu na iya bukatar a daidaita su a hanyar da ba mu taɓa yin ba a baya.
Mun yi imanin cewa waɗannan matakai na da muhimmanci wajen taimaka wa juna, don mu iya yin aiki, mu ba da ayyukanmu tare da taimakon da suke bukata, kuma mu ci gaba da ba da sabis ɗin da duniya ta dogara da shi.
Aikin da muka tsara zai kasance yana jiranmu idan lokacin ya kai.
A yanzu, lokaci ne na taimakon juna, da kuma samar da wuri don muhimmin aikin da zai zo a cikin makonni masu zuwa da watakila watanni masu zuwa.
Don yin wannan, muna bukatar ku duka, kuma muna son ku kula da kanku da kuma iyalanku, domin ku kasance da kyau a lokacin da ake bukata.
Yanzu, don Allah ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Catherine, CRT (Amanda K, Amy V, Brian J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da kuma Tony S), da kuma sauran 'yan ƙungiyar jagoranci (Grant I, Heather W, Jaime V, Jeannine U, Lisa S, Robin A, Ryan M, da Toby N).
Angiotensin - Convert Enzyme 2 (ACE2) shine enzyme wanda ke da alaƙa da farfajiyar waje na sel (cell membranes) a cikin huhu, jijiyoyin jini, zuciya, koda da kuma hanji.
ACE2 yana daidaita haɓakar aikin angiotensin-converting enzyme (ACE) ta hanyar rage adadin angiotensin-II da kuma ƙara angiotensin (1-7), wanda ya sa ya zama maƙasudin magani mai mahimmanci don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin ƙofar shiga cikin ƙwayoyin cuta don wasu coronaviruses.
An ambaci nau'in ɗan adam na enzyme kamar hACE2.
Angiotensin-converting enzyme 2 shine methyloenzyme mai ɗauke da zinc wanda yake a cikin ciki da kuma saman sauran ƙwayoyin halitta.
ACE2 sunadarai suna da N - ƙarshen peptides M2 yankin da C - ƙarshen calectrin renal amino acid mai ɗaukar yanki.
ACE2 shine nau'in membrane na I wanda yake da nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'i nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'i nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'i nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau.
The ACE2 extracellular yankin da aka disassembled daga transcellular yankin da wani enzyme da ake kira Shadez, da kuma sakamakon da m gina jiki da aka saki a cikin jini da kuma ƙarshe ya tsallake a cikin fitsari.
ACE2 yana cikin yawancin kwayoyin: ACE2 yana da alaƙa da ƙwayoyin ƙwayoyin ƙwayoyin cuta na huhu na II, ƙananan ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwallon ƙwallon ƙwallon ƙwayo.
Ana kuma samun bayyanar ACE2 mRNA a cikin ƙwanƙolin ƙwayar cuta, da kuma cikin stratum, hypothalamus, da kuma cikin ƙwayar kwakwalwa.
Ainihin aikin ACE2 shi ne ya zama mai maye gurbin ACE.
ACE tana sauko da kwayar halittar angiotensin I zuwa angiotensin II, wanda ke rage jijiyoyin jini.
ACE2 sa'an nan ya rushe carboxylic-terminal amino acid phenylalanine daga angiotensin II (Asp -Arg -Val -Tyr -Ile -His -Pro -Phe) kuma ya rushe shi zuwa cikin angiotensin mai haɓaka (1 - 7) (H -Asp -Arg -Val -Tyr -Ile -His -Pro -OH).
ACE2 [des - Arg9] - bredequinine, epelin, neurotensin, dinorphin A, da ghrelin, da kuma wasu peptides da yawa, kuma suna iya lalata su.
ACE2 yana kuma sarrafa jigilar membrane na aminin amino acid mai jigilar SLC6A19 kuma an bayyana rawar da yake takawa a cikin cutar Hartnup.
A matsayin furotin mai rarrafe, ACE2 ya zama babban wurin shigar kwayar cutar corona a cikin sel, gami da HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, haɗuwa da yankin enzyme na ACE2 zuwa kanc S1 na furotin SARS-CoV da SARS-CoV2 a kan sel yana haifar da endocytosis da canja wurin duka ƙwayoyin cuta da enzyme a cikin endosomes da ke cikin sel.
Wannan shigarwar kuma yana buƙatar mai gina jiki serine protease TMPRSS2 don tayar da furotin S, wanda aka hana shi a halin yanzu ana bincike a matsayin magani mai yiwuwa. Wannan ya sa wasu suka yi hasashen cewa rage matakan ACE2 a cikin sel na iya taimakawa wajen yaƙar kamuwa da cuta.
Koyaya, ƙungiyoyin ƙwararru da yawa da hukumomin tsarawa sun ba da shawarar ci gaba da magungunan ACE mai hanawa da magungunan ARB.
Binciken da aka yi da kuma nazarin da aka yi a kan 11 ga Yuli, 2012 ya gano cewa "amfani da ACE inhibitors ya danganci raguwa mai ban sha'awa na 34% a cikin haɗarin cutar huhu idan aka kwatanta da sarrafawa".
Bugu da ƙari, "haɗarin kamuwa da cutar huhu ya ragu a cikin marasa lafiya da aka yi wa maganin ACE, waɗanda ke da haɗarin kamuwa da cutar huhu, musamman a cikin waɗanda ke fama da rauni da rashin karfin zuciya.
Amfani da masu hana ACE ya kuma haɗu da rage mutuwar da ke da alaƙa da cutar huhu, kodayake sakamakon ba shi da ƙarfi kamar yadda haɗarin cutar huhu ke da shi".
Ana daukar kwayar cutar ACE2 ta mutum mai juyawa (rhACE2) a matsayin sabon magani don mummunan lalacewar huhu, kuma an nuna ingantaccen haemodynamics na huhu da kuma oxygen saturation a cikin 'ya'yan aladu tare da cutar cutar lipopolysaccharide-induced acute respiratory distress syndrome.
RhACE2 yana da rabin rai na kusan awa 10 a cikin mutane kuma yana da tsawon sa'o '30 na farawa da aiki tare da tsarin aiki na awa 24.
Sakamakon binciken da yawa ya nuna cewa rhACE2 na iya zama magani mai fa'ida ga mutanen da ba su da haƙuri ga ƙwayoyin cuta na RAS ko cututtukan da ke haifar da ƙaruwar angiotensin II. An kimanta rhACE2 da aka narke a cikin gwaji na asibiti don magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka.
COVID-19 apps su ne aikace-aikacen software na wayar hannu da aka kirkira don taimakawa wajen gano mutane ("abokan hulɗa") waɗanda ƙila sun kasance cikin hulɗa da mai cutar, a cikin martani ga annobar cutar coronavirus ta 2019-20.
A wasu yankuna da yankuna, an ƙirƙiri ko kuma samar da aikace -aikace da yawa tare da tallafin hukuma.
An tsara tsarin da yawa don gina aikace -aikacen gano hanyar tuntuɓar.
An tayar da damuwar sirri, musamman game da tsarin da ke dogara ne akan bin diddigin masu amfani da aikace -aikacen.
A cikin ƙananan zaɓuɓɓuka na ƙetare, ya haɗa da amfani da siginar Bluetooth don yin amfani da kusanci daga wasu wayoyin salula na mai amfani.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su hada aikin don tallafawa irin waɗannan aikace-aikacen tushen Bluetooth kai tsaye a cikin tsarin aikin Android da iOS.
A China, gwamnatin China ta yi amfani da wata manhajar Alipay don ba wa 'yan ƙasa damar bincika ko sun yi hulɗa da mutanen da ke da COVID-19.
Ana amfani da shi a birane sama da 200 na kasar Sin. A Singapore, ana amfani da manhajar da ake kira TraceTogether.
App ɗin ya samo asali ne daga ƙungiyar IT ta gida, an sake shi a matsayin tushen buɗewa kuma za a miƙa shi ga gwamnati. Arewacin Macedonia sun ƙaddamar da "StopKorona!"
Aikace-aikacen ya kasance ta hanyar sadarwa da fasaha da kuma ma'aikatar kiwon lafiya.
Ya zuwa 14 ga Afrilu 2020, wannan app yana jiran amincewar Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta ce manhajar gano mutanen da ke da cutar ta COVID-19 tana kan ci gaba, kuma za ta kasance a shirye don amfani da ita a cikin 'yan makonni. An shirya amfani da irin wannan manhajar a Ireland da Faransa.
Australia da New Zealand suna la'akari da aikace-aikacen da suka dogara da aikace-aikacen TraceTogether na Singapore da kuma yarjejeniyar BlueTrace. Rasha na son gabatar da aikace-aikacen geofencing ga marasa lafiyar da aka gano suna da COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba za su fita daga gida ba.
Ross Anderson, farfesa a fannin injiniyan tsaro a jami'ar Cambridge, ya lissafa matsaloli da dama da ake fuskanta a fannin amfani da manhajar, ciki har da rashin ingancin amfani da manhajar idan an yi amfani da ita ga mutane kalilan.
Da yake magance damuwa game da yaduwar aikace-aikacen "coronavirus" da ke yaudara ko cutarwa, Apple ya ƙayyade irin ƙungiyoyin da za su iya haɗa aikace-aikacen da suka shafi coronavirus a cikin App Store, tare da iyakance su ga ƙungiyoyi "a hukumance" ko kuma waɗanda aka sani.
Google da Amazon sun kafa irin wannan takunkumin.
Masu fafutukar sirri sun nuna damuwarsu game da tasirin sa ido ta hanyar amfani da manhajojin cutar coronavirus, musamman ma game da ko za a lalata tsarin sa ido da aka gina don magance cutar bayan da wannan barazanar ta wuce.
Amnesty International da kuma wasu ƙungiyoyi fiye da 100 sun ba da sanarwa game da iyakance irin wannan sa ido.
Kungiyoyin sun bayyana sharudda guda takwas ga ayyukan gwamnati:
Kulawa dole ne ya zama "mai inganci, ya zama dole kuma ya dace";
Ya kamata a yi sashe na ƙarshe don tsauraran matakan kulawa da kulawa;
Amfani da bayanan ya kamata a iyakance ga COVID-19 dalilai;
Dole ne a kiyaye tsaro da kuma ɓoye bayanan sirri, kuma a nuna cewa an kiyaye su bisa hujja;
Kulawa ta dijital ya kamata ya guje wa faɗakarwa da nuna bambanci da kuma rashin iko;
Duk wani raba bayanai tare da wasu za a bayyana shi a cikin doka;
Dole ne a sami matakan da za su kare haƙƙin 'yan ƙasa na amsawa ga cin zarafi da kuma na cin zarafi;
"Ma'ana mai ma'ana" zai buƙaci "haɗin kai mai ma'ana" ta duk "masu ruwa da tsaki masu dacewa", gami da ƙwararrun masanan kiwon lafiya da ƙungiyoyin marasa ƙarfi.
Tsarin da aka gabatar na Google / Apple yana nufin magance matsalar sa ido ta hanyar cire tsarin sa ido daga tsarin aikin su lokacin da ba lallai ba ne.
Wasu ƙasashe sun yi amfani da hanyar sadarwar wuri maimakon aikace-aikace, suna kawar da buƙatar saukar da aikace-aikace da kuma ikon kaucewa bin sawu.
A Isra'ila, an yarda da bin diddigin hanyar sadarwa.
Maganin tushen hanyar sadarwa da ke da damar samun bayanan wuri mara kyau yana da mahimman matsalolin sirri.
Duk da haka, ba duk tsarin da ke da uwar garken da ke bukatar samun damar bayanan wuri na mutum ba; an tsara tsarin tsare sirrin sirri da yawa waɗanda ke amfani da uwar garken don sadarwa da juna kawai (duba sashe na ƙasa).
An yi amfani da tsarin da ba na app ba don gano hanyoyin sadarwa a Koriya ta Kudu.
Maimakon amfani da keɓaɓɓen app, tsarin ya tattara bayanan sa ido daga tushe daban-daban, gami da bayanan sa ido na na'urar hannu da bayanan ma'amalar katin, kuma ya haɗa su don samar da sanarwar ta hanyar saƙonnin rubutu ga mutanen da ke da yiwuwar kamuwa.
Baya ga amfani da wannan bayanin don faɗakar da abokan hulɗa, gwamnati ta ba da bayanan wuri a bainar jama'a saboda canje -canje masu nisa a cikin dokokin tsare sirri na bayanai bayan barkewar cutar MERS a cikin wannan ƙasar.
Wannan bayanin yana samuwa ga jama'a ta hanyar aikace-aikace da yanar gizo da yawa. Kasashe da yawa, ciki har da Jamus, sun yi la'akari da amfani da tsarin tsakiya da tsare sirri.
Har zuwa 6 ga Afrilu, 2020 ba a ba da waɗannan bayanan ba.
Binciken tuntuɓar mai kare sirri wata ƙa'ida ce mai kyau, tare da tarin littattafan bincike tun daga aƙalla 2013. A ranar 7 ga Afrilu, 2020, fiye da ƙwararrun ƙwararrun ƙwararru doan dozin suna aiki kan mafita masu aminci, kamar amfani da Bluetooth Low Energy (BLE) don yin amfani da kusancin mai amfani da wasu wayoyin salula.
Koyaya, PEPP-PT ƙoƙari ne na daidaitawa wanda ya ƙunshi ma'auni na tsakiya da rarrabuwa, kuma ba yarjejeniya ba ce. Yarjejeniyar da aka rarraba ta ƙunshi Tsarin Tsari na Tsare Sirri na Tsari (DP-PPT / DP-3T), Lambar Sadarwar Takarda (TCN, a baya lambar taron Sadarwa, CEN), Tsarin Sirri mai mahimmanci da Tsarin Tsarin Sadarwar Sadarwa ta Wayar hannu (PACT) da sauransu.
A cikin waɗannan ƙa'idodin, bayanan mutum da za a iya ganewa ba ya fita daga na'urar, kuma duk na'urar da aka yi daidai da ita ce ta mallake ta.
The Privacy Group a MIT Media Lab yana haɓaka SafePaths, dandamali don amfani da fasahohin kare sirri yayin tattarawa da amfani da wuri ko hanyar ƙetare bayanai don bin diddigin yaduwar COVID-19.
Wannan ya dogara ne akan binciken da aka fitar a cikin takarda mai taken "Apps Gone Rogue: Maintaining Personal Privacy in the Epidemic" wanda aka fitar a watan Maris na 2020. Wani irin wannan yunƙurin shine SafeTrace ta Enigma MPC, kamfanin haɓaka fasahar ɓoyewa, wanda aka kafa asali a MIT Media Lab.
SafeTrace yana amfani da fasahar kayan aiki mai aminci, wanda ke ba masu amfani damar raba wuri mai mahimmanci da bayanan lafiya tare da sauran masu amfani da hukumomi ba tare da yin sulhu da sirrin wannan bayanan ba.
A ranar 5 ga Afrilu, 2020, an kafa ƙungiyar TCN ta duniya ta ƙungiyoyi waɗanda suka haɗu da juna a cikin mahallin da ke da mahimmanci iri ɗaya da ƙa'idodi iri ɗaya, tare da maƙasudin rage rarrabuwa, da kuma ba da damar haɗin kai na duniya na aikace-aikacen ganowa da faɗakarwa, wanda shine babban mahimmin abu don samun ingantaccen aiki.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta bude hanyar BlueTrace, yarjejeniyar da hukuma ta yi amfani da ita.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke kula da Android da iOS, sun sanar da wani shiri don gano hanyar sadarwa, wanda suka yi iƙirarin zai kiyaye sirrin sirri ta hanyar amfani da Bluetooth da fasahar ƙananan makamashi da kuma ɓoye ɓoye ɓoye.
Ya kuma wallafa bayanai na musamman na manyan fasahohin da za a yi amfani da su a cikin tsarin.
A cewar Apple da Google, an tsara tsarin a matakai uku:
Bayar da kayan aiki don ba da damar gwamnatoci don ƙirƙirar Aikace-aikacen Kula da Sirrin Sirri na Coronavirus
Wannan aikin yana aiki kai tsaye a iOS da Android
Sake sanya magani (wanda kuma aka sani da sake sanya magani, sake fasalin, sake sanyawa, ko sauyawar magani) shine sake sanya magani da aka amince dashi don magance cuta ko yanayin likita daban da wanda aka fara kirkirar sa.
Wannan tsari ne na binciken kimiyya wanda a halin yanzu ake amfani dashi don samar da ingantaccen magani na COVID-19.
Sauran hanyoyin bincike sun hada da samar da allurar COVID-19 da kuma hada jini da aka yi da jini. SARS-CoV-2 yana da kusan furotin 66 da ake niyya, kowannensu yana da wuraren da ke da alaƙa da ligand.
Nazarin waɗancan wuraren haɗin haɗin yana ba da kyakkyawan tsari don haɓaka maganin rigakafin ƙwayoyin cuta don kariya daga furotin na COVID-19.
Mafi mahimmancin sunadarai masu kama da SARS-CoV-2 sune sunadarai masu kama da Papen, RNA mai dogaro da RNA polymerase, heliques, S sunadarai da ADP ribophosphate.
Hussain da sauransu sun yi nazarin wasu magungunan da za su iya zama masu cutarwa, wanda aka inganta da kuma nazarin su don daidaita tsarin su da mafi yawan magungunan da aka amince da su don hanzarta ci gaban ingantaccen maganin SARS-CoV-2 a cikin binciken asibiti wanda za a ba da shawarar a cikin tsarin binciken asibiti.
Chloroquine wani maganin maleriya ne wanda kuma ake amfani dashi don kariya daga wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar cewa chloroquine da hydroxychloroquine da ke da alaƙa za su kasance cikin magunguna huɗu da za a yi nazari a matsayin ɓangare na gwajin asibiti na Solidarity.
Gwamnan New York Andrew Cuomo ya ba da sanarwar cewa gwajin New York na jihar na chloroquine da hydroxychloroquine zai fara a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquyl phosphate a ƙarƙashin Amfani da Gaggawa (EUA).
Ba a amince da maganin ta hanyar FDA ba, kuma an ba da izinin amfani da shi a matsayin magani na gwaji a cikin marasa lafiya da ke asibiti amma ba su iya samun magani a cikin gwajin asibiti ba.
CDC ta ce "amfani, sashi, ko tsawon lokacin da za a yi amfani da hydroxychloroquine don rigakafi ko maganin kamuwa da SARS-CoV-2 ba a kafa shi ba tukuna".
Likitocin sun ce suna amfani da maganin ne kawai lokacin da "ba su da wani zabi".
Wata ƙungiyar bincike a Turkiyya a Istanbul tana yin wani karamin bincike kan amfani da chloroquine a hade da zinc, bitamin A, bitamin C da bitamin D.
Akwai wasu manyan karatu da ake yi a jami'o'in Duke da Oxford.
Makarantar likitanci ta NYU Langone tana gudanar da gwaji kan aminci da ingancin amfani da maganin hana cutar ta hydroxychloroquine.
Gwaje - gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun yi ikirarin cewa favipiravir ya "zama mai tasiri sosai".
A Shenzhen, 35 daga cikin marasa lafiya sun gwada mummunan a cikin matsakaicin kwanaki 4, yayin da tsawon lokacin rashin lafiya ya kasance kwanaki 11 a cikin marasa lafiya 45 da ba su karɓa ba.
A cikin wani binciken da aka yi a Wuhan na marasa lafiya 240 da ke fama da cutar nimoniya, rabin marasa lafiya sun sami favipiravir, rabin kuma sun sami omifenovir.
Hukumar Kula da Magunguna ta Italiya ta tunatar da jama'a cewa shaidar da ke akwai a yanzu don tallafawa maganin yana da ƙanƙanci kuma na farko.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi magungunan daga Japan don ajiyar su, kuma za ta yi amfani da sojojin don kai magungunan asibitocin jami'a, inda za a yi amfani da maganin don kula da marasa lafiya na COVID-19.
A cewar South China Morning Post, Shinzo Abe ya aika da shawarwari ga gwamnatin Trump game da sayan maganin. Wannan maganin na iya zama mai tasiri a cikin mummunan yanayin rashin lafiya, inda cutar ta riga ta ƙaru.
Ba zai iya zama lafiya ba ga mata masu juna biyu ko mata masu ƙoƙarin yin ciki.
Wani binciken da aka yi na maganin maganin rigakafin cutar Lopinvir da ritonavir, Lopinavir/ ritonavir (Calatra), ya kammala da cewa "babu wani amfani da aka gani".
An tsara maganin ne don hana kwayar cutar HIV yin kwaya ta hanyar yin amfani da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado tana ƙoƙarin yin gyare -gyare ga magunguna don gano wani fili wanda zai ɗaure ga ƙwayoyin SARS - CoV-2. Akwai suka a cikin al'ummar kimiyya game da tura albarkatu don sake amfani da magungunan da ake haɓaka, musamman ga HIV / AIDS.
WHO ta hada Lopinavir/Ritonavir a cikin gwajin Solidarity na kasa da kasa.
An kirkiro da kuma haɓaka Remdesivir ta Gilead Sciences don maganin cututtukan Ebola da cututtukan Marburg. Gilead Sciences daga baya ya gano cewa Remdesivir yana da aikin rigakafin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka da cututtukan cututtukan cututtuka.
Matsalar da ke tattare da maganin na kwayar cutar ita ce, haɓakar juriya ta hanyar maye gurbi wanda zai iya haifar da cututtuka masu tsanani da kuma yaduwar cutar.
Wasu binciken farko na gwaji sun nuna cewa akwai yiwuwar ƙwayoyin cuta masu yawa ga rigakafi ga maganin rigakafi. Akwai gwaji na asibiti da yawa da ke gudana, ciki har da gwaji biyu da Asibitin Jami'ar Cleveland ke gudanarwa; daya ga mutanen da ke da matsakaiciyar cuta kuma ɗayan ga mutanen da ke da cuta mai tsanani.
Akwai gwaji na asibiti guda uku na intravenous na bitamin C da ke gudana ga mutanen da ke asibiti da marasa lafiya tare da COVID-19; biyu ana sarrafa su (a China, Kanada) kuma ɗaya ba tare da sarrafawa ba (a Italiya).
Jihar New York ta fara gwaji don maganin rigakafin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) tana shirin yin gwajin asibiti don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka.
Ana ci gaba da gwaji na biyu na angiotensin-converting enzyme 2 a kan mutane 200 da ke cikin mawuyacin hali, asibitoci a Denmark, Jamus, da Austria don tantance tasirin maganin.
Masu bincike daga Cibiyar Kula da Zuciya ta Montreal a Kanada a halin yanzu suna nazarin rawar colchicine wajen rage kumburi da rikitarwa na huhu a cikin marasa lafiya da ke fama da alamun COVID-19.
Nazarin mai suna COLCORONA yana ɗaukar manya 6000 masu shekaru 40 da haihuwa waɗanda aka gano da COVID-19 kuma waɗanda ke fuskantar alamun rashin lafiya waɗanda ba sa buƙatar shiga asibiti.
Mata masu juna biyu ko masu shayarwa ko kuma waɗanda ba sa amfani da maganin hana haihuwa ba, ba za su iya shiga cikin wannan rukunin ba.
Ana gwada wasu magungunan kashe zazzabi a Italiya.
Ana amfani da heparin mai ƙananan ƙwayar ƙwayar ƙwayar cuta don magance marasa lafiya, wanda ya sa Hukumar Magunguna ta Italiya ta buga jagororin kan amfani da shi.
An sanar da wani binciken da aka gudanar a Italiya a ranar 14 ga Afrilu, wanda ya yi nazari kan marasa lafiya 300 da ke gudanar da bincike kan amfani da sinadarin anoxaparin sodium a magungunan rigakafi da na magani.
Tun da SARS-CoV-2 kwayar cuta ce, yawancin binciken kimiyya ya mai da hankali kan sake amfani da magungunan da aka amince da su don maganin kwayar cuta, waɗanda aka haɓaka don barkewar barkewar cutar kamar MERS, SARS, da West Nile Virus.
Ribavirin: Ribavirin an ba da shawarar don maganin COVID-19 bisa ga jagororin edition na 7 na kasar Sin.
Umifenovir: An ba da shawarar Umifenovir don maganin COVID-19 bisa ga jagororin fitowar na 7 na kasar Sin
Wasu daga cikin kwayoyin cutar da aka gano a matsayin yiwuwar sake amfani da su a matsayin maganin COVID-19 sune:
Tocilizumab (mai adawa da IL-6 mai karɓa): China ta amince da shi.
Hakanan ana gudanar da gwaji a Italiya da China. Duba Tocilizumab#COVID-19.
Alurar rigakafin COVID-19 allurar rigakafi ce da aka tsara don kariya daga cutar Coronavirus 2019 (COVID-19).
Ko da yake babu wata allurar rigakafin da ta kammala gwajin asibiti, amma ana ta yin kokari don samar da irin wannan allurar rigakafin.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba a sa ran samun allurar rigakafin cutar SARS-CoV-2 ba, cutar da ke haifar da cutar, a cikin ƙasa da watanni 18.
A watan Afrilu, ana sa ran a samu karin rigakafin cutar a cikin mutane biyar da ake sa ran za a samu.
An gano COVID-19 a cikin watan Disamba 2019.
Babban barkewar cutar a duniya a cikin 2020 ya haifar da saka hannun jari da ayyukan bincike don haɓaka allurar rigakafi.
Kungiyoyi da yawa suna amfani da kwayoyin halittar da aka wallafa don haɓaka allurar rigakafin da za a iya yi don kariya daga SARS-CoV-2.
Kamar yadda aka bayyana a watan Afrilu, abubuwan da ake bukata na shirin CEPI don samar da allurar rigakafin cutar shine saurin aiki, karfin masana'antu, babban tsari da kuma samun damar duniya.
A watan Afrilu, masana kimiyya a CEPI sun ba da rahoton cewa a farkon shekarar 2020 akwai 10 daban-daban na'urorin fasahar da ke karkashin bincike da ci gaba don samar da ingantacciyar allurar rigakafin COVID-19.
Mahimman manufofin dandamali da aka haɓaka a cikin binciken tsaro na Phase I sun haɗa da:
Kwayoyin nucleic acid (DNA da RNA) (Mataki na I mai haɓaka da mai neman rigakafi: Moderna, mRNA-1273)
Mai ɗaukar hoto na kwayar cuta (mai ɗaukar hoto na farko da kuma wanda ake son a yi wa allurar: CanSino Biologics, adenovirus type 5 vector)
Kamar yadda masana kimiyyar CEPI suka sanar a watan Afrilu, akwai adadin allurar rigakafi guda 115 a cikin farkon matakin ci gaba, 78 daga cikinsu an tabbatar da su a matsayin ayyukan aiki (79 bisa ga Cibiyar Milken), da kuma wasu 37 da aka sanar, amma ba a samun cikakken bayani ba (ana tsara ko kuma ana shirin).
Gwajin farko na I - II yana ƙunshe da gwajin aminci da rigakafi, wanda aka saba yi a bazuwar, an sarrafa shi da placebo, kuma an yi shi a wurare da yawa, tare da ƙayyade mafi daidaito, ingantaccen sashi.
Gwajin na III yawanci yana haɗawa da ƙarin mahalarta, tare da ƙungiyar kulawa, yayin da ake lura da illa a mafi kyawun sashi, da kuma gwada ingancin maganin don hana cutar.
Daga cikin 'yan takarar allurar rigakafi 79 da ke cikin ci gaba (wanda aka tabbatar a farkon Afrilu 2020), 74 ba su da kimantawa a cikin mutane (har yanzu suna cikin binciken "preclinical").
A Australia a ranar 24 ga watan Janairun 2020, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar yin allurar rigakafin kwayar cuta, wanda zai gyara kwayar cutar ta hanyar kwayar halitta don haifar da amsawar garkuwar jiki.
A Kanada a ranar 24 ga Janairun 2020, Cibiyar Alurar rigakafi ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aiki a kan rigakafin, da nufin fara gwajin ɗan adam a 2021.
A ranar 26 ga Janairu, 2020, an sanar da ayyukan ci gaban allurar rigakafi a Cibiyar Kula da Cututtukan Cutar da Cutar Cutar Cutar da kuma a Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanin magungunan Yansen, wanda Hanneke Schütemecker ke jagoranta, ya ba da sanarwar cewa ya fara aiki kan samar da allurar rigakafi.
Yansen yana haɓaka allurar rigakafin baki tare da abokin haɗin gwiwar fasahar kere kere.
A ranar 18 ga Maris, 2020, Emergent Biosolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka maganin.
A ranar 8 ga Fabrairu, 2020, Oncogene, wani dakin gwaje-gwaje a Romania, ya wallafa wata takarda kan tsara wani maganin da ke kama da fasahar da ake amfani da ita don maganin rigakafin cutar sankarar daji.
A ranar 25 ga Maris, shugaban cibiyar bincike ya sanar da cewa sun kammala aikin samar da allurar rigakafin kuma suna fara gwajin.
A ranar 27 ga Fabrairu 2020, NuGenrex Immuno-Oncology, wani reshen Genrex, ya ba da sanarwar cewa suna fara aikin allurar rigakafi don ƙirƙirar allurar rigakafin mai suna L-Key peptide don kariya daga COVID-19.
Suna so su samar da wani mai neman allurar rigakafi wanda za a iya gwada shi a cikin mutane "a cikin kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye-shiryenta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Bincike da Bincike ta Sojojin Amurka a Fort Detrick da Walter Reed Army Institute of Research a Silver Spring, Western Maryland, sun ba da sanarwar cewa suna aiki a kan allurar rigakafi.
A ranar 10 ga Maris, 2020, kamfanin Emergent Biosolutions ya sanar cewa yana da hannu a cikin ci gaba da kuma samar da maganin.
Kamfanin Novavax Inc. zai yi aiki tare da kamfanin.
Abokan hulɗa sun sanar da shirye -shiryen gwajin gwaji na farko da na gwaji na farko a cikin Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki tare da masu bincike 11, kuma cewa zai ɗauki aƙalla shekara ɗaya da rabi zuwa biyu don haɓaka allurar rigakafi, koda kuwa a kan hanya mai sauri.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasahar kere kere a Quebec City, Quebec, ya ba da rahoton ci gaban kwayar cutar kwayar cutar coronavirus, a karkashin wani bangare na kudade daga Cibiyar Nazarin Kiwon Lafiya ta Kanada.
Ana gudanar da bincike a cikin dakin gwaje-gwaje, tare da shirin gwajin mutum a watan Yuli ko Agusta 2020.
A farkon wannan makon, The Guardian ta ba da rahoton cewa Shugaban Amurka Donald Trump ya ba da "babban kuɗi don sayen rigakafin COVID-19 na musamman" ga Kurwack, wanda gwamnatin Jamus ta ƙi.
A ranar 17 ga Maris, 2020, kamfanin hada magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
A halin yanzu ana cikin gwajin gwaji na rigakafin mai suna mRNA BNT162, wanda ake sa ran zai fara gwajin asibiti a watan Afrilu 2020.
A Italiya a ranar 17 ga Maris 2020, Tacis Biotech, wani kamfanin fasahar kere-kere na Italiya ya sanar da cewa za su sami sakamakon gwajin asibiti a watan Afrilu 2020 kuma ana iya fara gwaji a kan takararsu na karshe na rigakafi zuwa kaka.
A Faransa a ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) ta sanar da saka hannun jari na dalar Amurka miliyan 4.9 a cikin ƙungiyar bincike kan allurar rigakafin COVID-19, wanda ya haɗa da Institut Pasteur, Themis Bioscience (Vienna, Austria) da Jami'ar Pittsburgh, wanda ya kai ga jimlar saka hannun jari na CEPI a cikin ci gaban allurar COVID-19 dalar Amurka miliyan 29.
Sauran abokan haɗin gwiwar CEPI don haɓaka allurar COVID-19 sune Moderna, CureVac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na shida daban-daban.
Masu bincike a Kwalejin Imperial na London sun sanar a ranar 20 ga Maris, 2020 cewa suna haɓaka allurar rigakafin RNA ta kansu don COVID-19.
An kirkiro wannan maganin ne a cikin kwanaki 14 da samun jerin daga China.
A ƙarshen Maris, gwamnatin Kanada ta sanar da C$275 miliyan a cikin kudade don ayyukan bincike 96 kan matakan likita don kariya daga COVID-19, gami da yawancin masu neman allurar rigakafin daga kamfanonin Kanada da jami'o'i, kamar su Medicago da Jami'ar Saskatchewan.
A kusan lokaci guda, Gwamnatin Kanada ta ba da sanarwar C$192 miliyan don haɓaka allurar COVID-19 ta musamman, tare da shirin kafa "tallafin rigakafin" ƙasa na sabbin allurar rigakafi da yawa waɗanda za a iya amfani da su idan akwai wasu ɓarkewar cutar coronavirus.
A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoto game da gwajin PittCoVacc, wani allurar COVID-19 mai yuwuwa a cikin beraye, suna cewa "Alluran rigakafin SARS-CoV-2 S1 da aka bayar ta MNA sun haifar da halayen antigen-specific antibody [a cikin beraye], wanda ya bayyana ya fara makonni 2 bayan allurar rigakafi".
A ranar 16 ga Afrilu, 2020, a Jami'ar Waterloo School of Pharmacy a Kanada ta sanar da ƙirar mai neman allurar rigakafin DNA a matsayin mai yuwuwar fesa hanci.
Ta amfani da bacteriophages, za a tsara DNA don yin kwafi a cikin ƙwayoyin cuta na ɗan adam don samar da ƙwayoyin cuta marasa cutarwa, waɗanda za su iya ƙarfafa tsarin rigakafi don samar da kwayoyin cutar don kariya daga cutar SARS-CoV-2.
A watan Maris na 2020, Gwamnatin Amurka, masana'antu da jami'o'i uku sun hada da albarkatun kwamfuta na girgije daga Hewlett Packard Enterprise, Amazon, Microsoft da Google, don samun damar zuwa manyan kwamfutoci daga IBM.
Wasu allurar rigakafi suna da sakamako na banbanci, wanda kuma ake kira da sakamako na banbanci.
Wannan yana nufin cewa suna iya samun ƙarin fa'idodi daga cutar da suke hanawa.
Wani gwajin da aka yi a Australia ya nemi a kai ma'aikatan lafiya 4,170 aiki.
Zai yiwu cewa alluran rigakafin da ake ci gaba ba za su kasance masu aminci ko tasiri ba.
Binciken farko da ke kimanta ingancin allurar rigakafin ta amfani da samfuran dabbobi na musamman na COVID-19, kamar su mice ACE2-transgenic, da sauran dabbobin da ba dabbobi ba, da kuma dabbobi masu rai, sun nuna buƙatar matakan keɓewa na matakin 3 na biosafety don magance kwayar cutar da ke raye da kuma daidaita daidaitattun hanyoyin tsaro na duniya.
An gwada alluran don kariya daga SARS da MERS a cikin ƙirar dabbobi ba na mutum ba.
Har zuwa 2020, babu magani ko rigakafin rigakafi ga SARS wanda aka nuna duka lafiya da tasiri a cikin mutane.
Binciken da kuma samar da sabbin alluran rigakafi da magunguna don maganin SARS ya kasance fifiko ga gwamnatoci da hukumomin kiwon lafiyar jama'a a duniya, kamar yadda takardun bincike da aka buga a 2005 da 2006. Babu wani allurar rigakafin da aka tabbatar don karewa daga MERS.
Lokacin da MERS ta zama gama gari, an yi imanin cewa binciken SARS na yanzu na iya samar da ingantaccen tsari don haɓaka alluran rigakafi da magani don kariya daga kamuwa da cutar MERS-CoV.
Ya zuwa watan Maris na 2020, akwai rigakafin MERS (wanda ya dogara da DNA) wanda ya kammala gwajin asibiti na Phase I a cikin mutane, kuma wasu uku suna cikin ci gaba, dukansu rigakafin da ke dauke da kwayar cuta, biyu na adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), kuma daya na MVA-vectored (MVA-MERS-S).
Rubutun kafofin watsa labarun sun haifar da wata maƙarƙashiya, suna da'awar cewa an san kwayar cutar da ke da alhakin COVID-19 kuma cewa riga an riga an sami allurar rigakafi.
Takaddun da aka ambata ta hanyar sakonnin kafofin sada zumunta daban-daban suna nufin takaddun shaida na yanzu don jerin kwayoyin halitta da alluran rigakafi ga sauran nau'in coronavirus kamar SARS coronavirus.
Cutar kwayar cutar Coronavirus ta 2019 (COVID-19) cuta ce mai saurin kamuwa da cuta wacce cutar coronavirus ta 2 (SARS-CoV-2) mai saurin kamuwa da cututtukan numfashi ke haifarwa.
Alamun da ake yawan gani sun haɗa da zazzabi, tari, da kuma rashin numfashi.
Sauran alamun sun haɗa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, ƙanshin ƙanshi da ciwon ciki.
Lokacin da cutar ta fara kamuwa da mutum ya kan kai kimanin kwanaki biyar amma zai iya kaiwa daga kwana biyu zuwa goma sha huɗu.
Ko da yake mafi yawan lokuta ana samun alamun rashin lafiya, wasu suna kamuwa da cutar nimoniya da kuma ciwon gabbai da yawa.
Ya zuwa 17 ga Afrilu 2020, an ba da rahoton fiye da mutane miliyan 2.24 a cikin kasashe da yankuna 210, wanda ya haifar da mutuwar mutane sama da 153,000.
Fiye da mutane 568,000 ne suka warke. Cutar ta fi yaduwa tsakanin mutane ta hanyar kusanci, yawanci ta hanyar ɗigon da ake samu daga tari, hancin da ake yi, ko kuma magana.
Kodayake ana haifar da waɗannan ɗigon lokacin da aka fitar da numfashi, suna faɗuwa a ƙasa ko a saman ƙasa maimakon su zama masu yaduwa a nesa.
Mutane za su iya kamuwa da cutar ta hanyar taɓa wani abu mai datti, sa'an nan kuma su taɓa idanunsu, hancinsu, ko bakinsu.
Kwayar cutar za ta iya rayuwa a kan wani abu har tsawon sa'o'i 72.
Yana da mafi m a lokacin da farko kwana uku bayan bayyanar cututtuka, ko watsa zai iya zama yiwu kafin bayyanar cututtuka bayyana da kuma a cikin m matakai na cutar. The misali Hanyar ganewa ne real-lokaci reverse transcription polymerase chain reaction (rRT-PCR) daga nasal folic acid.
Ana ba da shawarar yin amfani da abin rufe fuska ga mutanen da ake zargin sun kamu da cutar da kuma masu kula da su.
Shawarwarin da jama'a ke bayarwa game da amfani da abin rufe fuska ya bambanta, wasu hukumomi suna ba da shawarar kada a yi amfani da su, wasu kuma suna ba da shawarar amfani da su, wasu kuma suna ba da shawarar yin amfani da su.
A halin yanzu, babu wani rigakafin COVID-19 ko kuma takamaiman maganin rigakafin cutar.
An samu karuwar cutar a cikin yawancin ƙasashe a duk yankuna shida na WHO.
Mutanen da suka kamu da kwayar cutar za su iya zama marasa lafiya ko kuma su yi alamun da suka yi kama da mura kamar zazzabi, tari, gajiya da kuma rashin iskar iska.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwo ko matsi na ciwo a cikin kirji, rikicewa, wahalar farkawa da kuma fuska ko kuma baki; neman taimakon likita nan da nan idan waɗannan alamun sun bayyana.
Aƙalla, ana iya samun alamun cututtukan sama na sama kamar yin hancin hanci, hanci mai gudana ko kuma hanci mai laushi.
Alamar gastrointestinal kamar tashin zuciya, amai da zawo an lura a cikin kashi daban -daban.
A wasu lokuta, a kasar Sin, an fara ganin kawai bugun zuciya da kuma bugun kirji.
A wasu lokuta, cutar na iya kara kamuwa da cutar sankara, rashin iya aiki da gaɓaɓuwa da yawa, har ma da mutuwa.
Wannan shi ne lokacin da aka haife mu.
Lokacin ɓarkewar COVID-19 yawanci kwanaki biyar zuwa shida ne, amma yana iya zama daga kwanaki biyu zuwa 14.
Kashi 97.5% na mutanen da suka kamu da cutar suna da alamun cutar a cikin kwanaki 11.5 da kamuwa da cutar. Rahotanni sun nuna cewa ba duk mutanen da suka kamu da cutar ba ne ke da alamun cutar.
Ba a san cikakken rawar da waɗannan masu ɗaukar hoto ke takawa a cikin watsawa ba; duk da haka, farkon shaida ta nuna cewa za su iya ba da gudummawa ga yaduwar cutar.
Ba a san adadin mutanen da ke da cutar ba kuma ana nazarin su, amma KCDC ta ba da rahoton cewa kashi 20 cikin 100 na duk mutanen da aka tabbatar da su ba su da alamun cutar a lokacin da suke asibiti.
Hukumar Kiwon Lafiya ta Kasar Sin ta fara hada al'amuran al'ada a cikin al'amurran yau da kullun a ranar 1 ga Afrilu; 130 (78%) daga cikin kamuwa da cutar 166 a ranar sun kasance marasa alamun a lokacin gwaji.
Dukansu mucous da saliva na iya ɗaukar babban adadin kwayar cutar.
Yin magana da ƙarfi yana fitar da ƙarin ɗigon ruwa fiye da magana da murya mai sauƙi.
Wani bincike a Singapore ya gano cewa tari da ba a rufe ba zai iya sauko da digo mai tsawon mita 4.5 (ƙafa 15).
Kodayake wannan kwayar cutar ba ta cikin iska, National Academy of Science ta ba da rahoton cewa watsawar bio aerosol na iya yiwuwa kuma samfurori daga masu tattara iska a cikin hanyoyin da ke waje da ɗakunan mutane sun ba da tabbacin tabbataccen kwayar cutar RNA.
Wasu hanyoyin magani kamar su shiga cikin jijiyoyin jini da kuma maganin zuciya na zuciya (CPR) na iya haifar da aerosols daga ɓoyewar numfashi kuma ta haka ya haifar da yaduwar iska.
Ko da yake akwai damuwa cewa zai iya yadawa ta hanyar farji, ana daukar wannan a matsayin mai saukin kamuwa. Wannan kwayar cutar tana da saukin kamuwa da cutar yayin da mutane ke nuna alamun; kodayake ana iya yaduwa kafin bayyanar cututtuka, amma wannan ba shi da haɗari.
Cibiyar Kula da Rigakafin Cututtuka ta Turai (ECDC) ta ce ko da yake ba a san yadda cutar ke yaduwa ba, mutum daya yakan kamu da mutum biyu zuwa uku. Cutar tana iya rayuwa a kan wasu wurare daga sa'o'i zuwa kwanaki.
Musamman, an gano kwayar cutar a cikin kwana daya a kan kwali, har zuwa kwana uku a kan roba (polypropylene) da bakin karfe (AISI 304), da kuma awanni hudu a kan 99% na jan ƙarfe.
Duk da haka, yawan zafin jiki da kuma yanayin zafi na iya bambanta.
Sabulu da maganin shafawa suna da tasiri idan aka yi amfani da su yadda ya kamata; kayayyakin sabulu suna kashe su ta hanyar lalata layin kariya mai ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙ ƙoshin ƙoshin ƙ ƙoshin ƙos
Sauran maganin, kamar su benzalkonium chloride da chlorhexidine gluconate (mai kashe kwayoyin cutar tiyata), ba su da tasiri sosai.A cikin binciken Hong Kong, an ɗauki samfuran saliva a matsakaita kwana biyu bayan fara asibiti.
A cikin biyar daga cikin marasa lafiya shida, samfurin farko ya nuna mafi yawan kwayar cutar, kuma mara lafiya na shida ya nuna mafi yawan kwayar cutar a rana ta biyu na gwaji.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka 2 (SARS-CoV-2) wani sabon cututtukan cututtukan cututtuka ne na cututtukan cututtukan cututtukan cututtuka na cututtuka na cututtuka, wanda aka fara warewa daga mutane uku da cutar nimoniya da aka danganta da rukunin cututtukan cututtukan cututtuka na cututtuka a Wuhan.
Dukkanin halayen sabon SARS-CoV-2 ana samun su a cikin coronaviruses masu alaƙa da yanayi.
A waje da jikin mutum, ana kashe kwayar cutar da sabulu na gida, wanda ke karya garkuwar kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Fuka-fukan su ne gabobin da COVID-19 ya fi shafa saboda kwayar cutar ta kai ga ƙwayoyin cuta ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin cuta na huhu na II.
Ƙwayoyin cuta suna amfani da wani glycoprotein na musamman da ake kira "peplomer" don haɗawa da ACE2 da shiga cikin kwayar halitta mai gina jiki.
An gano cewa akwai rauni a cikin zuciya a cikin 12% na mutanen da aka yi wa asibiti a Wuhan, China, kuma wannan ya fi yawa a cikin cututtuka masu tsanani.
Matsanancin cututtukan zuciya na iya zama sanadin cututtukan jiki da cututtukan tsarin garkuwar jiki yayin ci gaban cutar, amma kuma lalacewar myocardial na iya zama sanadiyar ACE2 masu karɓa a cikin zuciya.
ACE2 receptors suna da yawa a cikin zuciya kuma suna da hannu a cikin aikin zuciya.
An gano babban yaduwar thrombosis (31%) da venous thromboembolism (25%) a cikin marasa lafiyar ICU tare da cututtukan COVID-19, wanda zai iya danganta da rashin lafiyar rashin lafiya.Binciken gawa na mutanen da suka mutu daga COVID-19 sun gano lalacewar radiation (DAD) da kuma lymphocyte-carrying exogenous matter a cikin huhu.
Kodayake SARS-COV-2 yana da saiti don ACE2-mai nunawa na ƙwayoyin epithelial na hanyoyin numfashi, marasa lafiya da ke da COVID-19 mai tsanani suna da alamun cututtukan cututtukan cututtukan cututtuka.
Musamman, an nuna cewa kwayoyin T-cell na GM-CSF masu cutarwa suna da alaƙa da zaɓin IL-6 masu cutar ƙwayoyin cuta da cutar huhu mai tsanani a cikin marasa lafiya na COVID-19.
An kuma lura da kwayoyin lymphocytic a cikin binciken gawa.
WHO ta wallafa wasu ka'idojin gwaji da yawa don cutar.
Hanya ta yau da kullun don gwaji shine ainihin lokacin juyawa juyawa polymerase sarkar amsawa (rRT-PCR).
Wannan gwajin ana yinsa ne akan samfurin numfashi da aka samu daga hancin hancin hancin; ko da yake ana iya amfani da samfurin hancin hanci ko hancin hancin.
Sakamakon zai kasance a cikin 'yan sa'o'i zuwa kwana biyu.
Ana iya amfani da gwajin jini, amma yana buƙatar ɗaukar samfuran jini biyu a cikin makonni biyu kuma sakamakon yana da ƙarancin darajar nan da nan.
Masana kimiyya na kasar Sin sun sami damar ware wani nau'in kwayar cutar ta corona da kuma wallafa jerin kwayoyin halittar don haka dakunan gwaje-gwaje a duniya za su iya samar da gwajin polymerase chain reaction (PCR) da kansa don gano cutar ta kwayar.
Har zuwa 4 ga Afrilu 2020, gwaje-gwaje na rigakafin cutar (wanda zai iya gano cutar da ke aiki da kuma ko mutum ya kamu da cutar a baya) yana cikin haɓaka, amma har yanzu ba a yi amfani da shi sosai ba.
Kwarewar Sin da gwaji ya nuna cewa an samu tsarkakewa daga 60 zuwa 70 cikin dari.
A Amurka FDA ta amince da gwajin a kan-wuri a farkon kulawa don amfani a ƙarshen wannan watan a ranar 21 ga Maris, 2020. Ka'idojin gwaji da asibitin Zhongnan na Jami'ar Wuhan ya bayar sun nuna hanyoyin gano kamuwa da cuta dangane da yanayin asibiti da haɗarin annoba.
Abubuwan da ke faruwa a cikin ƙwayar cuta na yau da kullun suna da yawa, ba daidai ba, kuma suna da rarrabawar baya a cikin kamuwa da cuta na farko.
Ci gaban cutar na iya nuna subpleural dominance, crazy paving (ƙarfin bangon da aka yi wa katako tare da canzawar ƙwayoyin cuta), da kuma ƙaruwa.
Dataarancin bayanai da ake samu game da cututtukan fata da cututtukan cututtukan COVID-19.
Muhimman abubuwan da aka gano daga binciken gawa shi ne:
Macroscopy: Ƙonewa a cikin ƙwanƙolin ƙwanƙwasa, pericarditis, ƙwanƙwasa na huhu da kuma ƙwanƙwasa na huhu
Akwai nau'i huɗu na cutar da ake samu daga cutar nimoniya ta ƙwayar cuta:
Mild pneumonia: ƙwayoyin huhu, ƙwayoyin huhu masu yawa, manyan ƙwayoyin huhu marasa kyau, kumburi na ciki tare da lymphocytic interstitial, da kuma ƙwayoyin polymorphic giant.
Cutar cutar huhu mai tsanani: cutar huhu mai tsanani (DAD) tare da zubar da iska mai yawa.
DAD yana haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka (ARDS) da kuma mummunan rashin lafiyar oxygen.
Kula da cutar huhu: kula da leaks a cikin cavities da kuma interpulmonary interpulmonary fibrosis
Jinin: DIC; Leukoarythroplastic reaction
Matakan kariya don rage yiwuwar kamuwa da cuta sun haɗa da zama a gida, guje wa wuraren da jama'a ke da yawa, wanke hannu da sabulu da ruwa akai-akai kuma aƙalla na 20 seconds, kiyaye tsabtataccen numfashi mai kyau da kuma guje wa taɓa idanu, hanci ko baki da hannaye marasa wankewa.
CDC ta ba da shawarar rufe baki da hanci da kayan rufewa idan ana yin tari ko hanci, kuma idan ba a da kayan rufewa, a yi amfani da abin da ke cikin idon sawun.
Ana bada shawara a kiyaye tsaftace hannu bayan an yi tari ko hancin.
CDC ta ba da shawarar yin amfani da abin rufe fuska a wuraren da jama'a ke taruwa don rage yawan kamuwa da cutar daga mutanen da ke da alamun cutar. Dabarun nisantar da jama'a na nufin rage hulda da mutane masu cutar a cikin manyan kungiyoyi ta hanyar rufe makarantu da wuraren aiki, da iyakance tafiye-tafiye da soke manyan tarurrukan jama'a.
Sharuɗɗan nisantar juna sun haɗa da cewa mutane su nisanta aƙalla ƙafa 6 (1.8 m).
Babu wani magani da aka sani da tasiri don hana COVID-19. Tun da ba a sa ran samun allurar rigakafi har zuwa aƙalla 2021, wani muhimmin ɓangare na gudanar da COVID-19 shine ƙoƙarin rage girman annobar, wanda ake kira "rage girman ƙwanƙwasawa".
CDC ta kuma ba da shawarar cewa mutane su riƙa wanke hannayensu da sabulu da ruwa a kai a kai na aƙalla aƙalla sakan 20, musamman bayan sun yi amfani da bayan gida ko kuma idan hannayensu sun yi datti, kafin su ci abinci da kuma bayan sun shaƙe hanci, hancin, ko kuma hancin.
Bugu da ƙari, yana ba da shawarar yin amfani da maganin wanke hannu na giya wanda ke da aƙalla 60% na barasa, amma kawai lokacin da sabulu da ruwa ba sa samuwa. Yankunan da ba sa samun saukin wanke hannu na kasuwanci, WHO ta ba da shawarwari biyu don samar da gida.
A cikin waɗannan hanyoyin, ana samar da maganin antimicrobial daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don taimakawa wajen kawar da kwayoyin cuta a cikin giya; ba "wani abu mai aiki ba don maganin hana haihuwa".
Glycerol an yi amfani da shi a matsayin mai moisturizer.
Ana kula da mutane tare da kulawa mai mahimmanci, wanda zai iya haɗawa da maganin maganin, taimakon oxygen da kuma samar da taimako ga sauran gabobin da suka shafi.
CDC ta ba da shawarar cewa duk wanda ake zargin ya kamu da cutar ya sanya abin rufe fuska.
An yi amfani da extracorporeal membrane oxygenation (ECMO) don magance matsalar rashin numfashi, amma har yanzu ana cikin tunani.
An ba da shawarar tsaftacewar mutum da ingantaccen salon rayuwa da abinci don inganta rigakafi.
Jiyya na taimako na iya zama da amfani ga mutanen da ke da alamun rashin lafiya a farkon lokacin kamuwa da cutar. WHO da Hukumar Lafiya ta China ta buga shawarwari don kula da mutanen da aka kwantar da su a asibiti tare da COVID-19.
Masu binciken cututtuka masu tsanani da masu binciken huhu a Amurka sun tattara shawarwarin magani daga hukumomi daban -daban a cikin wani tushe mai kyauta, IBCC.
Kamar yadda ya kasance a watan Afrilu 2020, babu wani magani na musamman na COVID-19.
Don bayyanar cututtuka, wasu likitoci sun ba da shawarar paracetamol (acetaminophen) maimakon ibuprofen don amfani na farko.
Dole ne a yi taka tsantsan don rage haɗarin yaduwar cutar, musamman a tsarin kiwon lafiya, lokacin da ake gudanar da ayyukan da ke haifar da aerosols kamar shigar da bututun ko aikin hannu.
Ga ma'aikatan kiwon lafiya da ke kula da masu dauke da COVID-19, CDC ta ba da shawarar a sanya mutum a cikin wani dakin keɓewar masu kamuwa da cutar (AIIR) ban da yin amfani da matakan kariya na yau da kullun, matakan kariya na tuntuɓar, da kuma kiyayewa ta iska. CDC ta tsara jagororin amfani da kayan kariya na mutum (PPE) yayin annobar.
Kayan aikin da aka ba da shawarar sune: PPE, kayan aikin numfashi ko abin rufe fuska, kayan kariya na ido, da safar hannu na likita.Idan akwai, ana fifita kayan numfashi (a maimakon abin rufe fuska).
An yarda da masu numfashi na N95 don tsarin masana'antu, amma FDA ta ba da izinin amfani da abin rufe fuska a ƙarƙashin Dokar Amfani da Gaggawa (EUA).
An tsara su ne don karewa daga ƙwayoyin iska kamar ƙura, amma ba a tabbatar da inganci ga takamaiman ƙwayoyin halitta don gwaje - gwaje marasa izini.
Idan ba a da abin rufe fuska, CDC ta ba da shawarar amfani da garkuwar fuska ko, a matsayin makomar ƙarshe, abin rufe fuska da aka yi da gida.
Yawancin shari'o'in COVID-19 ba su da tsanani da za su buƙaci a yi amfani da na'ura ko wasu hanyoyin, amma a cikin ƙananan adadin shari'o'in ana yin hakan.
Ana nazarin nau'ikan taimakon na numfashi ga mutanen da ke fama da rashin numfashi da ke da alaƙa da COVID-19 a cikin asibitoci, tare da wasu shaidu da ke nuna cewa ana iya kauce wa shigar da bututun tare da babban shigarwar hanci ko kuma matsin lamba mai kyau na iska.
Ba a sani ba ko kowanne daga cikin waɗannan abubuwa biyu suna ba da irin wannan fa'ida ga mutanen da ke da mummunar rashin lafiya.
Wasu likitocin sun fi son amfani da shigarwar injin na'ura idan akwai saboda wannan fasaha tana iyakance yaduwar ƙwayoyin aerosol fiye da na shigarwar hanci mai gudana. Babban lamari ya fi yawa a cikin tsofaffi (masu shekaru 60 da sama da shekaru 80).
A cikin ƙasashe da yawa da suka ci gaba, babu isassun gadaje a asibiti, wanda ke iyakance ikon tsarin kiwon lafiya don kula da hauhawar adadin masu cutar COVID-19 da ke sa a yi amfani da asibiti.
Wani bincike a kasar Sin ya gano cewa kashi 5 cikin 100 suna cikin rukunin kulawa mai tsanani, kashi 2.3 cikin 100 suna bukatar taimakon na'ura don yin jinya, kuma kashi 1.4 cikin 100 sun mutu.
A China, kusan kashi 30% na mutanen da aka kwantar da su a asibiti tare da COVID-19 a ƙarshe an shigar da su cikin ICU.
Cutar ta'addanci ta zama mai rikitarwa yayin da COVID-19 ke haɓaka cutar cututtukan numfashi (ARDS) kuma samar da iskar oxygen ya zama da wuya.
Ana buƙatar tsarin kula da matsin lamba da masu saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin sa.
Ƙarin PEEP ba zai iya kasancewa a kan tsofaffin na'urorin ba.
Bincike kan yiwuwar magani ya fara ne a watan Janairun 2020, kuma magungunan antiviral da yawa suna cikin gwajin asibiti.
Remdesivir ya fi kowacce alamar da za a samu.
Ko da yake ana iya samun sabbin magunguna har zuwa 2021, da yawa daga cikin magungunan da ake gwadawa an riga an amince da su don wasu amfani ko kuma suna cikin gwaji mai ci gaba.
Ana iya gwada maganin rigakafin cutar a cikin mutanen da ke da mummunar cuta.
WHO ta ba da shawarar cewa masu sa kai su halarci gwajin inganci da amincin maganin da ake tsammani. FDA ta ba da izinin ba da izinin ba da izinin ba da izinin plasma mai amfani da lafiya a matsayin magani na gwaji a cikin yanayin da rayuwa ta mutum ke cikin haɗari mai tsanani ko gaggawa.
Ba a yi nazarin asibiti da ake bukata don nuna cewa yana da aminci da tasiri ga wannan cuta ba.
A watan Fabrairun 2020, China ta ƙaddamar da wata manhajar wayar hannu don magance barkewar cutar.
Ana tambayar masu amfani da su shigar da sunansu da lambar ID.
Wannan app yana iya gano yiwuwar kamuwa da cuta ta hanyar gano 'abokan hulɗa' ta amfani da bayanan sa ido.
Kowane mai amfani zai iya ganin matsayin wasu masu amfani guda uku.
Idan aka gano yiwuwar kamuwa da cutar, manhajar ba kawai tana ba da shawarar keɓe kai ba, amma kuma tana faɗakar da hukumomin kiwon lafiya na gida. Ana amfani da bayanan wayar salula, fasahar gane fuska, binciken wayar salula da kuma nazarin bayanai na wucin gadi don bin sawun mutanen da suka kamu da cutar da kuma waɗanda suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta baiwa hukumomin tsaro damar bin diddigin bayanan wayar salula na mutanen da ake zargi da dauke da cutar korona.
An dauki wannan matakin ne don aiwatar da killacewa da kuma kare mutanen da suka yi mu'amala da mutanen da suka kamu da cutar.
Bugu da ƙari, a cikin Maris 2020 Deutsche Telekom ta raba bayanan wurin wayar tarho tare da Cibiyar Robert Koch, wata hukumar gwamnatin tarayya ta Jamus don bincike da kuma hana yaduwar cutar.
Rasha ta yi amfani da fasahar gane fuska don gano waɗanda suka keta dokar keɓewa.
Kwamishinan kiwon lafiya na yankin Italiya, Julio Gellero, ya ce masu amfani da wayoyin salula sun sanar da shi cewa "kashi 40% na mutane suna yin wasu motsi".
Gwamnatin Jamus ta shirya hackathon na karshen mako na awa 48 tare da masu halarta sama da 42,000.
Haka kuma, shugaban kasar Estonia, Kirsty Kaljulaid, ya yi kira ga duniya baki daya da ta yi amfani da hanyoyin da za su iya magance yaduwar cutar.
Mutane na iya fuskantar rikici daga keɓewa, ƙuntata balaguro, sakamako masu illa na magani, ko tsoron kamuwa da cutar da kanta.
BBC ta ruwaito Rory O'Connor ya ce, "Rashin zaman lafiya, rashin zaman lafiya, damuwa, damuwa da kuma koma bayan tattalin arziki sun zama hadarin da ke lalata lafiyar mutane da kuma jin dadin rayuwa".
Wannan cuta na iya samun sauƙin ci gaba tare da ko ba tare da alamun da suka yi kama da na wani sanannen cuta na sama ba kamar na sanyi.
Yanayi mai sauki yakan warke cikin makonni biyu, yayin da mai tsanani ko mai tsanani zai iya warkewa cikin makonni uku zuwa shida.
Dangane da bayanai daga wasu kwayoyin cuta irin su SARS da MERS, mata masu juna biyu na iya fuskantar haɗarin kamuwa da cutar COVID-19, amma ba a cikin bayanai game da COVID-19. A wasu mutane, COVID-19 na iya haifar da cutar nimoniya ta hanyar shafar huhu.
A cikin mutanen da abin ya shafa, COVID-19 na iya saurin zama mummunar cutar numfashi (ARDS), wanda zai iya haifar da rashin numfashi, bugun jini ko kuma gazawar gabobin jiki da yawa.
Matsaloli da ke tattare da COVID-19 sun haɗa da rashin lafiya, hawan jini da kuma raunin zuciya, koda da hanta.
An ba da rahoton cututtukan ƙwayar cuta, musamman karuwar lokacin prothrombin, a cikin 6% na mutanen da aka kwantar da su a asibiti tare da COVID-19, yayin da aka lura da aikin koda mara kyau a cikin 4% na wannan rukunin.
Kimanin kashi 20-30 cikin ɗari na mutanen da suka kamu da COVID-19 suna nuna ƙaruwa a cikin ƙwayoyin enzyme na hanta (transaminases).
A cewar wannan rahoton, matsakaicin lokacin tsakanin bayyanar cututtuka da mutuwa ya kasance kwanaki goma, tare da kwana biyar a asibiti.
Koyaya, matsakaicin lokacin tsakanin asibiti da mutuwa ya kasance kwanaki bakwai tsakanin marasa lafiya da aka canza zuwa ICU.
A cikin binciken da aka yi na farkon lamura, matsakaicin lokacin daga nuna alamun farko har zuwa mutuwa ya kasance kwanaki 14, tare da cikakken kewayon kwanaki shida zuwa 41.
A cikin binciken Hukumar Kiwon Lafiya ta Kasa (NHC) ta China, mace-macen maza ya kai 2.8% yayin da mace-macen mata ya kai 1.7%.
Gwajin ƙwaƙwalwar ƙwayar cuta na ƙwayar cuta na ƙwayar cuta na nuna lalacewar ƙwayoyin cuta na ƙwayoyin cuta tare da ƙwayoyin cuta na ƙwayoyin cuta a cikin huhu biyu.
An gano canje -canje na kwayar cutar kwayar cuta a cikin kwayoyin cutar.
Fushin huhu ya yi kama da na ARDS.
A cikin kashi 11.8% na mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito, an lura da lalacewar zuciya ta hanyar matakan troponin ko kuma bugun zuciya.
A cikin watan Maris, Amurka ta ba da rahoton cewa kashi 89 cikin 100 na mutanen da aka kwantar suna da cutar da ta riga ta kasance a cikin asibitoci.
Amma, ƙididdigar mutuwar ta yanayin ya bambanta saboda waɗannan bambance - bambance na yanki da kuma matsalolin da ke tattare da tsarin.
Rashin ƙididdigar ƙananan cututtuka na iya haifar da ƙididdigar mutuwar.
Koyaya, gaskiyar cewa mutuwar ta kasance sakamakon shari'o'in da suka gabata na iya nufin cewa an rage ƙimar mutuwar yanzu.
Masu shan sigari sun fi wadanda ba sa shan sigari saurin kamuwa da COVID-19 sau 1.4 kuma suna iya buƙatar kulawa mai tsanani ko mutuwa.An bayyana damuwa game da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka.
Hukumar asibitocin Hong Kong ta gano cewa wasu mutanen da suka warke daga cutar sun yi rashin karfin huhu da ya kai kashi 20 zuwa 30 cikin dari, kuma binciken huhu ya nuna cewa akwai raunin gawar jiki.
Hakanan zai iya haifar da ciwon bayan kulawa mai tsanani bayan warkewa.
Har zuwa watan Maris na 2020, ba a san ko kamuwa da cutar da ta gabata ta samar da ingantacciyar rigakafi na dogon lokaci a cikin mutanen da suka warke daga cutar ba.
Ana ganin rigakafi a matsayin mai yiwuwa dangane da halayyar sauran coronaviruses, amma an ba da rahoton maganganun da suka gwada tabbatacce ga coronaviruses a kwanan baya bayan murmurewa daga COVID-19.
Wadannan cututtukan ana daukar su ne mafi muni fiye da sake kamuwa da cutar.
An yi imanin cewa cutar ta samo asali ne daga wata kwayar cuta da ke yaduwa ta hanyar kamuwa da cuta daga dabbobi zuwa ga mutane.
Ba a san ainihin asalin cutar ba, amma ya zuwa watan Disamba na 2019 kusan kusan ana yada cutar ne ta hanyar mutum-da-mutum.
A cikin wani binciken da aka buga a cikin The Lancet a cikin Janairu 2020, na farkon shari'o'i 41 na COVID-19 da aka tabbatar, an ba da ranar farko ta bayyanar cututtuka 1 ga Disamba 2019.
Bayanan WHO na nuna cewa an fara samun alamun cutar ne a ranar 8 ga watan Disamba, 2019.
Ana amfani da hanyoyi da yawa don ƙayyade yawan mutuwar.
Waɗannan lambobin suna canzawa ta yanki da lokaci kuma suna shafar yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin da ya wuce daga farkon ɓarkewa da halaye na yawan jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambar cutar ICD-10 ta gaggawa U07.1 don mutuwar da aka tabbatar da cutar SARS-CoV-2 da kuma lambar cutar U07.2 don mutuwar da aka yi daga COVID-19 ba tare da asibiti ko cutar ba.Rashin mutuwa-mataki yana nuna yawan mutuwar da aka raba ta yawan shari'o'in da aka gano a cikin wani lokaci.
Dangane da bayanan Jami'ar Johns Hopkins, a ranar 17 ga Afrilu 2020, adadin mutuwar duniya ya kai kashi 6.9 cikin dari (153,822/2,240,191).
Lambar ta bambanta a yanki. Sauran matakan sun haɗa da yawan mutuwar (CFR), wanda ke nuna yawan mutanen da aka gano da suka mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR) wanda ke nuna yawan mutanen da suka kamu da cutar (wanda aka gano da wanda ba a gano shi ba) da suka mutu daga cutar.
Wadannan kididdigar ba su da lokaci kuma suna bin wani yanki na jama'a daga kamuwa da cutar zuwa warkewa.
Ko da yake ba duk mutanen da suka kamu da cutar ba ne ke da rigakafi, amma kasancewar rigakafi zai iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar barkewar cutar a Italiya, a Castiglione d'Aida, wani ƙauye mai mutane 4,600, 80 (1.7%) sun riga sun mutu.
A Gangelt, cutar ta yadu a cikin karnival da kuma matasa, wanda ya haifar da raguwar mutuwar, kuma ba duk mutuwar COVID-19 za a iya rarraba su a hukumance ba.
Ƙari ga haka, tsarin kiwon lafiya na ƙasar Jamus ba mai tsananin gaske ba ne.
A cikin Netherlands, kimanin kashi 3 cikin 100 na masu bayar da jinin da aka tantance za su iya samun rigakafin.
An tabbatar da mutuwar 69 (0.004% na yawan) daga COVID-19.
Annobar da kuma mutuwar da ta haifar ya bambanta a kan maza da mata.
Nazarin da aka yi a kasar Sin da Italiya ya nuna cewa maza sun fi mutuwa.
Maza suna da haɗari sosai a lokacin da suka kai shekara 50, kuma banbanci tsakanin maza da mata ya ragu ne kawai a lokacin da suka kai shekara 90.
A China, mutuwar maza ya kai kashi 2.8 cikin ɗari kuma na mata ya kai kashi 1.7 cikin ɗari.
Ba a san ainihin dalilin da ya sa ake samun bambancin jinsi ba, amma ana iya danganta shi da hali da kuma halayen 'yan Adam.
Bambancin rigakafi na jinsi, ƙarancin shan sigari a cikin mata da haɓaka yanayin cutar a cikin maza kamar hawan jini a cikin ƙananan shekaru fiye da mata na iya ba da gudummawa ga babban mutuwar maza.
A Turai, kashi 57 cikin ɗari na waɗanda suka kamu da cutar maza ne, kuma kashi 72 cikin ɗari na waɗanda suka mutu daga COVID-19 maza ne.
Har zuwa watan Afrilu na 2020, gwamnatin Amurka ba ta bin diddigin bayanan jinsi na masu kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtukan ƙwayoyin cuta kamar su Ebola, HIV, Influenza, da SARS suna shafar maza da mata daban.
Ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, yawancinsu mata ne, kuma su ne suka fi kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar na hukuma shine "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin Corona, VI na nufin Virus, D na nufin cuta, kuma 19 na nufin shekarar da aka fara gano cutar wato 31 ga Disamba, 2019.
An zaɓi sunan ne don kauce wa nassoshi ga wani takamaiman wuri na ƙasa (kamar China), jinsunan dabbobi ko rukuni na mutane, wanda ya dace da shawarwarin ƙasashen duniya don suna don hana cin mutunci. Kwayar cutar da ke haifar da COVID-19 ana kiranta mai saurin cutar numfashi mai saurin numfashi coronavirus 2 (SARS-CoV-2).
WHO ta kara amfani da "COVID-19 virus" da "virus da ke da alhakin COVID-19" a cikin sadarwa ta jama'a.
Ana kiran cutar da kwayar cutar a matsayin "coronavirus".
A lokacin barkewar farko a Wuhan, China, an kira kwayar cutar da cutar "coronavirus" da "Wuhan coronavirus".
A cikin Janairu 2020, WHO ta ba da shawarar 2019-nCov da 2019-nCoV a matsayin sunayen wucin gadi na cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka, wanda ya dace da ka'idojin 2015 na rashin amfani da wurare a cikin sunayen cututtuka da ƙwayoyin cuta.
An fitar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakokin iya aiki a cikin sarkar samar da kayayyaki, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar su hanci da ɓangarorin ventilators.
A wani misali, lokacin da wani asibitin Italiya ya bukaci bawul din sanyaya numfashi, kuma mai samar da kayan ba zai iya samar da su ba a cikin lokaci, wani kamfani na gida ya sake yin aikin injiniya kuma ya buga bawul 100 da ake bukata cikin dare.
Bayan barkewar cutar COVID-19, makirci, bayanan da ba daidai ba da kuma bayanan karya game da asalin cutar, matakanta, rigakafinta, maganin ta da sauran bangarorin ta sun taso kuma sun yadu da sauri a yanar gizo.
Mutane suna iya watsa ƙwayoyin cuta zuwa wasu dabbobi.
Binciken ya kasa samun shaidar kwayar cutar a aladu, dabbobin daji, da kuma kaji.
Babu wani magani ko allurar rigakafi da aka amince da shi don magance cutar.
Binciken kasa da kasa kan alluran rigakafi da magunguna a cikin COVID-19 ana gudanar da su ta hanyar ƙungiyoyin gwamnati, ƙungiyoyin ilimi da masu binciken masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta ƙaddamar da gwajin "Solidarity Trial" don tantance tasirin maganin magungunan rigakafin cutar guda huɗu da ake da su, waɗanda suke da kyakkyawan fatan samun sakamako mai kyau.
A halin yanzu babu allurar rigakafi, amma hukumomi daban -daban suna ci gaba da haɓaka masu neman allurar rigakafi.
Ana amfani da aikin da ya gabata akan SARS-CoV saboda duka SARS-CoV da SARS-CoV-2 suna amfani da ACE2 mai hanawa don shiga cikin ƙwayoyin mutum.
Ana gwada dabarun rigakafi guda uku.
Da farko dai, burin masu binciken shi ne samar da cikakkiyar maganin cutar.
Manufar amfani da irin wannan kwayar cutar, ko a kashe ko a kashe, shine don samar da saurin rigakafin jikin mutum ga sabon kamuwa da cuta tare da COVID-19.
Wata dabara kuma, wato, subunit vaccine, tana da burin samar da maganin da zai sa rigakafin ya kasance mai saukin kamuwa da wasu kwayoyin cutar.
A game da SARS-CoV-2, irin wannan bincike ya mai da hankali ne kan furotin S-contact wanda ke taimakawa kwayar cutar ta shiga cikin mai karɓar enzyme ACE2.
Wata dabara ta uku ita ce allurar nucleic acid (DNA ko RNA, sabon fasahar samar da allurar).
Dole ne a gwada allurar rigakafin gwaji don aminci da tasiri a kowane ɗayan waɗannan dabarun.A ranar 16 ga Maris, 2020, an fara gwajin gwaji na farko na allurar rigakafi tare da masu aikin sa kai guda huɗu a Seattle.
Allurar rigakafin na dauke da kwayar halittar da ba ta da illa wacce aka kwafa daga kwayar cutar da ke haifar da cutar. An ba da rahoton haɓakar ƙwayoyin cuta a matsayin ƙalubalen da ke gaban ci gaban rigakafin SARS-COV-2, amma yana da rikici.
Akwai gwaji na asibiti sama da 300 da ake gudanarwa a halin yanzu har zuwa watan Afrilun 2020.
Gwaje -gwaje bakwai suna kimanta maganin da aka riga aka amince da shi don cutar zazzabin cizon sauro, gami da karatu huɗu akan hydroxychloroquine ko chloroquine.
Tare da gwaji na Mataki na III na tara a kan remdesivir a kasashe da yawa, wanda aka shirya za a sanar da shi a ƙarshen Afrilu, yawancin binciken na kasar Sin yana kan magungunan rigakafin rigakafin da za a iya amfani da su.
Ya zuwa watan Afrilu na 2020, ana gudanar da nazarin ci gaban asibiti don allurar rigakafin COVID-19 da masu neman magani. Ana tantance magungunan rigakafin cutar da yawa don maganin COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir haɗe tare da interferon beta.
Har zuwa Maris 2020, akwai hujja na gwaji don tasirin Remdesivir.
An lura da ci gaban asibiti a cikin marasa lafiya da aka yi wa magani tare da amfani da ba a yarda da shi ba na remdesivir.
Ana gudanar da gwajin gwaji na asibiti na III a Amurka, China da Italiya.An yi nazarin chloroquine, wanda aka riga aka yi amfani da shi don magance zazzabin cizon sauro, a cikin China a watan Fabrairun 2020 tare da sakamakon farko.
Duk da haka, an yi kira ga nazarin nazarin bincike.
Hukumomin kiwon lafiya na Koriya da na China sun ba da shawarar yin amfani da Chloroquine.
Koyaya, Cibiyar Nazarin Kwayoyin Halittu ta Wuhan ta ba da shawarar a yi amfani da allurai na gram ɗaya a kowace rana, tana mai cewa ninki biyu na wannan adadin yana da haɗari sosai kuma yana iya zama mai haɗari.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa don hydroxychloroquine da chloroquine a kan 'yan likitocin da ke kula da mutanen da ke da COVID-19. jagororin fitowar na 7 na kasar Sin sun hada da interferon, ribavirin ko umifenovir don amfani don kariya daga COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar adadi mai yawa na ribavirin don hana SARS-CoV-2 na artificial.
Nitrizoxanide an bada shawarar don ƙarin karatu a cikin kwayoyin bayan nuna ƙarancin ƙaddamarwa na SARS-CoV-2. Nazarin ya nuna cewa an buƙaci shigar SARS-CoV-2 ta hanyar haɗuwa da ƙwayoyin cuta na farko tare da ACE2 mai ƙarancin ƙwayoyin cuta, ta hanyar transmembrane protease serine 2 (TMPRSS2).
Nazarin na Chloroquine da Hydroxychloroquine tare ko ba tare da azithromycin ba suna da manyan iyakoki, wanda ya hana ƙungiyar likitoci karɓar waɗannan jiyya ba tare da ƙarin karatu ba. Oseltamivir ba ya hana SARS-CoV-2 na kewaye kuma ba shi da sananniyar rawa a cikin maganin COVID-19.
Hawan cytokine na iya zama rikitarwa a cikin matakan baya na COVID-19 mai tsanani.
Akwai shaidar cewa hydroxychloroquine na iya samun halayen anti-cytocaine.Tocilizumab ya shiga cikin jagororin magani ta Hukumar Lafiya ta China bayan kammala wani ƙaramin bincike.
Yana cikin gwaji na bazuwar na 2 a cikin Italiya bayan nuna sakamako mai kyau a cikin mutane masu mummunan cuta.
Idan aka hada da gwajin jini na serum ferritin don gano karuwar cytokine, ana nufin a magance irin wannan karuwar, wanda ake tsammanin shine dalilin mutuwa a cikin wasu mutanen da suka kamu.
Interleukin-6 receptor agonist an amince da FDA a cikin 2017, bisa ga nazarin yanayin da aka yi a baya don magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka na cututtukan cututtukan cututtukan cututtuka na cututtukan cututtuka na cututtuka na cututtukan cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka.
Har zuwa yau, babu wani gwaji da aka yi a kan mutum, da aka yi a kan mutum, da ya nuna cewa tosalizumab yana da tasiri a maganin CRS.
Ana bincika canja wurin tsarkakakkun da kuma karfafawar rigakafin da ke samarwa ta hanyar tsarin garkuwar jikin mutanen da suka warke daga COVID-19 zuwa ga mutanen da suke buƙatar su a matsayin hanyar allurar rigakafin da ba ta dace ba.
An yi amfani da wannan dabarar don SARS tare da sakamako mara kyau.
Cutar kwayar cutar kwayar cuta ita ce hanyar da ake tsammanin maganin rigakafi na iya yin sulhu da kariya daga SARS-CoV-2.
Koyaya, wasu hanyoyin, kamar su kwayar cutar kwayar halitta da ke da nasaba da kwayar cuta da / ko phagocytosis na iya yiwuwa.
Sauran hanyoyin maganin rigakafin rigakafi, misali amfani da magungunan rigakafin monoclonal, suna cikin ci gaba.
Za a iya ƙara samar da maganin da ke ba da lafiyar jiki, wanda ya ƙunshi ruwa daga jinin da aka warke da shi kuma yana da takamaiman rigakafi ga wannan ƙwayar cutar, don saurin tsarawa.
Cutar cutar coronavirus, rukuni na cututtukan da ke da alaƙa da kusanci
Li Wenliang, likita ne a asibitin Wuhan, wanda ya kamu da cutar COVID-19 kuma ya mutu bayan ya wayar da kan jama'a game da yaduwar cutar.
